var title_f18_27_18864="Rheumatoid neutroph dermatitis";
var content_f18_27_18864=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F80854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F80854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rheumatoid neutrophilic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 290px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous papules of rheumatoid neutrophilic dermatitis are symmetrically scattered in this patient with rheumatoid arthritis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Samuel Moschella, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18864=[""].join("\n");
var outline_f18_27_18864=null;
var title_f18_27_18865="Sugammadex: International drug information";
var content_f18_27_18865=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sugammadex: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10149866\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bridion (AU, IS, NZ, NO)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10149867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F10149868\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reversal of neuromuscular blockade induced by rocuronium or vecuronium",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F10150204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &ge;2 to &le;17 years: Routine reversal of rocuronium-induced neuromuscular blockade: 2 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults &ge;18 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Reversal of rocuronium- or vecuronium-induced deep neuromuscular blockade: 4 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Reversal of rocuronium- or vecuronium-induced moderate neuromuscular blockade: 2 mg/kg; may repeat with 4 mg/kg if reoccurrence of blockade occurs",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Immediate reversal of rocuronium-induced neuromuscular blockade: 16 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Wait 24 hours before readministering rocuronium or vecuronium",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;30 to &lt;80 mL/minute: No adjustment required",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute: Use not recommended for dialysis patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Mild-to-moderate impairment: No adjustment required",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Severe impairment: Has not been evaluated",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F10149871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, solution: 100 mg/mL (2 mL, 5 mL)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10537 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.25.216.6-6250843016-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18865=[""].join("\n");
var outline_f18_27_18865=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149866\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149867\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149868\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10150204\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821247\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10149871\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10537\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10537|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_27_18866="Classic Kaposi sarcoma - papules and plaques";
var content_f18_27_18866=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F69584&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F69584&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classic Kaposi sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple violaceous papules and plaques are present on the distal upper extremity of this patient with classic Kaposi sarcoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18866=[""].join("\n");
var outline_f18_27_18866=null;
var title_f18_27_18867="Chronic PV thrombosis MRI";
var content_f18_27_18867=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F61314&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F61314&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic portal vein thrombosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flow-sensitive coronal MR image through the liver of a 45-year-old man with cirrhosis demonstrates a linear filling defect in the main portal vein (arrow) representing a nonocclusive thrombus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18867=[""].join("\n");
var outline_f18_27_18867=null;
var title_f18_27_18868="Prevention and treatment of viral gastroenteritis in adults";
var content_f18_27_18868=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prevention and treatment of viral gastroenteritis in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/27/18868/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/27/18868/contributors\">",
"     Neil R Blacklow, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/27/18868/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/27/18868/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/27/18868/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/27/18868/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/27/18868/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral gastroenteritis is currently recognized to be caused by four agents: rotavirus, norovirus, enteric adenovirus, and astrovirus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/10/6313?source=see_link\">",
"     \"Epidemiology of viral gastroenteritis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The majority of the information available on the prevention and treatment of viral gastroenteritis is derived from studies of norovirus and rotavirus, the two viruses that are the medically most important causes of this syndrome. Consequently, most of the discussion that follows is directed at these two agents. However, the general infection control measures that are described below should also be considered applicable for all cases of viral gastroenteritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measures designed to prevent viral gastroenteritis fall into two general categories: infection",
"    <span class=\"nowrap\">",
"     control/viral",
"    </span>",
"    inactivation and vaccine development.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42789?source=see_link\">",
"     Rotavirus vaccine",
"    </a>",
"    is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40937?source=see_link\">",
"     \"Rotavirus vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Infection control measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate infection control measures partially depend on the epidemiologic setting in which viral gastroenteritis is taking place. For disease outbreaks occurring in health care and long-term care facilities (typically caused by norovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]), standard enteric precaution measures should involve careful handwashing and use of barriers, such as wearing gloves. A meta-analysis, not limited to viral gastroenteritis, suggested that handwashing with soap reduces diarrheal risk by 47 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/4\">",
"     4",
"    </a>",
"    ]. A similar reduction in diarrheal risk with handwashing with soap was noted in a large randomized controlled trial of childhood diarrhea in Pakistan that was published after the meta-analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/5\">",
"     5",
"    </a>",
"    ]. School absenteeism due to norovirus infection may be reduced by use of alcohol-based hand sanitizers and daily disinfection of classroom surfaces with quaternary ammonium wipes; this is superior to soap handwashing and routine cleaning procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9912?source=see_link&amp;anchor=H3#H3\">",
"     \"Prevention and treatment of viral gastroenteritis in children\", section on 'General measures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cohorting of patients may become necessary in outbreaks that are slow to control. Similar measures should be employed in acute care hospitals for adults [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/2\">",
"     2",
"    </a>",
"    ]. For outbreaks in pediatric hospitals or day care centers (typically caused by rotavirus [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]), appropriate handling of diapers, use of double diapers, and proper disposal of feces are also necessary.",
"   </p>",
"   <p>",
"    In outbreaks related to contamination of an identified source such as water or food, implementation of public health measures should directed at identified sources [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/1,9,10\">",
"     1,9,10",
"    </a>",
"    ]. Most foodborne cases of gastroenteritis in the United States are due to norovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/10\">",
"     10",
"    </a>",
"    ]; contamination of food occurs either at the source environmentally (eg, oysters or raspberries) or by food handlers [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/11\">",
"     11",
"    </a>",
"    ]. Recurring norovirus outbreaks on cruise ships have presented difficult problems in infection control requiring isolation of ill crew members (and passengers, if possible) and disinfection of ships with chlorine solutions, phenol-based compounds, or accelerated",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    products [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/2,12\">",
"     2,12",
"    </a>",
"    ]. Norovirus is a very stable agent that easily persists in the environment and is notoriously difficult to eradicate; it persists after treatment with chlorine solutions that are well beyond concentrations present in public water systems [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/13\">",
"     13",
"    </a>",
"    ]. Norovirus is the most infectious of viral pathogens, with a median infectious dose of only 18 viruses, which further compounds problems for eradication [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/14\">",
"     14",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Vaccine development",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Rotavirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;A vaccine against rotavirus has been developed. This topic is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40937?source=see_link\">",
"     \"Rotavirus vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Norovirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;No effective norovirus vaccine is available for clinical use, but results from an efficacy trial appear promising [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/15\">",
"     15",
"    </a>",
"    ]. The study included 98 healthy adults aged 18 to 50 with functional fucosyltransferase 2 gene (required for the susceptibility to infection with the prototype norovirus, Norwalk virus). Participants were given two intranasal doses of vaccine or placebo three weeks apart and then challenged orally with a norovirus homologous to that in the vaccine. The proportion of individuals who experienced acute Norwalk virus gastroenteritis was significantly lower in the vaccine group than in the placebo group (37 versus 69 percent; p = 0.006), as was the proportion infected with the virus (61 versus 82 percent; p = 0.05). Among those who became infected, the vaccine delayed the onset of illness and reduced overall disease severity. No serious adverse events were associated with the experimental vaccine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary treatment for viral gastroenteritis is fluid replacement. No specific antiviral agents are available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Oral rehydration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients can be easily managed with commercially available oral rehydration solutions that contain glucose or sucrose and electrolytes (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/17/32025?source=see_link\">",
"     \"Approach to the adult with acute diarrhea in developed countries\"",
"    </a>",
"    ). Fluids and electrolytes should be administered parenterally if there is severe dehydration, which is typically seen in infants, older adults, or in those who are debilitated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Medications for symptomatic treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluid replacement is paramount in the treatment of viral gastroenteritis. Oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     bismuth",
"    </a>",
"    subsalicylate can reduce the severity and duration of abdominal cramping caused by norovirus, but the drug does not affect the number, weight, and water content of stools or the amount of virus excreted [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18868/abstract/16\">",
"     16",
"    </a>",
"    ]. The efficacy and safety of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"     loperamide",
"    </a>",
"    is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/3/9267?source=see_link\">",
"       \"Patient information: Viral gastroenteritis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H190975204\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Viral gastroenteritis is recognized to be caused by four agents: rotavirus, norovirus, enteric adenovirus, and astrovirus. The majority of the information available on the prevention and treatment of viral gastroenteritis is derived from studies of norovirus and rotavirus, the two viruses that are the most important causes of this syndrome. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Appropriate infection control measures partially depend on the epidemiologic setting in which viral gastroenteritis is taking place:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For disease outbreaks occurring in healthcare and long-term care facilities (typically caused by norovirus), standard enteric precaution measures should involve careful handwashing and use of barriers, such as wearing gloves.",
"     </li>",
"     <li>",
"      Cohorting of patients may become necessary in outbreaks that are slow to control. Similar measures should be employed in acute care hospitals for adults.",
"     </li>",
"     <li>",
"      For outbreaks in pediatric hospitals or day care centers (typically caused by rotavirus), appropriate handling of diapers, use of double diapers, and proper disposal of feces are also necessary.",
"     </li>",
"     <li>",
"      In outbreaks related to contamination of an identified source such as water or food, implementation of public health measures should directed at the source. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Infection control measures'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A vaccine against rotavirus has been developed. This topic is discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40937?source=see_link\">",
"       \"Rotavirus vaccines\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with viral gastroenteritis should be treated symptomatically; the mainstay of therapy is replacement of fluid and electrolyte losses. Oral rehydration therapy is effective. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No antiviral agents are available for the treatment of viral gastroenteritis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/1\">",
"      Fankhauser RL, Monroe SS, Noel JS, et al. Epidemiologic and molecular trends of \"Norwalk-like viruses\" associated with outbreaks of gastroenteritis in the United States. J Infect Dis 2002; 186:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/2\">",
"      Centers for Disease Control and Prevention (CDC). Norovirus activity--United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2007; 56:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/3\">",
"      Said MA, Perl TM, Sears CL. Healthcare epidemiology: gastrointestinal flu: norovirus in health care and long-term care facilities. Clin Infect Dis 2008; 47:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/4\">",
"      Curtis V, Cairncross S. Effect of washing hands with soap on diarrhoea risk in the community: a systematic review. Lancet Infect Dis 2003; 3:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/5\">",
"      Luby SP, Agboatwalla M, Painter J, et al. Effect of intensive handwashing promotion on childhood diarrhea in high-risk communities in Pakistan: a randomized controlled trial. JAMA 2004; 291:2547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/6\">",
"      Sandora TJ, Shih MC, Goldmann DA. Reducing absenteeism from gastrointestinal and respiratory illness in elementary school students: a randomized, controlled trial of an infection-control intervention. Pediatrics 2008; 121:e1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/7\">",
"      Blacklow NR, Greenberg HB. Viral gastroenteritis. N Engl J Med 1991; 325:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/8\">",
"      Cunliffe NA, Booth JA, Elliot C, et al. Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom. Emerg Infect Dis 2010; 16:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/9\">",
"      Bresee JS, Widdowson MA, Monroe SS, Glass RI. Foodborne viral gastroenteritis: challenges and opportunities. Clin Infect Dis 2002; 35:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/10\">",
"      Centers for Disease Control and Prevention (CDC). Multisite outbreak of norovirus associated with a franchise restaurant--Kent County, Michigan, May 2005. MMWR Morb Mortal Wkly Rep 2006; 55:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/11\">",
"      Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med 2009; 361:1776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/12\">",
"      Centers for Disease Control and Prevention (CDC). Outbreaks of gastroenteritis associated with noroviruses on cruise ships--United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/13\">",
"      Parashar U, Quiroz ES, Mounts AW, et al. \"Norwalk-like viruses\". Public health consequences and outbreak management. MMWR Recomm Rep 2001; 50:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/14\">",
"      Moe CL. Preventing norovirus transmission: how should we handle food handlers? Clin Infect Dis 2009; 48:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/15\">",
"      Atmar RL, Bernstein DI, Harro CD, et al. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 2011; 365:2178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18868/abstract/16\">",
"      Steinhoff MC, Douglas RG Jr, Greenberg HB, Callahan DR. Bismuth subsalicylate therapy of viral gastroenteritis. Gastroenterology 1980; 78:1495.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2686 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.247-661AF214C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18868=[""].join("\n");
var outline_f18_27_18868=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H190975204\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Infection control measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Vaccine development",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Rotavirus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Norovirus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Oral rehydration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Medications for symptomatic treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H190975204\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/17/32025?source=related_link\">",
"      Approach to the adult with acute diarrhea in developed countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/10/6313?source=related_link\">",
"      Epidemiology of viral gastroenteritis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/3/9267?source=related_link\">",
"      Patient information: Viral gastroenteritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9912?source=related_link\">",
"      Prevention and treatment of viral gastroenteritis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40937?source=related_link\">",
"      Rotavirus vaccines",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_27_18869="MRI lateral disc L5";
var content_f18_27_18869=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F81881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F81881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lumbar spine MRI showing a lateral disc extrusion impinging the L5 nerve root",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Sagittal T1-weighted MRI shows a disc extrusion (white arrow) at the L4-5 disc level. B) Axial T2-weighted image at the L4-5 disc level shows the disc extrusion to be left paracentral in location (white arrow), obliterating the left lateral recess where the descending L5 nerve root would be expected. Note the normal appearing right descending L5 nerve root within the contralateral lateral recess just prior to its exit from the thecal sac (white arrowhead).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Eric D Schwartz, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18869=[""].join("\n");
var outline_f18_27_18869=null;
var title_f18_27_18870="Airway stenosis tomogram";
var content_f18_27_18870=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F62310%7EPULM%2F70207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F62310%7EPULM%2F70207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Airway stenosis tomogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 316px; height: 210px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Two tomographic images demonstrate focal tracheal stenosis (red arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Focal tracheal stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 302px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shaded surface display reconstruction of a high resolution chest computed tomographic data set reveals a focal area of tracheal stenosis (red arrows) just above the thoracic inlet.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18870=[""].join("\n");
var outline_f18_27_18870=null;
var title_f18_27_18871="Amphotericin B lipid complex: Drug information";
var content_f18_27_18871=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Amphotericin B lipid complex: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?31/21/32084?source=see_link\">",
"    see \"Amphotericin B lipid complex: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/41/42646?source=see_link\">",
"    see \"Amphotericin B lipid complex: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F134818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Abelcet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F134819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Abelcet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F134840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifungal Agent, Parenteral",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F134822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note: Premedication:",
"     </b>",
"     For patients who experience infusion-related immediate reactions, premedicate with the following drugs 30-60 minutes prior to drug administration: A nonsteroidal anti-inflammatory agent &plusmn; diphenhydramine",
"     <b>",
"      or",
"     </b>",
"     acetaminophen with diphenhydramine",
"     <b>",
"      or",
"     </b>",
"     hydrocortisone. If the patient experiences rigors during the infusion, meperidine may be administered.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Usual dose:",
"     </b>",
"     I.V.: 5 mg/kg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Manufacturer&rsquo;s labeling: Invasive fungal infections",
"     </b>",
"     (when patients are intolerant or refractory to conventional amphotericin B): I.V.: 5 mg/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Indication-specific dosing:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Aspergillosis, invasive (HIV positive or HIV negative patients) (alternative to preferred therapy):",
"     </b>",
"     I.V.: 5 mg/kg/day; duration of treatment in HIV-negative patients depends on site of infection, extent of disease and level of immunosuppression; in HIV-positive patients, treat until CD4 count &gt;200 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     and evidence of clinical response (CDC [adults], 2009; Walsh, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Blastomycosis, moderately-severe-to-severe (unlabeled dose):",
"     </b>",
"     I.V.: 3-5 mg/kg/day for 1-2 weeks or until improvement, followed by oral itraconazole (Chapman, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Candidiasis (unlabeled dose):",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Chronic disseminated candidiasis, pericarditis or myocarditis due to Candida, suppurative thrombophlebitis:",
"     </i>",
"     3-5 mg/kg/day.",
"     <b>",
"      Note:",
"     </b>",
"     In chronic disseminated candidiasis, transition to fluconazole after several weeks in stable patients is preferred (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      CNS candidiasis:",
"     </i>",
"     3-5 mg/kg/day (with or without flucytosine) for several weeks, followed by fluconazole (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Endocarditis due to Candida, infected pacemaker, ICD, or VAD:",
"     </i>",
"     3-5 mg/kg/day (with or without flucytosine); continue to treat for 4-6 weeks after device removal unless device cannot be removed then chronic suppression with fluconazole is recommended (Pappas, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Coccidioidomycosis (unlabeled dose):",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Progressive, disseminated: (alternative to preferred therapy):",
"     </i>",
"     2-5 mg/kg/day (Galgiani, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      HIV-positive patients with severe, nonmeningeal infection:",
"     </i>",
"     4-6 mg/kg/day until clinical improvement, then switch to fluconazole or itraconazole (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cryptococcosis:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Cryptococcal meningoencephalitis in HIV-positive patients (as an alternative to conventional amphotericin B in patients with renal concerns):",
"     </i>",
"     Induction therapy: 4-6 mg/kg/day (unlabeled dose; CDC [adult], 2009) or 5 mg/kg/day (Perfect, 2010) with flucytosine for at least 2 weeks, followed by oral fluconazole.",
"     <b>",
"      Note:",
"     </b>",
"     If flucytosine is not given due to intolerance, duration of amphotericin B lipid complex therapy should be 4-6 weeks (Perfect, 2010).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Cryptococcal meningoencephalitis in HIV-negative patients and nontransplant patients (as an alternative to conventional amphotericin B):",
"     </i>",
"     Induction therapy: 5 mg/kg/day (with flucytosine if possible) for &ge;4 weeks followed by oral fluconazole.",
"     <b>",
"      Note:",
"     </b>",
"     If flucytosine is not given or treatment is interrupted, consider prolonging induction therapy for an additional 2 weeks (Perfect, 2010).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Cryptococcal meningoencephalitis in transplant recipients:",
"     </i>",
"     Induction therapy: 5 mg/kg/day (with flucytosine) for at least 2 weeks, followed by oral fluconazole",
"     <b>",
"      Note:",
"     </b>",
"     If flucytosine is not given, duration of amphotericin B lipid complex therapy should be 4-6 weeks (Perfect, 2010).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Nonmeningeal cryptococcosis:",
"     </i>",
"     Induction therapy: 5 mg/kg/day (with flucytosine if possible) for &ge;4 weeks may be used for severe pulmonary cryptococcosis or for cryptococcemia with evidence of high fungal burden, followed by oral fluconazole.",
"     <b>",
"      Note:",
"     </b>",
"     If flucytosine is not given or treatment is interrupted, consider prolonging induction therapy for an additional 2 weeks  (Perfect, 2010).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Histoplasmosis:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Acute pulmonary (moderately-severe-to-severe):",
"     </i>",
"     5 mg/kg/day for 1-2 weeks, followed by oral itraconazole (Wheat, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Progressive disseminated (alternative to preferred therapy):",
"     </i>",
"     5 mg/kg/day for 1-2 weeks, followed by oral itraconazole (Wheat, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Sporotrichosis (unlabeled dose):",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Meningeal:",
"     </i>",
"     5 mg/kg/day for 4-6 weeks, followed by oral itraconazole (Kauffman, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Pulmonary, osteoarticular, and disseminated:",
"     </i>",
"     3-5 mg/kg/day, followed by oral itraconazole after a favorable response is seen with amphotericin initial therapy  (Kauffman, 2007)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F134834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/41/42646?source=see_link\">",
"      see \"Amphotericin B lipid complex: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Premedication: For patients who experience infusion-related immediate reactions, premedicate with the following drugs 30-60 minutes prior to drug administration: A nonsteroidal anti-inflammatory agent &plusmn; diphenhydramine",
"     <b>",
"      or",
"     </b>",
"     acetaminophen with diphenhydramine",
"     <b>",
"      or",
"     </b>",
"     hydrocortisone. If the patient experiences rigors during the infusion, meperidine may be administered.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Usual dose:",
"     </b>",
"     5 mg/kg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Manufacturer&rsquo;s labeling: Invasive fungal infections",
"     </b>",
"     (when patients are intolerant or refractory to conventional amphotericin B): Children: I.V.: 5 mg/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Indication-specific dosing:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Aspergillosis (HIV-positive patients) (alternative to preferred therapy):",
"     </b>",
"     Infants and Children: I.V.: 5 mg/kg/day for &ge;12 weeks (CDC, [pediatric], 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Candidiasis, invasive (HIV-positive patients) (alternative to preferred therapy):",
"     </b>",
"     Infants and Children: I.V.:5 mg/kg/day; treatment duration based on clinical response, treat until 2-3 weeks after last positive blood culture (CDC [pediatric], 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Cryptococcus neoformans",
"      </i>",
"      , disseminated disease (non-CNS disease) (HIV-positive patients):",
"     </b>",
"     Infants and Children: I.V.:5 mg/kg/day (with or without flucytosine); treatment duration of non-CNS disease varies by clinical response and site/severity of infection (CDC [pediatric], 2009)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F134823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F134824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Manufacturer&rsquo;s recommendations:",
"     </i>",
"     No dosage adjustment provided in manufacturer's labeling (has not been studied).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Alternate recommendations (Aronoff, 2007):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intermittent hemodialysis: No supplemental dosage necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Peritoneal dialysis: No supplemental dosage necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT): No supplemental dosage necessary.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F14478090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling (has not been studied).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F134799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, suspension [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Abelcet&reg;: 5 mg/mL (20 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F134785\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F134802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For patients who experience nonanaphylactic infusion-related reactions, premedicate 30-60 minutes prior to drug administration with a nonsteroidal anti-inflammatory agent &plusmn; diphenhydramine",
"     <b>",
"      or",
"     </b>",
"     acetaminophen with diphenhydramine",
"     <b>",
"      or",
"     </b>",
"     hydrocortisone. If the patient experiences rigors during the infusion, meperidine may be administered.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Administer at an infusion rate of 2.5 mg/kg/hour (eg, over 2 hours for 5 mg/kg). Invert infusion container several times prior to administration and every 2 hours during infusion if it exceeds 2 hours.",
"     <b>",
"      Do not use an in-line filter during administration.",
"     </b>",
"     Flush line with dextrose; normal saline may cause precipitate.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F134846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W;",
"     <b>",
"      incompatible",
"     </b>",
"     with NS or other electrolyte solutions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Anidulafungin, telavancin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Caspofungin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Doripenem, tigecycline.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F134801\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of invasive fungal infection in patients who are refractory to or intolerant of conventional amphotericin B (amphotericin B deoxycholate) therapy",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F134847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Lipid-based amphotericin formulations (Abelcet&reg;) may be confused with conventional formulations (Fungizone&reg;) or with other lipid-based amphotericin formulations (amphotericin B liposomal [AmBisome&reg;]; amphotericin B cholesteryl sulfate complex [Amphotec&reg;])",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Large overdoses have occurred when conventional formulations were dispensed inadvertently for lipid-based products. Single daily doses of conventional amphotericin formulation never exceed 1.5 mg/kg.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F134838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nephrotoxicity and infusion-related hyperpyrexia, rigor, and chilling are reduced relative to amphotericin deoxycholate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Chills (18%), fever (14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Serum creatinine increased (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Multiple organ failure (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension (8%), cardiac arrest (6%), hypertension (5%), chest pain (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (6%), pain (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypokalemia (5%), bilirubinemia (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (9%), vomiting (8%), diarrhea (6%), gastrointestinal hemorrhage (4%), abdominal pain (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Thrombocytopenia (5%), anemia (4%), leukopenia (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Renal failure (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Respiratory failure (8%), dyspnea (6%), respiratory disorder (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Sepsis (7%), infection (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Allergic reactions, anaphylactoid reactions, anuria, arrhythmias, asthma, blood dyscrasias, bronchospasm, BUN increased, cardiomyopathy, cerebral vascular accident, cholangitis, cholecystitis, coagulation abnormalities, deafness, dysuria, encephalopathy, eosinophilia, erythema multiforme, exfoliative dermatitis, extrapyramidal syndrome, hearing loss, hemoptysis, hepatic failure (acute), hepatitis, hepatomegaly, hepatotoxicity, hyper-/hypocalcemia, hyperkalemia, hypomagnesemia, injection site reaction, jaundice, leukocytosis, MI, myasthenia, oliguria, peripheral neuropathy, pleural effusion, pulmonary edema, pulmonary embolism, renal function decreased, renal tubular acidosis, seizures, shock, tachycardia, thrombophlebitis, transaminases increased, veno-occlusive liver disease, ventricular fibrillation, vertigo (transient), visual impairment",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F134805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to amphotericin or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F134789\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylaxis: Has been reported with amphotericin B-containing drugs; facilities for cardiopulmonary resuscitation should be available during administration due to the possibility of anaphylactic reaction. If severe respiratory distress occurs, the infusion should be immediately discontinued; during the initial dosing, the drug should be administered under close clinical observation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infusion reactions: Acute reactions (including fever and chills) may occur 1-2 hours after starting an intravenous infusion. These reactions are usually more common with the first few doses and generally diminish with subsequent doses. Infusion has been rarely associated with hypotension, bronchospasm, arrhythmias, and shock.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Antineoplastics: Concurrent use with antineoplastic agents may enhance the potential for renal toxicity, bronchospasm or hypotension; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Nephrotoxic drugs: Concurrent use of amphotericin B with other nephrotoxic drugs may enhance the potential for drug-induced renal toxicity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Leukocyte transfusions: Acute pulmonary toxicity has been reported in patients receiving leukocyte transfusions and amphotericin B; amphotericin B lipid complex and concurrent leukocyte transfusions are not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F134793\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Amphotericin B may enhance the nephrotoxic effect of Aminoglycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): May diminish the therapeutic effect of Amphotericin B.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colistimethate: Amphotericin B may enhance the nephrotoxic effect of Colistimethate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Orally Inhaled): May enhance the hypokalemic effect of Amphotericin B.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the hypokalemic effect of Amphotericin B.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Amphotericin B may enhance the nephrotoxic effect of CycloSPORINE (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Flucytosine: Amphotericin B may enhance the adverse/toxic effect of Flucytosine. This may be related to the adverse effects of amphotericin B on renal function.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gallium Nitrate: Amphotericin B may enhance the nephrotoxic effect of Gallium Nitrate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saccharomyces boulardii: Antifungal Agents may diminish the therapeutic effect of Saccharomyces boulardii.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F134795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13314059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Amphotericin crosses the placenta and enters the fetal circulation. Amphotericin B is recommended for the treatment of serious, systemic fungal diseases in pregnant women, refer to current guidelines (King, 1998).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F134830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F134808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if amphotericin is excreted into breast milk. Due to its poor oral absorption, systemic exposure to the nursing infant is expected to be decreased; however, because of the potential for toxicity, breast-feeding is not recommended (Mactal-Haaf, 2001).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F14477892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     If on parenteral nutrition, may need to adjust the amount of lipid infused. The lipid portion of amphotericin B (lipid complex) formulation contains 0.045 kcal per 5 mg (Sacks, 1997).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Abelcet Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg/mL (20 mL): $240.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F134797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     BUN and serum creatinine levels should be determined every other day while therapy is increased and at least weekly thereafter. Renal function (monitor frequently during therapy), electrolytes (especially potassium and magnesium), liver function tests, temperature, PT/PTT, CBC; monitor input and output; monitor for signs of hypokalemia (muscle weakness, cramping, drowsiness, ECG changes, etc)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Abelcet (AR, AT, AU, BE, BR, CZ, DK, FI, FR, GB, GR, HN, IE, IT, NL, NO, NZ, SE, SG, TR);",
"     </li>",
"     <li>",
"      Ambisome (AU, FR, HK, IL, KP, NZ);",
"     </li>",
"     <li>",
"      Ampholip (IN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F134788\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Binds to ergosterol altering cell membrane permeability in susceptible fungi and causing leakage of cell components with subsequent cell death. Proposed mechanism suggests that amphotericin causes an oxidation-dependent stimulation of macrophages.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F134804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Exhibits nonlinear kinetics; volume of distribution and clearance from blood increases with increasing dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Increases with higher doses (likely reflects increased uptake by tissues); 131 L/kg with 5 mg/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 173 hours following multiple doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: 0.9% of dose excreted in urine over 24 hours; effects of hepatic and renal impairment on drug disposition are unknown",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dialysis: Amphotericin B (lipid complex) is not hemodialyzable",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 97, 169.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention, &ldquo;Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2009, 58(RR-11):1-166. Available at",
"      <a href=\"file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf\" target=\"_blank\">",
"       file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/19730409/pubmed\" id=\"19730409\" target=\"_blank\">",
"        19730409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention, &ldquo;Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2009, 58(4):1-207.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/19357635/pubmed\" id=\"19357635\" target=\"_blank\">",
"        19357635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chapman SW, Dismukes WE, Proia LA, et al, \"Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2008, 46(12):1801-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/18462107/pubmed\" id=\"18462107\" target=\"_blank\">",
"        18462107",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      De Marie S, &ldquo;Clinical Use of Liposomal and Lipid-Complexed Amphotericin B,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 1994, 33(5):907-16.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/8089064/pubmed\" id=\"8089064\" target=\"_blank\">",
"        8089064",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Edwards JE Jr, Bodey GP, Bowden RA, et al, &ldquo;International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 1997, 25(1):43-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/9243032/pubmed\" id=\"9243032\" target=\"_blank\">",
"        9243032",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Galgiani JN, Ampel NM, Blair JE, et al, \"Coccidioidomycosis,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(9):1217-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/16206093/pubmed\" id=\"16206093\" target=\"_blank\">",
"        16206093",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gould FK, Denning DW, Elliott TS, et al, &ldquo;Guidelines for the Diagnosis and Antibiotic Treatment of Endocarditis in Adults:  A Report of the Working Party of the British Society for Antimicrobial Chemotherapy,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 2012, 67(2):269-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/22086858/pubmed\" id=\"22086858\" target=\"_blank\">",
"        22086858",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hiemenz JW and Walsh TJ, &ldquo;Lipid Formulations of Amphotericin B: Recent Progress and Future Directions,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 1996, 22(Suppl 2):133-44.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/8824978/pubmed\" id=\"8824978\" target=\"_blank\">",
"        8824978",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hooshmand-Rad R, Chu A, Gotz V, et al, \"Use of Amphotericin B Lipid Complex in Elderly Patients,\"",
"      <i>",
"       J Infect",
"      </i>",
"      , 2005, 50(4):277-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/15845425 /pubmed\" id=\"15845425 \" target=\"_blank\">",
"        15845425",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kauffman CA, Bustamante B, Chapman SW, et al, \"Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2007, 45(10):1255-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/17968818/pubmed\" id=\"17968818\" target=\"_blank\">",
"        17968818",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      King CT, Rogers PD, Cleary JD, et al, \"Antifungal Therapy During Pregnancy,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 1998, 27(5):1151-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/9827262/pubmed\" id=\"9827262\" target=\"_blank\">",
"        9827262",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kline S, Larsen TA, Fieber L, et al, &ldquo;Limited Toxicity of Prolonged Therapy With High Doses of Amphotericin B Lipid Complex,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 1995, 21(5):1154-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/8589135/pubmed\" id=\"8589135\" target=\"_blank\">",
"        8589135",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mactal-Haaf C, Hoffman M, and Kuchta A, \"Use of Anti-infective Agents During Lactation, Part 3: Antivirals, Antifungals, and Urinary Antiseptics,\"",
"      <i>",
"       J Hum Lact",
"      </i>",
"      , 2001, 17(2):160-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/11847833/pubmed\" id=\"11847833\" target=\"_blank\">",
"        11847833",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mora-Duarte J, Betts R, Rotstein C, et al, &ldquo;Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2002, 347(25):2020-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/12490683/pubmed\" id=\"12490683\" target=\"_blank\">",
"        12490683",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pappas PG, Kauffman CA, Andes D, et al, \"Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2009, 48(5):503-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/19191635/pubmed\" id=\"19191635\" target=\"_blank\">",
"        19191635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perfect JR, Dismukes WE, Dromer F, et al, \"Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2010, 50(3):291-322.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/20047480/pubmed\" id=\"20047480\" target=\"_blank\">",
"        20047480",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rapp RP, Gubbins PO, and Evans ME, &ldquo;Amphotericin B Lipid Complex,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1997, 31(10):1174-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/9337444/pubmed\" id=\"9337444\" target=\"_blank\">",
"        9337444",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rex JH, Pappas PG, Karchmer AW, et al, &ldquo;A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole Plus Placebo Versus Fluconazole Plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2003, 36(10):1221-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/12746765/pubmed\" id=\"12746765\" target=\"_blank\">",
"        12746765",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sacks GS and Cleary JD, &ldquo;Nutritional Impact of Lipid-Associated Amphotericin B Formulations,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1997, 31(1):121-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/8997484/pubmed\" id=\"8997484\" target=\"_blank\">",
"        8997484",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Slain D, &ldquo;Lipid-Based Amphotericin B for the Treatment of Fungal Infections,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1999, 19(3):306-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/10221369/pubmed\" id=\"10221369\" target=\"_blank\">",
"        10221369",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Walsh TJ, Anaissie EJ, Denning DW, et al, &ldquo;Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2008, 46(3):327-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/18177225/pubmed\" id=\"18177225\" target=\"_blank\">",
"        18177225",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wheat LJ, Freifeld AG, Kleiman MB, et al, \"Clinical Practice Guidelines for the Management of Patients With Histoplasmosis: 2007 Update by the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2007, 45(7):807-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/27/18871/abstract-text/17806045/pubmed\" id=\"17806045\" target=\"_blank\">",
"        17806045",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8724 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-B28792CD2A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18871=[""].join("\n");
var outline_f18_27_18871=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134818\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134819\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134840\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134822\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134834\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134823\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134824\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478090\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134799\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134785\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134802\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134846\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134801\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134847\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134838\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134805\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134789\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298745\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134793\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134795\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13314059\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134830\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134808\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14477892\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322988\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134797\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038525\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134788\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134804\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8724\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8724|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?31/21/32084?source=related_link\">",
"      Amphotericin B lipid complex: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/41/42646?source=related_link\">",
"      Amphotericin B lipid complex: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_27_18872="PUPPP abd thighs";
var content_f18_27_18872=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F56116%7EDERM%2F75861&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F56116%7EDERM%2F75861&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    PUPPP",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 479px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous plaques are present in areas of striae in this woman with PUPPP. This disorder is also&nbsp;called polymorphous eruption of pregnancy (PEP).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    PUPPP",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 344px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFYAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDokXI4DM3XmkNn5ijfyParJTaxCg8dcVKqhh6E1wczO/lRyup6eEBdAQc88VFp160EoXOOeQR2rpp4w4II5HesDUrEg+YvytXfgsa8O9fhPNx+AjiI3j8Rv2twroSeQOavKAV5XjrmuLstRaBwkgKt/Oupsb2OVR8wz719LCpGrHmg7o+YlTlSlyzVmXJHGcrjAPQVTu5cHrirErJg42k465xXKeINcgsLd5ZG+bGAo6k+1KUlBczOijTc5WQuu6vHp9uOQ0zghFzzmudsI5J5zLcktK/Jz2rItna/v2urkEs/CKT90V1NjGqIGAy3vXzuLxLrSt0Pp8NQjQh5lyJ/4FA9c1OTlsgcD2qvAjGQu6gAdFFWlBYZIwxrkbNZb6EUrSbggG0Y7d6tRQnZkgAmkiiffl8HPY9qs7V3AE4AqSnorIhWFSxY5Y1JFBhssBtxxUsaEDipNh5C9KBK+wKgJC4HFShAoIxknmnKrbRjk96asUhmxuAXqOKVyuUGX5gCRzU6QgdDye9OESklcHOOuKmSMR8c/iKLi5RmwbcE5HrThtiHfFToVdcRrz6mnx24GTjJpMpLuQAbzu3Egeop6gEHZnH0qcpuUhMZ/lTwrKArBT+HNJNoGkVHjY885pCuTwDt9MVPgli2OaWIPuG8Ar14p3ArkEOQuSv96jqeV47GrDxYJIBck9M9KZsPAII9RimIqzQeYSACQffpVdoRkYDED17VobeMdM+tV2hA77gPegTKFxENhZecHpSoqeWpYHkcYFWpYvlfqARTIlZYBn5gOlLqO2lyFIhv9vQ0/wAoZCgY9xUjD5gc4xSAF2LEfgKdxWI2hOwlRg9M01oSBzg/TrVlT82CB70SR45wCD6Gi5LRQkjwOf5VFJCXYc4x0q6xyDt61G6YbkEj3pktWM5ogCSPzqvND2PAxmtV4+vGPrVdkJHAxTuK3UypodqqQcnvn0qq8K7slSpPQjoa2JI1/iB9KhmiBHB57Yp3HdoxQrpIWjJznscYqePU7iJ8OqTIemeGokjIY+o64qvIgKgnt6VtTxE6fwsmUIVNJo27XVlKnZKR/sN1rSS7R2xINpP61wjnkkKWB9KsW1/NANpO+M8FGPSvVoZknpNHm4jLVvA6jV9NjugGjOHAyrDsa5wK0FyFnHk3A+6/8L1s6ff70/0dlYY5jY8in30EGpwsjAhx2969mlVUkrbHjVKMqbsxdK1bDeROu2QdQT1+laocG6Vlf5WHH1FccsOCLO5Ox0/1Mo4/A06z1K4tbtIroFirgA1U1pcUT0B+EGeprPvHKoVGeKtIxaLK9+fpVO+k2DAG49TmsomctDhvFLnZjNcpGn7oBeSe2Oa6jxEu6Q7Tz1wa511LqSv6cAVhU+K5y1W2e7SQ4LZHHpVdE2nPQdOa1JEJZjnjqeOKj8kOOxXrmvjT9GsUNmOSOKhubZZF6nOM8CtGSIlDk8DiojHz6entQFjlr/Sd6goMk9qyZlurF8nLKOh9K7mRArHOTn9Kq3NsJk2su4n2rajXnSfuuxzYjDU66tJHI3l9deQzxZkGOinmvL9Q1S8v9ZJvopYQnCxyDFev3OleTIWjBweorOvNKiuIz58SuB/eHP4V1TxtSpHlmclHCRoSvFHPaIsSxBifmrobYkHc3II4FZH9jyWrk2zHaOdrVYhuZYDtnQqfXtXLc6+e+jN6PJIZWJ9Fq/bgqpLYB9azLC5hkIAkG4cda0ElGSo5Oe1A0rllSW4GCOmTTxHlWJXmmQow+cnJ7CrSt8i7wFJOME1Ny0gt1JUFlwRViNDtAZcc0oB3nu1BcA9GH4UttxtDgux8ZyT+lS+WnU/jjtREwGN7YwKGXHzgkqepPak2VFEykBBg8HipCnPqD6U2LcwU/KR2zUjQtMdyuMrxSuHLqRklH2pGdtBcp82CD6HtVsRsgH8WfTtULwFp/vY45GaTHGz3JItpUmM4bv3p0aEjDnLDoRUgj2jCjj+dRSs8ZxHkZ68U79yUrvQRg24g7c9vekbBXAG3Ixzzg1IhLE7lx75pLhQx3bSMYouPld7MXAWPDNuxzmoyN5J5xSqVZQoQgN0yOaWQEL8xIAo5mKxCyZO0n/gXpUZVSxC8kd8dKnAwMEEs3cDtSTfKoIIPr8tUncVitMm6JiTkkcZ/lVGwDbHU5wDwDWlNHuB29cZ5qpYuMyR5Axzn1NS3qUl7o+RVCZxyf0psYGPlzn6damWISPvBwB1BpwiLEFWIzTT7CtYqJF+83cjI5zUjIHwVbBHapiQAckY96zX1O2Wcx+Ypf0zVWJbJ5AQM44/nUbglfl5yOQe1TI8brujIYU91DRr8oB9utMnRmYeMdfejnHHIHWrMqDcM5UHsR1qFlwBgED3pisVnjBySOveqjpj2ArRdclgfSqkiYBB5HrQKxQnjD/MowfX1rOaNlOD371rk4fGDVOdQ+SDTTE/MyrlCudoGKpIoDkhgo68jNas8fHQ9O/Ss24QIAyElT1A7VSeotyCSWRJMp8jDup/WtKx1jc6x3RKP0Dr0P1rGZwZDwQO9RSlWBwvHcV1UMTOlLTYyrUYVFZo7O5SK+iMUoCzAZRgetYN2zkKkwxNEc57kVBpOp7WW2uG+Xqj+/pV/xFCZrE3cWd8Yw4B6j0r6TD4iNaN0fP18O6MrM7OxlD20bA9VBqK/cFTjr/Kqejyn+zrcKeNgqS85+UZ6dT3qorQ5ahzOqRiTc3y5HUmub2/NLGOR2rqNSO1SAAVrm2+SZmb7vJxWNTc5Ki6nv00bDCggknGAajMfljaANoOB/wDWq+QVDHPbr/jUQVuSeATgN3/KvjD9GKrgMo254HGelQGMjnGQfXmrrQyK7bD3555P1pHVVXc/B6ZqRmPIozk8nPSmKCT83DDvWlOm4EbQPQ4qnIAhBXBB4607ha5BPEHj4Hzdqz/IDcFcc962VG0BWJzzimSIhOQD9apMiyMOWzQk4XI9fWqz6YkoKFc5rotnoB+VIqZOMY98U+Yl00zjW0IBw8O5HzhgOxpGtL2zcFZdyk9xXbSW4RxJ/CcBj6elJPZLcW8iqOc4waOYXszk49RlgcLcRnBBORzmtCG6tZgGEg3jnFaM2inzlYr8pXHA6VTPhtXRmVec8EDFHNfcORrVF6OZWyQygDnipkDFwAVKnmsX+wZIydkzqPY0iaXfqxK3ElO6BKRtTxYkUrzzyM1dQo+AOcfw5rkVj1Eo7NcvgZxxUMEN+0IlFxICecDipui/ea2O6GwKQq9DxtpUlj2YVvnPBxXCvLqSgqLiUr69KW2m1HYUSVuuCTzn6U9HohWaV2dk91BbH97MM/Wqk2v2SuNsjNz1A4rJt9FZwJLt2du+TVm502CCEFEUseuB932+tS5dDSFNyepv2NzHdQh4JBID3zVuXkABQ3uK4/w65h1ZreP/AFcgyR1xXbYAjzuOB7UXuKUXCVmVBGgLIrM5HP09qdKXRAccHjA71LIF2iPaCDyealVBsXqF7ZHQUkgbK8RZyCPvdOR0pShaXYV5zySetOb5WYRMCV6kjrSKszqdjZPfNO9hNdQdV3lRwRVeceXKMJ8pGDzVpYhuwcgnrzTXA3dzjrn0pkO1yo8bZHzDb0xjqKzYLQreOVBBPU54rYl2gFTnd2FUrd3S4ZGXIbp9amVrmsL2dicKAB8pZuoqJpGBI24qzGOu38qcqK4+YZYdlPSncmy6nNeIL021sYY+JHOB6msezsEkT96PvH5nP863fGEKvYiVUHmRODn0FUNIuUGzcRg+vpUSbvY6aFJTi3YpOLrTWLxnzIwecf0re0y7iuowwIyeoJpl/bGHLRr5kEgzt9K5aWW40+6c2OMZztPcVtGXc5a1KUHodm64J3HPPFV5V3LheorAtNdlVtt3EQp/jXoK2IdTtZxmOVCTx1qlrqY7bjiQvDDLdMetU7qPLkoDnuAavMQ5wpAUelV3Q8kHnPFBWxSaMovIJ4qm5XO7BFacqHG5vu96qCND8yE4NHoS7NambNluoBHT8KzmjKtt6qea15ogpzgD3FVHjyrGqM/IwLlcPtQDbnmqzDBwMVr3Srvx/F6VkzqEZto4q07ktmbeA7CEyHHIxW74U1T+0LO4tLg5ljGGB7isO7LYyMjvWdY3/wDZWuQXQOEf93ID0we9d+CrOnUOfE0vaU33R6zpbFbeNRg4GBxVq4QlMnP4VlaTN5ikrg4569jWlLMscfzNkkV71OXunztZamDq/wAgOR14rkr+5VpNqD5s4UDvW9rV2Zp/LiGWJwABU+jaCiyiaVAzkd+30rixmKjRWu4YbBTxUuVaLqz2JbnJGEC4GQWHNWokDjecnI471mwxrGWfzC+/nB6D6VbgldPujcoOCcd6+UZ99yprQuui7W2AZ6YqpdRsEyQDjnBp/wBpKE8deeaj+0GQsjq3ryKTEqbKLSI8gUZ6cVC6jnBxnjFW5bfHzHOBVbYruzRnIA5pA4roMJIIxjFKv3gegwQT6UFCR6DOQBUiHOQvr+NUmZvYb5ZySOBjNNCFQeOvPNTnLbcdDmnlBtwc+nSmRewkMYZSsgypHI9DTLQNZ3rRyHfHJyhPr6VZjj5B75qWeBJotrtz1UjsfWhoE9dTTW2VkUso/CqtvGomljZe/cU2G+Cxxh2+cfK3PeoJr0LNuz65rNs2jC+gs1spLAAdeAKgSAD5W7/rUou0aXII21DcXGGGxhkHtSvc1VJ7FC2tVxMmASrEYqC0tgLUAgEjir8JXzWdTnfyee9VnmCApkZzmhXNfZ30KM1uMEhQW71XhWSKTKBQB0BGa1DMq5ORjvVKS5UjcgUD1NNOxpHD8ys0WoyZCr3Up8sHO1e/4VT1rUo3/dwKI4k+Uep9zWZe3Jx9/PtWdGHvpxDHnBPzse3tRzX0R0KjCCudB4QjL3Mt2ACo+RSe9dd5uIdr4fcegrM0i0jSxVYMJt4Iz1rUitj97IA7g1W2h51RJybY1FYq2Vxnj6VNEv7sZcuVqWVXaLaF2gmmojIygRgjPJB6U7WMHqBRCCRyffjFLGqoAPuse2etS+SN5YZJ9TVSbfDL5gUNQ9NSUubQdIGVyzjvgYGKZE33j8pCnkVYRhcw8Nx/Fg1UIMJxgYPTvmnzdhct9GSMsbNuLAseduOlZ4kWO4YFQf1IP0rSKpkHyyAQOcd6oywp9pAGAwOev9KmVzSFtiyqBxkHj3po3KSe3QYp87YUKi4Ydj2oSMgFmwenAouK3UxtZtUvYZFwRxj1rjLRnid4nBDRnFeg3ED79wfCd0rifEUDW12LlQdjcSZ/nSkrq52YaXLK3Q3NOuGa38pzvB5BPam3mlAgSMF4/lWbp12AqqSvPNbMV2rqM8+maVzoq0uZmXPpiYC4A96yrjR0it5XKYPUMO1dhMY2hDAAnpxVVohcyJEGyg5b/CjmaOKVC+6OWjGo2cUZyJPl5DdasQ60mSk6NCR144rp5rXcvzoMnpVM6XDIh3oPnJPIrSNSxzTodUZwu4HQYZWz6GqsksZ+63B9KsTeFkkcNEzRknopxVSXw9fQjatwxX3GatST1MXFrRkbuJFJ3AgjjNU5c4xnIzSXOkX0IUedubOMYp0nh/UZOkv5DmqTRk4tGVc4wPUHGKzLvBc89ulbNx4c1Ilv3ijoMYNQHwlfyt88oA7nGaadiZXOSvZVC5Oc9K5TWLngr6CvVh4DeZszTyAH0FTw/DbTXcGWBpj3LtkVrGqk7iin2OD8G+JJCio0vI+U8130T3d/jykZQRgsRW/pfgnS7Fd1vZW6P6hBn8621tYo/uoB9K6nmcoK0DD+zI1JXk9DmNP0II5kf5pOM1uxWqov3cY9v5Vc285XrTAJGmQKnyZwWPb6V5lSpKb5pu7PTpUIU48sFZGyjxhTyeBzjGRVld8gAibkjoBgCqoiMb7RnnmrKLtJTsp9eDU7nY1bVDir+VtyZXX75ApplBy7Hn0HOKeI2VdpJkUnOOgHtiq4C+ZhOQw5z/D9PUVLRpGSkidJfMzyMEcEd6atr5bk9Vx2pjfuWU7dwHtirsJR3Pc4zjGTikTNaaFGVdmVHOOx61Viul3FSuGU4OO1bE8JABIGe+KoyQRq2WHGe9FzG0bD4cN247VM6FUIFRIwXGcY/nWiu14gVJwvvV3MGinHkOysMEdxVjAJBOMfzpcfNuYAjHApMYBIAOOtNMmS7GN4pZobdbuHI2EE4HasaXUyY1ccZ7etdFqiCS1mhfgOu015zGbu7Y29rHhYCULPxkis5Jt6HbhZRt7x0gvyUxng9Penm9Tby4HY49axP7PvRHvLoGP8IGakOnXCqoe6yx7KoqeRnapRexcuNQeBX2v8pGaoxam0qli/U+tJNoc87qFuHx0bilTw7bxjmSXPcg0+Vl88Er9Rxviy8nj0NVJdS2IULcntVmXRoiAEMr893q3a6FFFsKxAMT949aXI+5ftY22MezhuNRkwN0cZ6tjk/QV02m6aI4lEcTKqnqepNW7O1EZxFtXHUt3regICZTDelWkkc1WtZlO1VrZgShUYyT1rVt55mk/1YweQMdqasRaJlc/Ke4qwLcLgltoI4ANP0OSc1LVk0/mllVEGM5NQIwy4Py56+ufWpJXZimwtzyTng0yVomZ+pBAHSkYqOhMsiqoViSex9ahukYpwCAOScU3y1iwyndnkcVYR3kH74YB6duKL30Fy8uqIILdRAjnIP04pJEO7cRg9BjvVtFwdqD5AOKhJxKy4JJGcHoKqxF3cQ5XIxhfYcVj3yMl4jLyQc8da2wyuqqGznrnpWTeoY7kbzkE4qZLTQ0pPV3LiPG8YJxk8c0w4LYKkLjqBipkiRUGSG3enWlMQKfK+RQxXM+ZkiUgqzccHPasbUfIuI/LlThuzdK6CSBSSrbipqu9nC6/vEyQcDNFzaEorc88ntZdNk5y9tngjkj61fsrxHjOHJNdHe2yZPHHYYrA1DRwsrSQP5LkZwOQaThfY7YV7qzLH2ohfvlV4NX9PdZdxi6D1PNcTcy3kTbJofkzjevIxXUaDcxkqy4K46ZrOzW5rNR5bo3YNxYk5yOKnMIbjp3yO1VgTn5QMdznpVyKQA5fjA4HrQckknsTw2y5BI4A5NMlgEpEa8kck/wAqnhkQAlW4x0zVu2jXf0xnknPWqics0c/Np+bgLj5VO5iB3qykaiJpGAx6ZHNas6qgccA9DWPM3nyBI8iBfvep+lXcydmVtgkO8qAB93jrUUmOvGParFw+PlXj2FZs13HHIscjbXbtVXJtfYnUAknH4dakVdoyBT1TCYBB4zmmvhRtIyPShsdkQyy4TA4rOklJbGT1q1ctgYFQRQmQ55xSLRLCm4DJHI7VbCELuUD1xTbe2YMHYqF/ugVbClQwIB5pXGy2sSyKMsCeh9KkSFYyELNu6ZPas6yu45pXiCMCg4zwBWpGxZd3OAfxNO5rJNKxCAEWQ/NuIIyetRKiyLGygggYJ96kuFbJwfoBz+FKp+VWG3I4OBzz/Om9jNNoYPvkH7wHNFq7K5GR1/L/AAp1xgKm5QfTgVCSwVVGPoBx/wDXqbGsYuxfebadjrnPcGopdpXt0qCMS7C2DIp4PaplRn+VCFGOr0rEySsUZRtZgMADvVuAjy1BPDYGe1VrUNJKRgH3q28RRcrkelO5DjYuqEYfKMMvGMdqinOJMqQWxn61As2F6/P1PvUyThhyBu9fWncjlM+9YyRkj769QK5ESRwahcI3DP8AOAo612d5HuUvHgSfzHpXG6nHu1WJ1+VGBB47+lK+prRSvZmjYEyJhlPuastGBKXwPLAxuIzUVvC0wVUb5B96tMxoiKAOBz9aDqcknoVsTmECJQgPWqcZO5gwYN37itR97yMVZVjx2FRLbmKItxz3HehscZdyCO3BXOM98dKuiUM6jbgAY/KpNNU8hl/CpXAGFij4BySaVyJSu7FZIXkYuo/dj2xWhbWsiLuIPl9CBTcNDGzctn8qkFyHKKq447dBRcmTctFsWiT5akHaoGAPWo98kshB2qccYFTiJyg+7jt60+GI5JOCR74odzJWQsE6JEsbjDDjkcGpY1Q7sqACfrVd4+G2DYe5I4xU0MTLGGXLFuvtVIiSW6HwNG0TDBUAcDFIpjYqVw3HamCGRZ1Yng9jU/kqN0kSjf069aFchpIrmVm+UgDPYVAyyeYxGcj3q+cYAHysfT1qBVMbBmHyk8kGm0JSILpnCBRHheKyr52hlhO4nuw9K3ZMmUZYBfQjrWTdRG4vchRhexNTJG1NltY98eCSd3J4pRGsagEHjoAcmrMSttywGahE480g96NiLtgVyu6NASBnPTmqtxG7ORgcDPB60+bzVl3DIXoRnIzSrMZGAZdrCgdmtSg0b9W4/WoJbZZECsSG7VpSR4ZgCNo5LVERu+ZOvpQCm73RzlzYBSy7fu8g1myaSQDLbs8Eg7L0b8K6x2V5NkiYGKq3FuS+A5Cg8LQ7HSqrej3OZj1eezYJdIWUc7k5H41rQ6pDcoDG4JIyOafdWsAYgryBk8VgahZPasL2xVSufmTsRUuHY6IuLOos7xRcxoWyTzmt2G+VFZgPYZrk/DU0d1eNLuCgRkbSOhrVsw13OVV8QJy5/vHsKIJs5q7imaMrSXpDkbYQev8Ae/8ArVVmcEbYxwOwqzK5ZPLQYQdhSLCoQkc/hWyjZHnubKZjxkkkk1U/s6FrjzXBLDnk8Vpuo7/dPNQPtUHHPqKmVmVC62FBCxfMcnuaoyShlOD37VYl4HXI9aoXkZeIkEr9KllxiOwrnJx06Vct4xt7Yqpp5RR8y9Od1W0n3y7F45z9alyNORk5TBXOQnpU8NqrLuYkLnORUkMauAx5x3Aq4gXO0cDPX3qkrGcm3oc/DbhW2lhuAyecVroNkKKmMY9c1HbJG2wuAeMZHWrA2gYUbQBkf/Wp2L9pdWIJE6gH8cetMjzHgE4PTJ7VciIdTt5I61UvR8xyTjpn1oEySRA7/PIuRzkc59c0NCs6+UpCrgkFf4qjictHtXbkcZP+ea0LcbEUbTvPoAPwpbGkJsqIDFFsXBU9Q3NSRsrAhyoI9Og/CnKGeQiTAXsO5p7KrOCueDtIU9PwoTHNFKG3ZZzjpmrEkbMCuMg8VOIQdhwCM8npTpF278kH0HTigyvqZ88O0gYAx055FVWMyp8rbueQwrUkw6lsg44LmqZU5B/1YzwTUmnLdFQXBKZkRgR3XpWDrgVlWaPAZSCa6G4C5LAnaevYVkalarNETHnJH6UN21CKsx1jKcgR4A4Jx39qvyTMmweX15z7VkaAxZjDIf3kfy8iuiSEMAzEMFHQU33NW0nqQ22J9wYENjoRSzQOyYB4UZxipodzylV4+lWEDbzv4XsaW6CTsytBLFFECiN6k+tXIWR4wdh656804qkO3IHvmpFSORXkUYU+tNaGcmmISLnaqAAA4pHtyh4XvzipNPeN0IUFcHkHqasyFeQzcnsO1NbEczi7FdGZFK8kN0I7VLbxBCcnc3cGgoUkKoWK479vaniPySGVQ+epzTG2mtCco2DuXPFQxQzRyblwC33QeRimzSPu2DhuvWrEbOIiHVeB1zRuTZxRMzoygTH5vYd6a/EZAPy47CqjFh86tuJIwTwKkE5MPzEbyegXqKaZm4NbDkQlegweg4H0qZVGCpTpyKbaOysQ6AY5Xmob8SK4cFsZzjtTuTy62CRN65CYYHHX+Qqg9tsv1ZQSOu3PJrSgiRkDbtzeuao3p8q5QxsCMY57VMkaQveyLSqGGG7nPpUSWSHezh/lPHNSwKeTxxSurFiVJK07XJu1oiBn2ui43EetRMElYtnnsPSrcqfuywyO2e9Z8TIZSXBU56kUnoUlfYXywrkNknPSkRowcbfmNTvhgHLEgHI7VFJEWBaPBVu1AnruVJoYmnyoy2OuaqXXBDgZK1eTchIIyAOCar5jDssi7c9PekzSF76kAKyKdynkZ4rMmiKSbOsJP3fStwxYO9D/AA9KxrvzZJGIRty+gwKRtB3v2MuyUWurTGNcGWPAX1OcV1FnH5NqkSAHPLHHBNYFkvn6p5xXBiXHPqa6i1TcPm5Pfmqvqc9R3JFjCjJ6dfalYY4PJPvVjmRRgE989qrtGsa5BY/7RNNyMVErzn1HtjtVZnAwxGc8fSp3Xepwcc5B6Uzyl3Ek8/XOaTLSKRYliGHQ9TQ1uZICNuWznHrWgYs4yOB2qdFHQYz3NSWtNTKjsWMfzfL6471YtrNY8/Id3v1q6OMhecdR6U2NjJIPlwuMj396WiL5nIbbR+XIQ3Ac9P8APSrORHyN2PQ9c1B5bI/mFyw9CabPJ5mEXaOeRjNNaiktdCtZENIyfxDnGetaC5AwrAN246VkWYxJ168n3rZQhIxs+8eo9a0tdGV9SpC0scx5+Xuc4H5U5k83JJJB557VYuAF+6cDv/hTYctnIKn61nY0unqV4sRkjCgA4xjqParKPg8MP/r+tQXJKkkIAOwz1NMyfL3KQAetN7DirFxp3kP8IHp15qC3kVeMtuzy2c1UknaNlAbKnjg08sqMGbaFx3PNZ3Z0KF0X1cJzuG719f8A69PuX82PCHB7HPWqqvuT5cY7MaaHIkKgnHX6U1LoZ+z1JYpAsZ3K0jKcD0zUdwoTLysh3Hp1I+goJLAony5OWPoKTHks0aLgt95jzSuVFFd8qx8xc7h0NU5I1JYAcH0q6sgLMsatI3r6VUuYXMbfNyew7fU0ipRMZgLPUlm5IPyn/GuktnTC+Wp55IrEu4laLawznoRVrTJmksgWPzIcMe/BqovSxEtTbijVW4wrD9Kk3r5hIxuXtjisnDRTGQyHLc7R6Vo2z7hJI4BYLxTTG6fUuKolBypBP40Sxq4273QDt2+tOjmWRF3EYIyMetQ3SM3Kg7iccjoKZlG/NYIVgilUb93pjpzUl1IjzYhBO3uKpxTRAGM4Dbv1qxE0Mbnc4LD+EHrTLcdbsctwyY+VjVtI2ncFHPTketZr36NKqqAoB6GtKFyYVMTlTn7o60IJRa1sHlSSkl8Bc4BxVhoURM8njGO1VI/MkmXczKD0X6Vcmkkj2qV6g596pGc76Iz4RL8vQP0CmrpcrgkZccn61JG67d8i5bsMVKU8wHCHHpQiZPoRQSi542bWwTmp/LDxDPynbzuPWiCMjcjADv0xUSQuxYEgEnGM09SGk9gkxGeABgYLetZkrbb5cKGTbggnNadywQ7Hxnp9TWbEsa37jawZumegNRIqCtcmW4AChFfc3UUsku1tij5j6GlnljjIJUmQ9wM03C4Epw0nHamPlS3Hqy8DLLt5PNUL2MCQMFYnqD2q8Hyw3J8xGcEdvSlimEgYED5TgA0PXQIvl1MpImmQ5dhGDgKalQtbxHLblBwOauyspIVgPUVWdA5ARhgZytKxXNzb7EAlLKwZQGJ4wKZeQh4wc/MOfapynlZcgfQGmTvti3AEoe1AL4tCukqyQll4ZTjHas/UZVSFpCDnHrVwvDEDt5GcmsDXboM6QREsWbj2oWmpTVnoS6QvkxjzGzJIxdgOTzW7bMcgyYwegHpXP6cjcYGQOvvWus5II8px68VKdyZI1xKNuAQB69hVK9n2fLuye9Vvta+XhO/Ax1NNTO4+acD3p3FyjoW6E4A6VcRAeS2T2FRLFiMfLkdPrT3AVQQvGO1NkokY4yFUg9DxUcYUFh19+lMSTeTgOOgFTJGTnYM+oIxgUkUQtcos4iHJ9uv51MrRoAEG0dh/ntStFFG2dqD0JBpsg3H5FwQc8nv7UJA5JLQVCZFYLkHpTYo1yPMzuUnHOOT6VZtreXCPzsfofWlv0MT7FjKkDBGcgn1qrWQoPWxkWTLt/edcdfar0UvCgZGD+lYulq7t+8Yt7djV7aI335OSOh5zSuU6djSfADkjDYwfeqsc2S3IB7Y7n0pEmVlITBHqfWqT4iuCSMjA4B/I0mOMTTmQBsMQMc4B7n0pi7YwVJPPUHqKi+0oNxEZHQZApWcucjHfvSuy3ApX22GVVyAMcbacrxmDG1jIeR8v6VFeoZI855HIJ6L9Kz0uDuUY+bPrjNJo2pWehcVp1zjaO3ynNWredmCh+T0J7iqAP7vGAASeDxS2rv8AMMDIOBUm0o3NaMg/cJB6E9xUF9MSwQtkscY9qXeFA4zj071lvchr58H5hgBTTOdaO5rwqfKCjOAep4A+tTyoM/MwfHPTAFVrSYtJtKng4Jq6kJIY4+YdO5/CmlciUmzBvstJhe46CqNjL9nvWjfISTn2yK2b6EsWKD5ieorH1G3ICsBiReRx3pJ2Y0u5tvcLdPGowPccDFTKssOY0bcTz0yKi0e1SaGOQYOV6f3a2FhZCBuAI5zVWKdSK0iU7USFye69FovrwLINhyVHzE9M1clwXLKy9OoqgYobliI9zFTkg9zVWErSfM0Zv7y4vFKqQh6jPX6VpiB0jyV3MO9SFFRcqSvGAQKuRBTEqE9R0IprzLlU0VkY9qnm3SHYD07Y/A1vfZy8+2HKjbknsBUsCQKoGzDg59c1ZVxIGEZK5BXPpQo2MalZyeiK8EJDYJyQMDH+NXZTGQM/Pxxk8ZqBIpIE5OeOQB1pkCGebLoVAHykniqSM5JPW48LIFUqe+TgVM8kigEJkcdPWoRGY5mfeQp9+p9at2jCSMsX3jPShET01HvPmNWCq3qCcGq8gaU7g21ge4FPmfYwO392OpHb8KJJRIh8vscAY5oZKVtSsxwNxIBHNUrWVJZZCFO/PXrWg8Zki3PneOSM1nWG1bmQEjbnOfSpaNopOLZejgAXLc5/PNMVHj6BdvpViSJSVZid3QAHvTP3m2RsDd2HanYyu2VzKEBZhz1PrT3dC3HRh6VAZHkG0QqJAcE9jUrBSCF69MEUkU1YglRyr/NvBHGR0qq8UmUZG5HUYq60Zz1IA5wO9NlljKhOTnjp1oGpEK5V8k5OOciklJkiIUD6inyTAIWGPYVWMg5KkoMZ+tAJdTMvQIo5AyhY8ZyfWuatoPtF0ZGztJ4B7CtbXLnz2S3RtzNy30qTT7fZtymR0qJdkbKTe5at4gqKMAAetDlnOEOf89KHdX3BMc1ZtLUiPem7K8889utSVyJasht7MSNyMnqQeoqf7MRIV5ZV5GOhp6bWO4uAQu4c0+KbzlJ6AZHWhEyJ8BoFwq56Ad6qTB2jPBwOen+c1cRWY5JIH+zz+FMeQqMt04/H6VZil2IQrMuMKcdSDnNPWfylCFAc+naiIKCAgXHOM8e9WUCuD8vA79O/X60KzFJNFYyM43EEZ6DFOiQkBiDnJB44FI8TrMznPl84Gen0pzuUALgHj72OR6ZqkLlL6eXJEhMhRlXZgoSD7ioL6ZCyMuQqqEBbq1WWeb7PE0MiooTlfMA5rG1F5GnxK+XwMc7uKtoxW9kczbzR+Sqrt46EtzV9mEnzuSwPTcDXLWUxjwg2rj0HNayys+3eQM9hWL3PV5NDTW5CkqxwvbvilkkBUgjIH9ax5Z2jYbPxFS2NyOQ+C5pmMotGlDcYA2qAenB9KsJIS6sNvoR3+tZUCsJdoycnIwe1ay4kBWTjpgng/nSsXdWJZdrDAXB9/Ssu4tQXLMMuCQKsSy+XJ156Bv8AGqhufNlCBjkdD6U7GaTjsNSMbwGaT2xUrIY8FSwOQMMOTz+ladmA6BcZB5yT0qS4jkeRV/d7QeSOCaVjdVLmYJnH+tQZ9QaxJZ1TVAT8oYYHPeuou41DYx7cdq4Lxf8A6LNjtIP3bDruzQlclNNHcWLBtmBntW1EoKgtnnjArhfBWsJqOmQusgaRPllwf4hXcWk27PHbr6U7HPK6EnhBLYwB7DpWPeW7YI2nr1JrpWQeXhOM+tZd5COfm5HUjtUuIRmY2hTm3uXtiTydwye1bfnNLc85/ugVzV6Ht7mO4VclDk/SulgjF3CssRBJGVOfWmndFrlTuyNh5cTFFKjOCOuazxdpHI8SBt3Ut6VrP5qxJAyguf4sVRNsiXLSEfOR2pryOmDWty0rJAoaRuAOQTVyzvoJWwp5xwazrqLzv3ZbHQYxVi0sBAfnx8oyeOtUZSjFrU2QikAYXB5zT4LZlfarBARnOO9NBZo12DoOSOwq0rxgHLEtjPNUcruhq2sqf8tCU9SasFAA4AJXPUdqgjMks6sHwCM7D2qxEDyzOTk96ERJvqULx2QhEjZlI45pba5KDZt2M2OO4p8aSPcsU5UHnJo2HzT0IA3ZHSlqXdW5S08W+IB268/WobZhE+xiqlhnmn2kplZ1cDkZ4qk8ImvG2c4NV5omK3iy1K/LZAP0qlaxLud+Agb061PPlCcgLz09qqtEzIFQ4Y88N1qZPUqCsi5JchSgXbycYIpsq/dVHOTyP8KhhtyJckZHuatOgXBjI4GOaCZ2i7IjUSfuw23cRzionGWO1uh5pJ2EWU3ndnr1poYogON5J9eaYWFwofg5Y1C8iIX5PHbsDUtw7RxgIoY9cjqKZJOEUGQAnvxUlKL3KlvIdpL4MmevtVTU5EhgaQH7taMhXZlgVXrkCud1mRZ50t4+VPzP7elK9tR7soadE0szSyclzjn0roBHsiGwcAc1VtIlBGB+NaewmNepbOCO3/6qzNNDKVFWbeMkDqMYzV6S4K7JIWYlRgjpxT7iBFTKkhhwe2ap2ciSOyMcsvWlsb3Ulcm3D5mXA2kjIHOKfCQoyue3A9aqyxEbiuMcZGetOjfy1UkkHoKE7EtXRdllcLjAGBVOaV2IAJY9RgdKknldVHygk8Z64qEuwTfuyDxgjrRe5KhZXJUxlBu4P4fnWigZYwRg8jbz2P8AhWTuY7Q2d2fmrQjhDKmCyg9KqJnMtblc44b0+WobiZImCmMNz91s4NDuISAcFscEdzVJhvfzHDMc4Fa3sc9rkrzxPhfskOAfU9PXrVbUXDsojRY+MEL0qzCNzKSAUxye4ps0cQbMTSv0HzKBRzBZJnmMUMzskmWwT0xW1DCPLU+Y/rzWdpEoktwck+mDWxbKZZOeo4Azmk0dsajaM7U1uLaMNu3AHPSsS31hJdQRVJD91Ndpc2iTRncXJHUV5f46t10W+j1A4EAIGemxv/r9KSV3Y05ly6nqem3AkjV1GTj8q0rVg0xyA2f0rmvDl2txbxOrAo6BgQexrpYVAAIUE5pnMnZ2K+qWmxQYWznkj1rlbe7aPUBbygq7MevpXZpBPJJL5pVQD8pVcVyXiu0NtcwXwJzA+WH94dKRvG3ws6vS5RkLnjtmtVSpmHy4Yjk44Nc1o8iuqsW54xit+zYvdAuRs7dqaRz35W0F9CTGX59RXAeO4Bc2aySJkROr49h1r0i+RlAMgz2xjGPQ1yPii0E1lKoznaeKn4ZFR1Rw2nD+wdWSeDEdndECQDoD2Nep6bdB4w24EdSc9q8w0yyTVdGCXEmGQmMgeo6GtjwtfvGG025kPnQnbk917VdTuEY6WPU4JIvIeaZ9qAZJY/pWNeXMtxLmIeRAe5GWP4dqrXF6gVHmP7uPhIxzuNRSPLcRpIqFJG65OQo9/U1ncIU2ndkN/CyLuZy49WqTwzdGKWSFnOAcqCaGgV4yzyNIw7scCsxg1rNHcAEBW+vFJaMrl6M6nU5isaPGfmHAHXJqC1kIbzJOijLLVmzZLxVk378c7QKnlhOTtVc9Pm9Ku2pqppLlsU4JY3vDK/EXRfWt2Bw8ZUnCelVLO3TywAoVh36inxKvmsDmQZ7etUjGUlJ6F53CKEL/AHuDjrSOmIyY2BYgDaahSNGlHm5D4wKnV1hYISXyMLxQRtsWrSHja+38KWQeUg+YqnuaZA4ZCNwCjrjtUUfmST4ZsAHgEdaoys29Se2mSY7QCDzyD1qaLapwcAHtjFVcLFv8pB8vAI7+9VJWYpuVm5HT0NNaCcE2XZzEmfJbBPU/TtSj5MGLqSMH1rNdFbaScgDGcE1aRmyiQ4yox160MbVluRajcZRlx8x/i96TTIj5QbcShHOR/KjVFDQtkCPHP1ptlM8FuBINw6gg9PSo+1qXvTsi1NG7J5sP3v5iiOWMRF8EkHHPrUC3O/eCCpGM96IWOWDOpU9OKd+xPI7aiI4mYOEAznjHIpzAORs4A6nNRxbI3Ykkg8Yx0pvlDzGaOQkkflR0G0Suh27SSMcZpgMW1Vf9aRiIzsZtwbkGorqVPLwy/N2IFSxxTI9TvYoLd3kKjHAAPNc3ZRmRnmb7zEnJpdVnF1PFEARjljV20QbFI6j2zUyfQtRsie3UKcqvJ796vxZTgjI96jtIZMc8c8irN0VEJUcsKFEmT1sVLg5OAcgcD3rnvOMWrFY8cryB2rXuJ9sbLkZUVymjzi512/l6iNliUjnoMmoZtSvqdKgGzJPJqCdsuuQcfWrjEEbQMZHJPYVVniYDdG+c9DtzSsaRZMWjdFOCGA3Anp9MUy9uFCA5HTjb/hVCW4lT5CgPoc81XbfI/wAxPPUjoPzqkgloadiWYhhkjsMdvWteJwEBPpx61lWqmKJQCMeoPFXQxxx2HJOTVHPJcxIokkAYpu9hjsajeQKNx4Pp1+tJGdkWHc+uAMVBFIHIAyep65PXpSvcOWx0ERWOGOXfGcR/LgfMXPWq18AxXlWcKN5B4JqZQBaYSPdmHduxk7s9Pw9Kq6tKiMg2FSUBKgdDWjdkc8I80jw/wXqf2rSoZVO8svI9/SvQ9MEbqqrx714L8MdVCXd1Yl8lCHA9q9p0yeT5WU4B/HFaV6fs5uPYvDydSFzpxbKqlVzz3A4rzj4rWnn6Hdwuo2spwa9FguD5RDNzXI+N7A3dpIysdozn1Ix0rLbU3WujOK+DOsm60FLR2zNany8H07V7RpjZCsccDpxzXy78N746V4oktySFmZoyD6g8V9CWF4zFMYwfWtJ6M54JySOwfY6hkG4Ae5x9awNds/PtpQygq4IPtV+0uBs2lgAefmOM/wCNS3A8yFgRkEYxWTN4e6zhvDU58po3PzwMYzk+n/1q7HT5NyArlW68964d0On+JHQfduBu/wCBD/61dhphG5d2B6GmmKppK50NwWntwAd7LjBBzn3J7VhX8PmwSjjcvFbUUcjxFI9pQHdl3/pVS9iwCP3fIz8vApT1FHTQ8v09v7L165tpBiK4xKp9x1p+sxpbarbajFxhsSYHY96m8XQNDd210gAeJ8+2Dwa1jF9s0mSKRMuV+9jH5Va95WNrW95Fm3ZJn35B44z2rTsY5LxDHK7LFnhRxn6muP8ADNyfMa2n4lhO057jtXdWUYLqEIHfisrWNJNRRPJZodqnAAGAqmqGo2YWEhlx7V1VvbKsRZQPfuaydUQuDgH0okupzKbbMnwzKogaKTAKNj6DtV3WXmjgEkO5lz+89QKydKdLbWDHLzHIMj6iut+zxspON2RggVW6NOdRldoxdJuWnRQkmQcjGORW0sn2ebb97gdqowWaWMpeJSVb7oA4BrTgxKjbYwz4G40RQVJJu62LUEqSKQUySOCByPpTZEVFYyFgvZqlgUKoJYByMgGmTMWAV/mDHB4rQ5k9dCBZQJeMMPf+lSecJDtDEIQc54pkqQwgKRgDnPaiNFIEisGB6DHWgbaJYw3ll05PqDSoRKpULj1AqWN2aLYVCkjt2FRptR84DMe5xVIlO9yGSBWGApAz0zT4ZxG4I69zTHkO9gvyjHBPWoYI2kZmZvlB6etGq1Ha694TXGaVI8NnPpTVDyIobG1OCaW9VCyHJxx1p8rjAKAgE4BAyajuaR0ikh9rGWJZSdg7dOalKKk4kb+L9KlsN0cQwe/ORUsqqRhtuG9aEZym+Yp3eJYwoZUZulMV0iyuPmzye5qG/WITKMgFeV44P19qjjWU3Cu3IGcn0oLtpYszQK24qCGI49qyL7UfKtpY2+7GMgkda1S8iyfO+EPOMVyfiG88668pBlV+ZsetS9rjh2Kti3mzFmxvY7iDXSacckBsxsT0P+NYenqzLvi259xwa39Pnhn/AHE6mKQ9EbgH6Gso7lVDVIEah+3fis++kA3YGM1YmnZIXhLZAGVz19xWDq98kFszlsBRzn0rVsyijnPHGux6PpM82f37YjiT+J3PCgfjVzwNpBsdItxcsXuXy8zN3c8mvPLSR/FfjO3uH5s7Ml41I6t0ya9osIv3KjaCcdKmUbaG3NZaFlLZGHsTkc9KrzxeWHXaSp9qubwo+YEcccdKpXd0hKgfLg/nQokKbTMuaNATuwMDjvTISHO1lUL3Jqrq92seMYG48f4VDp85ZupYk4AHNOxrZtXN+OLBRkBIA65p6u6kEk/L7cUQmV0yFChQOGPNNl3iNt2zJPAz2pNEoZd3+W2hjhRwvr9az4p2D5JCnrwap3k6qSvc9xVeOcCYMcnPtxRYfJc7FbqG3ij3T3KtIm4hMcZ71HfiPY0sMk0mxFl+YD5geM1BYPI1vGZvshQLvUSk7lTPXjtVbU7ieF5U3xEOF3FB0A6Ae1NkRjrofG/g3UTZeJ7acnCSNsbnsa+kdEm3wJsTeT1xXzHZ2UiQs7IVdTuWvdPA2pC4063bzypdRwR+eK9HH07NT7nBg53vE9T08XUnygwIPRmyah1qGRbZ1uCGBGOBgVl2aIHGJJHc+r4Fa9yJWs1EqqideGJJrz2tDv2Z8z+JrZtH8Y3DRAgb1njPrXuHh28S6sYpYiDvAYHNebfFywMV3aXoGASYycVqfDHV/MtFtJD80LYGe6npWktYpmSfLUa76nr+nyBcIcuCeEVc5rcSO4aMlbd0TsW4rAtLmRUAtFCserucCp7eeWSQJPqbAg/dVcD9azZrrLVGH41t5LdI7vALQOGJUc7e9XdOvcxReWQS5+Wk8SiSazmiSOR0bgu/p3rnfCVzlXgkOZIDsOT6dKnY1lG8bs9Ft44zF5t9MWUc7Qdqj/Go21LSkBSIbj/eQE1nhkcK1ywlb+GP+FfrQmpPHuChR22RpkfSmxQp33MnxVbwXlrI9vvDYONwIBqHw5M93pcRJ5X5W+orT1A3M9uweHauOrDFc5oDG11WeDzGCP8AMo9+9EdGacmhJ4ksjp93DqcCnaDtl9we/wCFdVod4sqLg5B6VHf2y3NjJFIBmRcVznhS5a1kks5s+ZCxHPXHY05LqZXurHremS749hHPY4qlqgx1Ayc8VV0ucqQVJBA6k1b1GWNoNxIUe56n60t0YJWkcRqeYp0fG3a4rr9OjKwKGbOQCG7VzOrRiTIUnGOtb3hucz6bEG/hGG+o4pUzerdKxrSsiQ8jcAc8U23ilaRfLICn3xj2p7hTCduAMdKZbSGTIRuAOo9asyjpEdfRtGwY8kHGQaaJ9se1eT355qS4Z/KWJkIXGCe9Qw25Qs3JGO3U0N2eg4tcuors8iAgEg9xzk06GxYFcy9+hP6UpxawbwrAHooNVhdGJPNdwFJyQaPUWsl7ppkLGSSQWHAAPNVnyHGVI6HB7VSF08k++NcnoD2HvUzTlZP3pyfU01ISg0PmfcwG7G3jFVm1FIIypOeeMDr+NMmlhETlfnIzwx6ntVU2u4rI3DHg5GVFOTNORNamhYziUmRz8p7+tTkDzo0BxycelIbeEwKocfKOD0zTJpFRH28N0z7VK0Ium/dJ5rrZJkAkDpililz8wbI/PFYQurmRguCOxPUGtjTYWRWEoU5PrTHOkoq7FugrLnYSezelRXQPkxlmPI5Bq/NkY+XOP4cVTvMmEjALE8GjYiMtihq10bbT96sTIBhR3rmoIWBV5Mu55ZverOoxM2qpGXLKgyR71q29mXj3gAkD7vrWUnd2NlaOtyiltkGWFgkoHKno1IrLeBYnZkkXnZ0Kn1FXIrXIba4xn8vaqmo3cNv/AAESgEBx2/GnY0i03Ykn1BhEYZiGkj6N/fHr9a828aaxJdb7OJyEC7p2H8Kjt+Nb2san5FtJcN0HRe5PauQt7R7i5hs3GZZ28+4P+zngfnVQWt30JmuXRbs6f4daWbayWeVCJJjvx6eg/KvS7FS7KB0PHXFYem2/kWqheMLgVtWk3lodpBA9s0t3dkSVloWrghCwkQADg85Nc9qkyZ+Tj2q/cXIk35Y/jXLa3fx2kM08zhI41LMT2AFUzOK1MPXbp5tQt7SIgyfex+ldV4f08wRp5uGk6t9a5fwRaPeNJq90hM90dyA/wJ/CPy5r0K0iKggjp371J0VJcseVEpUhAoVgw9M4qlqDCGMkkZx39avTSMFaTGR7iuX1i6ZgRnGarlOZNt2MLVdSRZ2ZmCrnA4wCajs71rqdRCuRjABrlrrV7C5vZ5JpBJ5LFI41ORnucfWu38KWDrbi4nB8x+2Og9BUyR2KUbaHS6XC8scJe2mkzEYJCvRl7Y9xUOvRxRmOMQvGIkCDeSDxmtWbcLe2L3ot/wB3gIM8jPXisLUXLSFPPE4HVxn8uaqxzKbvc+cks5Jt0bx4IHXHFbHhCQ2F01lNyhO5M9vUVoY7MKo3sW0iaMEMpyDXt4imqkGj5XDYl0aifQ9Z0pmkjQxKoGMZJro47Znj3y/MccKOlcF4P1WO7tI2YgnFeh2Fyhh24APYmvDZ9Om5K6PNviZo76lpMyD/AFijcvsRXkvhG+ax1e2fJXe3lSAjpzX0drcCywttAIx1xwa+dvFOnNpevTAKRFKfMjPYEdaum73iwqRaSmuh7fa3MkxVIdx44LHArRW03PvubpYyvZB3+tcP4K1Rr3T4iz7iAFYE5IPeu+0+FWAkIQfXmot0N1NJC3zedaNbWSu5fhpHzxXGNANL1p4mYqJ0DBj3Yda9OjhMsZwmVI+8RgV578QbeS3MV9EpMls28gd17j8s0McJXVjfsTE6rI5Z8Dsf6VrC5cyKtrEFyP4hgVzmhGO4iimgKlHUHjoc11sNtLlSWGCOgGTSEp2epTu0nnUiRicdW7Cua1aEW08MmB+7b5j616ALFpIyZNwA9Tya5fxHaqUbA9c8UmaQnd2L9q/mgfLlduBntXMeJ42sNXt76NSI2/duR69q2fD0hnsowSQ6jk+uKTxPZG90mZFJLgZU+4rTdEPSRY0jU5ZcJHt3MOWbnFbsVsGId98j9y3I/DtXE+E7hpIIyxwR1PpXc213EkQaUrgcbif6Vmuxct/dRRu4fmfC7jUfhm4eC7ubU8ANv5PrU+oXazBzGrK+OMjGRWHYTmPX4d38aFST+dNKzFOLlG7O2WR5hlEXg85HWrFmUBYKGDdMEY61WDsgG2INnnK0k0heRUQ7SCMgdqowtdWLc6vLjcvyrzk0x5CVOwshGAD2NQtd7CEbB7ZzTjcRjcAefQ0XFytLUSSVCR5jZPpnAAqvdSpKi7ei8YqG9VVXdHljjGBUEKzK4BAb0NK5cYpK9y9DGF3YPvim3Uq4ACEhen1qKXzo3A3KoI6iqskUrjcGIX3pN20HGKbu2LdPG06uQMkYwKSKW4lYLt2r14FQhWDMc9RxmtBJGgiG5QDtxwMmlds0fu6IlJaRFiVsYHUHrVhGzEw6BR271UiGzlHA3c4zySe1R/bDFkAMpPY9qpMx5W3oFrJ5c7iRiqHox9ql3lwX3GqtvJGtw/m7i4HyhqliLSsm3AY/wnihvQ2vrc17diIwEJIPPzVHeyokLu7Z2KT9DQiOCc42gACsPxFIIoFjXPmTNtx6DvRsc9k2UNMUyztNI27eSc+3aus0+HCZB61z+lQ424HPeurtVWKHIAPH05qYau7HWdjN1CBBIzIHRj1I6GuW1QLGdzsCBzzXSapcAs3PHvXnHiu8kmkSytCTLKcHHVV7mnuyqTfUybmY6pfNMQFs7X5skcMR1NXPAtk1zLLfTffuG3Ln+Few/KqGtqIbaDSrQYdgDIe4Xvk+9dr4asIIrRPMwAB1BwaqeiUUWv5zqobc+SBGqvkYIqq4YkpINpU8ds/WogksLZsbvLY/1cpyD9DSS37O2LiNo5wOjDANJGTuiK7cxxBWxuPH0ryvxrcya5rln4dtslHImvCO0QPC/Un9K7XxTqsem2FxdTNtjhQuxzzj0rlPhRptxe/aNa1BCLm/fzPmHRP4R+VG2o6ae7PRtFsVtLaNfuhQOPateORUkYqdq44xySajfiJcYGOpPAqlczMoILKPoOfzoQpe9qGrX2FKIdvHfvXlXxN8Sf2To8ghfN1MDHHjsT3rs9VuliSSR24Ar528c6sdX1uVg5MMJKJjp7mtIR5pWMptQiN+F+jtqni2GSXLQ2x81yT95uwP86+q9NtGkiRYwM47nFeG/AjTWZLi6YHDvgZ9hivoSzTZGoP5mlVfNIcPcgvMvTWpisUQ20TlRjmTBrk9eVLZi3lRxErkqhzWlq0hMpOGYEY2gHGK4rxJfrb2cjuSAASQRg0bjtZXucNcQgEgVRmi3KymusvbQdxisS5i2ZyOle9Lc+NS5kYXhW/fTdakspMbWO+PP6ivXNKvGZR90Y7tyK8Q8XxSW8sF7bnDowORXofgbWItSsY5CxJxgr6GvGxNLkndH1GXV/aUkpbo9DkJuISGYucck8AfQV5z8QfDf22wkKD94g3of9odq7n7bFFEzSMBgdPSsHVdUimUogPQjkVzrR3PTinJcttDyLwbqz6bqUYclVm+RgTja1e8aBqJaNQSPyzXgOv2JtdXlVV2iX94nsa9J8C6u1zYwOSBIo2P9RVy7nMo8rcH0PYI5fMTHGfasHxJYia3kL45GOas2F0BHkE8+9JqMhnTqSB61DKhdM898GSm0ubjT3zi3kOwk9UPI/LpXp1pLKdjRP8AL39/avLtRBsPEkM/SOUGMkdM9RXf6PdDYjOPpQi6iadzs4QHhyRyRXKeI1VUOABzzjvW7BdoUKk4PbFc9rztIWwOPWlIKK94xPDt0YrqaApuBO8GuklUSx8Hb2x6VxunzPb6vtOMSAiupeWVY2K4PH404vS5vVjroccjtpWr3Fk2Srtvj46ZrovDt+kF8TcozsnTJyKyPEtkzql/GWaaI5IPpS2csc00UkOdkiggn1HUU9tSocso8rO316EzmO58soHXdG3t7Vzdy5/tm0J4+cZPqe9dfBqEV34citZv+Pi2Y7D6qe1cpIEutStYoQTKjs7t/sjpTlqzKLcYtSWx29oI9owxqlL5ouC2zAPAx1FFoJIjhyCM9+1TTylGwQVAHWk0YxfK+4qhGjDTAGT9RVaWRQhI+U9A3apDKHV8Y6dT/hVdzC/GV3D1qWNXb1Jogrxbg2cdcnHFVJrhldQmEIOQM5p8tuY7bAY4POTVFFYzBYWDlR69aTLhBSu7lqd7p23hTuHOQOKkkkYwAvxx+dTpu8oeauPWpJo4ZYgGG32FSLmsUH2OoIB2DqcdKlt5ZPJGR16HGeKeiNtKhCEB5qGZjBtdXOzn5T0oT6jTu7D/ADVARFOG9cdaQjk5k+XupHWs9rl2lLHaeOMU/T53uJGeQheMKPWncpxtqaaBHRAucDqBU0USSThpFChBn0qtZyL9pO5GBx97HFaancp38seu3+tUjGTa0IVba5CktngH0Fc1cTNfam8gYmOJtq/X1rS1i/NtZSMI2XGQMjqaz9GUeUq5+Y8n+tOW1jSnF3uzZs5RCmWT5euQM/nV6a8DW58twwGDhTVQRNGAycj61i6rL5RLRYUknO3jNStBuCm9CtrupiGOV2IwAScf0rlNNBNvPq9yGTeDsU9QnaotSaXV7/7HCcIvzyt2A9KlvZJHWCzzhXIBUdCo61pHT3mW4dBdEtWluTc3I3SzfMQT0HYV04gjjGY3UxjAaNs5/On2lgPKRkXDKOg71YZbe5x5hMcoON2Ov1rPV6sOZFW2DyTM1m7AKf8AVSHIP49ql1G+Rrdi4IZfvKeopl7+5SQtIMnkFDXM6vdiKwmvb6Zvs8Slz2yBTIlZnLeMblvEWr2fh+3Y+RkT3jDnCA/Kv4mvUtEt4LW2jXhI1AAIOOlee/C2yYQyazexEyX0hlbj7o/hH0Ar0UF0bda7TGesbHH5UPexbVloas/3f9GnjmjbornBrIvic4kJVQenaqt3NBNeqqRtbORwyHI/EVHezSQwt52Gwpwy9DVeZg4tbnD/ABL1v+z9IljQjzJPkQepNeGyRu5SJBuldgAPcmus8daqdV1oovNvb5A54LdzUfgHSzq3iy3QqCkGZmz3x0/Wt4e7G5yTfPPlPcvhnov9maFa26pllQbj6nvXcSTXlqN0UK5A4Ibn8qxNI8uKMiZmVFHUdRTJpDNMws72U47PyPzrnTe51OF3Y17i5k8km7vLmGXyjMyIMgL9a8T+OmtfYbXZHcyzvcIojkf+IHnj2xXpuuatPp9vZyXn2csylGUEk+We5/XFfN/xu1GW88VxQfuhZW9ugtvKJKsh7jNbUo80jkrycUe9Tw+auSce3rWLd2hbgjAHpU1jrtrLGCZFP41oHZcJviKsp9O1e42pbM+ZUZR3R554osN+nyoRnuMVxPhfW5dF1MNkmBjiRR/OvYdUs/MhdMdR3rxTWLQ2uozRsvGeK4cTE9LAztdI9jubszw2t1byh43II2nrW3as8+xyoZ8DIPINeJeHden0sGFwZrVv4CcFfda7qx8b2KQDzUuc9o1T73tmvPcXFn0lLEwcdSPx5bRf2rbBAAXyQO+KyfC902n6wYGIWOfpk/xVHd38+r6s17KojUcJHnOxfTNQ6jbsyieP5XQgjHY+tO2ljmlO9TmR65Z6htABYhscADk/StPzJZYgwAjB/vnk/hXD+FdRGo2kbbv3o+Vs+veuytxtwcZOO5rE6o8u6MLxXbGWyfyyTKmHBPYg54q/4bvRJaROWJyvTPeptVeL7O4d1DEd65LwxdtHPNa7sGJyBn+72pmklzHpsV6sS5YhfTNRXN8sqHGR7kVlWxIIcuGYjpjFWWDMuYoxuPUmkyoU0ncxbtjHdRzbcBXBOOK6KB1GGDEl+fasq9tgYJDjkg/ias6TJvsY2VdxxjHuKIdh1XqaAzKpUgYwcg1h3Gl3ln5n2FRJAzB/KPBU+q1tAtGBIuGJ6jrirEUgcnj9a0tc5pXTvExLS5vX+RbeVWIxhyBj8a2dGtfsrtNOd08n3scAY7D2qfYjY5GfepE+bfGCCy9eaqyiiHJy3LUs0u0eX8vOTkZ4qwZ1MeJD261R+0FSoABUcZ9adI6RqQzbk6nPWoYWHM6JlY9u3rycVVhIDPKwCkn86VisvUADHHHemrIU4B+QcYxn8alopMjae5ZnC4VAcDnoPSrBkNtACAn1HBrKjuX+1ssmVjJJBI/rV5p0Z14BC8YJrPU05LuxuWU6zxgzYTIz1qaCazjBLsFA98k5rLksIL+IFrgwELkFDyK5HX9JaKJ5V1S7KZwGHy5Ppjua1UVa5j7O8uW56JPOghdkOR/OuU1u881ht6A8gDqK57RF1NJGjjupZokOGSVgSAferurTG2yuCGI4zUSXY0jDklYmtJtolywzjjNT27yLAzlSZOpANYUDuZA+SfUdvxrTtpDJII41YLjnPQ1Gpq0dQk5MCtEqs2Bx0qxaz+Wr/Ou4+nTNZFiWKOJFCbfut2NWIIgvzI+WJJwelaIxlFWsyn4rufN+zRK3DN0xjpVC2Fw91ElsSACFLDt9PWptbRZdRtAeThs7e1aFhttPKnwCVIODVPfU1pPlh7pNqpv9B2m5YSxMMhk4K/UVzWsasj27OD8gBPvUnizXLrVL8lsrGT90dh7VzlhbjU9UWHcfs8bbnbsT2FEkr6DjFqN5bmvoFo9rYPeOB5twd5z2HaodHjN9rMs5ACqdq/QVra9JFaaXIy8SEbFA9TS+E7Ty7dS33up5pzdlZGcXo5HWWNqrryMYHTOKhurCOSViXKNjlsY4rStyqRZYBuPyqnf3YVCoAwBSscvO7nL6nZRoxaQ7gOmG6/hXl/jy9/tfU7PQbPAheQG4x6Ag4rtPGutLYWMswP70jaoHcnpXI/DjSnvbmXUrnLF2wjEdeeT+JppW1Nlroz1Hw/YCysEjVB5YXG09CKL2ERBvKG+2bqhPI+lbOmRZgCZ6VR1K13S5G9Mdx0NJIh1NTACxrIZInaMjnDcj/wCtXD/EDxDJaWksMFwrMcrlfU9BXV+INsFvK0k4HHO3jivD9Zv/AO19RYQjFnCSEH9492NVGN2OpV925lxxsIWeQ5PJz716j8ENKIFxfMPmlbapPoK8/jspLu7gs7f78rBRjt6n8q+g/B+mR6ZY28EI+RFA4qqsuhz0ot3kdGlqsblom2y45HUN+FZt9aqxKxrslIJJU4zxXRTCMWBLqD6HPf271yGs3XlxMzOcDse1ZmsZMwNbQ3Fgk15p5uUhjxFKt2sRdewIPvXzz40t9Qm1nN/bRWpEarFBG4dY4+cDcCcnrXpnxH1nS7cWFncaUbszQieR/tDopyTgDHfjmsDVtM0prS5NhYy2csNnFeoWlZ8q5AKOD0PORXbQhZXZ42MxTc7R2QKjDPlsyn2rR03XL7TX4cyIOoaoAjYIHp60LDuGc9KzVSUdUdTpqWjO90rxBZaqoSQiOXHSuE+Iuk/ZrxLhOY3PWo5bXHzxlg3Yjg1n69f6g1mIZz5sIOMnqK2df2kbS3MY4b2c+aBjwJlgccd60rOIeaAx4PIqpaurLgDtmr4O2IOByhzxXM2dlraGvEAoIA5PFXFQSR7G4HSqVsQyq+eoq7Hlscc9OKRaRFpMzaPrKhj+4lOGGOh7Gu9u9VMMKAMQScBhXEXcP2uEYUhuh9q0dKv1vrE2FyQLqMgAn+IDoaiS6nVh371mdbKLW504oiM07cmVjzmuVjiOn69HJuJjmXbn3FdDYKTbLtPI6g1n+MFSLTRcKT5kTBuKTd0dTSSOq0+8jAAcgDvxWgt9uUlFeRADkqhOK4KKf/RYpWZiGYdOldxpmuP/AGc9usa7WUAbRzSik9xtO14opXl4kw/c5HHNP8NTssJXptYjH41VFs43SJwx4IHf6VJoAAM2c58wihb6BOyibwmAlC5QsxxhuKslVTAYYNZ0tqsk8cj5wnIHbPrVwzMAATuA71aOeVtLD0V1kJwD34qdUXJcdTxx1pkTAKcY3dwaFZlIUIQG5z70zNaj0CSbVZM4PHbFPlcklGGc9zTQwyd42496dG4C5ZQyenelYCsRh928lPQ9qa8qjAwR7g0GWJ2IQFT6E0vkDcTnJFQ0U9NyjqVy6odsWccgeoqhBqESxjc55/MVoXQdkyBgemM8ViahYNIAV2kdgTSaNYTSR0Gm6nEsbyK+SeAD3/Gmac8El+1zqEqyTZIjVj8sY9QPX3rj2Nzbchdy9QPQ1BNe3TEt9kbeehZqV2OTTdzodX1FbO9mksgrkgIQD196rTXZvpYlbBfHzHPT6VjWdpcyyGSQiMHkqlbFpEsS8rsPbd3oJ0k9C+gWJAiqpyemetXkt96YVWWU9Mdqdptuyjc6qQR6VaW4CTD5cDO05BOKEhJvoX7OKQRIkjbyBgt61OfJjlEQIHeoeAA6sAG7bqRyFVQQd2KpKxm3d6lXWolkhSRCrSIcrjg+9ZS6mj2uUcEdPcfUdjS6jcLhV+cOx6DoKnSwtWt/MmhUzNjJI7VduY1UHTVzmJZpb6WX7Ij7s7fMcYVR6+59q6Pw3YxWunAKvzZ5J6k+tQSXNtHc+THGSMY4HT6VdluYba0BOUAG7nvSVkzSfNy7GFrrefqUNsoIRPmYdc10ekr5KKFxxjgmues4Hlka5I+Z2zz6Vq2s1xHwgDLnmN8foazk7yHy3hZHTTXipDtbcG9etYep3yhCBkN0NVby9VHHyvA2Puk5Brk/F+spZadLcs/yop6dz2FUcvs7bnLeLLuXXfEkOl25+RBulb0r07wvZJZWkcKqFUDHFeefDvS5UWTUL1c3FwfMOew7CvRIZijjcNpA6HofxpyfQ05LI6aOfywcdOwrM1DUWjhbJ9qrvd4UfNg+hOa5HxfrcdjZzSO3Cj8zQjHkV7s474la7JM4sYHOZPvYPQVytlCkNtubjA59zT7OKS+uJLq4IMkrZznoO1Xo7Q6jfW9gi4Dt8x9u9arRHNN87sjpPhloxuLhtTlXjO2PP6mvYrZPIjLrGWTvs5I/CsPw5DBa20dvGVEcY2jFbUkhRSASp7Vz/E7nWo8i5SLUNTWbhWCEdjwa4HxpqqwWrfNlq29bl3Fnkxx0b0ryvxJeG9u2XOUQ4B9a1pQdSVjlxtaGHpc3UlEo0rTreS81S8zcL9oS3hgjlESknDZfOCeuBXLa/Je20s0DajJd2l+EuhKwwZh/Du7jGCMdOK6BNQt2sootT02K78hNkcglaNguchTjqK5nxPJcvqNvJdCGNJbaN4Ioc7YouQq8/Q5+tepy2PladRzudiEwOxFPEfHPBo2txjA+tSjaCBmvNPpkiAxHGe45x61UuLcSxurL8rVpBem3jjoaSReCM4oRoo3OFCfZrp4iMBScZ9K0bZgW2t0P61J4htWyJxGfl4JHcVVtTuVG6kdPWgpxNfTmKkpxgfyrQy4Qleo/WsqIlJUkByCMGtWF/MJXOQKGCRPayNna38XIParM2nwzkEfLIOQy9QazLbPmmEsQyHKH19q2LaTj5+o4JHFI1sS27anbuNtwkiEY+cVYvVnvLcx3DR8jhEGBn3z1pFnUSBfvKRmprpPMjjkjPzJ1zSVikns2UPD0reXJYXIxJETtz/EK7XTzGkSMCMEc+1c9/Z0V4FdTtkHO5Tg1JGmoW7f65Jo887xz+YpOL6GyrvZnSX13HBbs0fJ4IHqewpmlD7Pbor8knc31NZkaTzMrXW0RpyiIMAH1PrWnDIqjJIx2xTirbkylzbGit0I5lQsSr1YlRcAqTj+E1lF5FkBZA8Z6Ec4q/bSRouAPlJyfamgkkkmi0rJty2Qf0pfPQSoS+PQE9aj81HBRMEjsKiYIPvAD260yPUtXqmW3YjKsfQ0y3E0JxuymOQakikG3Bw2OmOlSLEHG7zCD2x0pWDn5VZlRY3kd5JQF9DU4hLOPnzx1HFPkDxoQVZx24ppRnKsDsIpNBKpcZyNwbB6dqrS24zlfv5PGOKtShgm2TaBngk1XmadSqowKk8se1IW5mXNsZsqy4PQYNUry0kCLu+UDj71dOirGPmZWJ5rL1R4ZOTINy5+Woki4XbsZlsy7goAxjkk1pKMuBtXI9Ky7ZQT9D0Pf6VetDMboCNU8vODUo1lT7GzDPIsTgKoxxjHNWWuNsAZ418w8YHYUy4BSEkAZHUZ6VRS8nll2hA3vitCIxurl6Kf7TlGTCgE/SpYpRJHw+e3Ip1uGI/eIqgDoB1pnnQodgIXngdMVSRm3f4UZM0SRXDMVLkdPwqW6vSLdiuBJjgVYZCLveQrL1YtzS3YWSIqsanjggdKDdzTaujnLKZUunkuQARzxzVrWbuOW3jiQKGkYKM+neqF7FIsnHzKGyB0AP9fpVB5s6hGAQ2xCTxip2R1TiptSR08N/arGsTBR79qs7onG6Jww+tYmnwK90j3C5XrtbpVrxDPp1unm2WYJFHKjo34UlC6uc7XK7ITUmYL97r09hXl3iZm1bxLbaeh32tsRLMB0LHoK6rVte8rT5Z5PuquSOn0rmvCdlJJYSXzsv2q6YyuX569P0oWmo4x5nZno2hxotqAoBGAMela0xVYCoGR6GuX0aGaONt9y0ZIyCRkVZ/tnbI8E20unRlPBocWlcmad7IivJnh3YZlA5AzXlHizU5dZ1MW8ZJtoG+Y/3mrqvHOveTB9ntTm4m+VcdQO5rlrCzW3twzqd3UA9zVwjbU56kr6Ims2WGPbsGRwT6Vs+AoDLq13cfeZVCL+PNc3K+IH5+Zj0Hetr4a6zDp2tPa3MgQzYZGb+93FVK7RnTSVS7PUtNsLmW6RN/lK3LHH3RStqoWV7dyzMp4bHBFTS3ot4zuJJfow5Bz71w/iXX7bSIJ7iRgztxFF3f8A+tUpLZHVUkrXkSeM9WyhgiP7wjt2964m0ggN0v255Ps3O7ySN/tjPFcZfarqF5eSXEsrBnJPHQD0FLpw1LUL6G1tnLzSnCgnA9SSewArtoqMFY+bxtGpiJXvouh6BcHwykL5Or/nH/hXE+KdRtr7U7f7Aky28FsluPOxuO0nk4471qSW+nmEwyeI7AT9DtikK5/3sfrXPalp02nXvk3JRyVEiSxtuWRD0YH0NdDaa0POp0XSb5j0/HB5zx0qMD5f/rVNGuFwO/U08JnPavMPpYxI+SBj9aQt8wB71OqgAbjkilUqg5H5UjRIoXUfmoy4BB4wa5IRtb3TxOu0KcjNdtIqgEgfjWFr8HmwiVB+8j5yB1FFy7EVq+4DPIarJcwXAfB2kYrOs5N8aiMcHkVfnO+3OOtAJWLkoO4XEXPYiteAq4VwQSRzWPp7jy0BPU4ZetXADad90WaTLt0LFzI8UqMex4q9K5a1jkjY7v4lqpOguenUik0248mVo7gBuMZxzikarVLuaunuUl2Mx8tx8p9PateBWUbWYNz1qhZ28IG6MZB6Z5qyFeNt0bAgHkGmRKSky887IUAQkHofSnxXKlCE4fOCD2qvbyy7iCAYz+lF1EHIkOd3qvpRuVG17NGuoDQDr+dIh8sLgn0BqjY3Jddrj5RwD3q+MHgg4zx7VSId4uxKbhgygIuSfmIOOPWrCgliCPzqm8CSMH3FMcZ9asiNtxJbg9/WgHJE0KGHIRuCcc9Km+1LEQjqDnuB0NUlnUuyDtyc1LwCCSuDjvRuJxv8RYlupMDy9rc8+1TSFWUOuGIGDVVEXcWhHzkfhTbQXQdmkCAHsB0NAnFFhGD7lZTu9x2qLfhijZC55JqWUbTvyMfXFVrgCUFdx57DpUsce4+6EH/LBlQAc56msqZIgrbgu9u45qVyqyc5Hv0qCeJpWeUvvGOoFQ1c6ILlM2NHM3zkCMdBnmrFvKI5mwSD7d6p+ZuLBRhQPve9W9MkjQE7/m6nI6mpijd6K9joLHe0QklBUDqD3FWYVjabdDlcdR2xUEFz58O0sVIHNL9pkt06b19NtanE09TQebbGV6E9c1nR2cbXO5nc47Gori7aUqgjO89/Sovt0qFVeMkgc4607oIQlFaFu5ZgQsakL71XkfysNJJgHgiqd7e3DbWRgo6le4rLkupZLkGc555HT8aHJGsKLtqX9QYEFS2D1Fc9busOuxb1+SQeXk+p6E1v3BhlUMqHgdqyZdPMl0CSdp4GKnluaqSUWjom8vyd6j5vSub1aNpWVW/iPepJtSnsQUuYZHH8LJzn3PvXNalqWoajcmOJTbQEbWZh85Ht6UrWJjNyWiKviCdL+6FpGM28IzIVPBPpW94PkiudMSI4DQEofr2/Ssqa3gt9PCxIFz1Ynk1W024msnMtntIxiRegb/69U1pYSuveOyvd8YITA45auYuZ47GCe8vHA4yKh1bxJeSWjC2ttjZ5Mrbhj6CuYvFvb+MS6hNvBPyqBhV+goSb3E6l9EQ6b5uo6pNfXKEK3CA9hWnfOcCNByRx7UmmIqW/UBQaqTSNdXDbM4UkA1Zyy0dyug8x2d8Kq/KD61iX/wA0rTY2jOB/jW5qBEUawp16n+tYGrSjYETOSMAVUTnb6klr4s1+MfZrbUpxAONp+b9TUEplnfzLhnllPVmbJNSadpjxpucEseavrZkglh1q7pbGcm2ZQi4YEYPpVrTJ5NN1CK7jjVzHkMj/AHXUjBB+oNXf7PYnI/lVyxZtPuY7iOOJ3jOdsiBlb2INLmMpIpkeGCMmx1SM4/1a3KFR7ZIzisnW7w393HJFAsFtBEsEMKktsRegJ7nk5rttU8RMbtzp9vY/Z2AISSxjyhxyucc4PeuX1i4k1C486aOBXCBQIYxGuB7CtIzsYVIKa1PQ2QDBBHI7UqhipGOAaeQFHYkHAp8aHOcHFcp6aRHswD0z6Ggxgjgc1bWNRhmGQeOe1KyqFwPzFSyyk6ERkkfKKoXMW5c+ta5HB3HKmq88QKgDikaJHF3MJsr3CjbGxyKvwfvYWKYwQRj0NaOpWizwlWA3dj6ViWDtFcmNyFOcGrYRXQvWgwpGeGHP1rUtz9ptniY/OPWsuQ+XLuHHOelWRI0YW4U+x+lTcuxp2Mn7oop5Xg+1VLkZuSwY7lpv2kRTLKhBU8NSyOROx7YzjHUUGkV1RuWV+qwrj8xWlZ3JldiWBHcCudsYySy8+UwyAPWprecxTiJ8gjv0ouHImdUlxEgVS2A3AOatbFkjzG3Tk1zUs+JF7xmti2m+VWXBGeRTuZyp8tmi87iMDcenU4qzHPtClmXB6ZqtMd6fIhIPUY61XngLR7m+THIFO4oxUtye4vZImyCHT0Hap7XVfMRdiZ7Y9KwVk2kI7ZB454rV0u1VUMrEdfWhM2nCKjqX7iAz7XUFT3GatwTReXsdWYgfjVcSgsQwGOxU0eUjTbkf8B3p2ML3VpF2F9rcEgsOmelWVlRcK77WxWVLGvm53Mjr3zwaiuZcoNsi5/vHnFD0FyqRbmR5pnH/ACzX7vOc0+CaVHGUAxwfpUFuR5SASE8dqWSU2yncCfT1qdy3d+6PkUNIRIAzN2rMuBN5mB/qxnJU8fQ1cM8jwlhFsJ/ias6WZkKxoQAOpxjmpZcE0iKFkbeqRnae/vU4tnER2j95346VnMjJIPm4PUE10NmZWh5VAKUUaTk4JNFayimkIZ2MYXjnvWpklMuQEHFVHhbeGLE5P8JxiiV1fAywwemcVdrIxnLmYq3ESSFY1Yk8Zx0qYAqfMdwSR09BVcu21hGT9McVVtnmnmZXDbe5NNdg0eqLV1HGULJGN3TJrEkVEkMkj5xxgVtsSWKtnFUb8QlQGHzHsP60NFU6ttGZX2hklCwMxZj3Oa0xO32VeQJc9TWA4eOYMoIXPAB6/WrUshji24LM3OfQ1KdjapHmSsS6hetHG2/azdqzTEbghjtUnoRTIXM0jCXBxzzTL5v3qhSFVBzihu4lHk0W5V1lUiUJGxbA5yahsERYB5hwfSo5StxNukyVX7q+tSLGfLMr52/3BTJbtGzK+rTbtkMeCp7+tVb3aqbVGCBQwa6nMmdiqcLVG7lJmCgkuvXB61RlYW4kMVltP3j0HvVeKMwQbienLE9zSw+bcXG4/MF5PtVbVpDJKIkPyr1ANMyl2Rn3U7PIzEnHWm6TZi8ufOm+4vTPemSRSXFwsEQ56E+ldRaWywQpGoGR14qrmMl2FjiUJ0AHQY60PBu/hBq35S/8tODSY28DtUmLiVGUrgbcfSrmjRWkmrWwuwhiLHiThC2DtDe2cUxgWGasaTp8V/qUNvKzrE2WYr94hQSQPfighouyr4uBKrA49FjgjMY+nGMVzfi22jTUE2LClwYUNysGNiy/xYx+HSt/7Ja6vbOmkC4tbuMFltnmLrMo67T2b2rK17To7N7JbdCgktI5WBz985zV3MmjpljVsDAFKmCpUZ988YpQmRz0PORViDGTvBx3FYHoaECr0/iAqUJu6LwelPdE5ZTtXtRGgPOaRREYznOMH6UyWAlAGXg9KtuiD+IjJ6A0uAepPFBSMmS3bPIBrndbsGQ+fCBuX7w9RXXyRseh4FUJ7fzQykcGmmWl1Oas7kTQ/MAQBwcVYt5PvQvjac4aqd5bNp0pkRT5THDDHSpbXDBgGyDQtC1qTWoiJlhbg/zq5CFdVJXJXg1m4Ik64dTmr1tJtkEnO1utBaZpQuqMFUkDOVNJKpa43cbu+e9VrmRfMRkPPWpGLPGHV/mTsaC4l+RwRjG1/fpVvTrh0UgqSo4J9KyHfzoOFPHOAelWbWYJENrH0ZaQ91Y34NQZGw2dnQHoavR3Ech5chSOR1rnZZY5Y1ER+oJqOJ3jbjn8ad7C9nGW2hvX1vD/AKwLu74FVbK4CynYxZc42+lTafP5uYnByfbpSS6ZNFcGSLBB54p76oE1G8ZM2LR4Y2PJyQDg1azCG3MwXJ49awZZjGymZdxHOc1a8xZEDghl/untTuYyp31NFl3HLyBkPY96hntVd1KIVIp1sVlUFlAK9KSVn34XLKeCR2o6EpNOyJDAQy4XDHuDRIjTsv735RwR61LhlC7iD9TUUYdGbaykHke1KxHMzPuZJ1kx8+zofSoboSJGJGBIPQetX5FnZSsjqSWzx3qKVbnz8Oo8tR1POKlo2VRIp20e6MyTAAg5Fa1ldkIQwxH2IFZ8C5vuNoVjyK1Qq+WRFy3YU4oVSV90JLKo+ZpOT7UqAS/MXGwdzVNo5CT5/IHQVZhKFfLXbjGMVaIdktB0t0ACsJUntjms251OSN/ljXIPJq6sKIWK4GOuBWPehJm6hSeeO9JvQumot2sWl1F5lYZH1xWJNPcQtkPlm4qGScxT7VLbs4ANPuJ1YATHOT09Klu50qKi9FuE8/lwKQvzHn6VGsx2PliSegqO8gZ1XyxtXsM5zTYyIXDNg44wOtAlqizpVngma4OdxPFV9WkgQ+XGCGpLu/2xYAxj9KypnG0MMszdWoItJyuxtuy+cxOQP502aeaWTYjBUxxmjaCuUxz3qOWURL8vzPjGMd6a3G0mEknlp5MJJPdh2rKlBkuAI+w+Ynqaszu0Nufm+dv5+lQW6rBGDI2WPPXrVIxl5Dnc2lqT79O5rHdyoz1nkPSpr273TBm4RegPrV7R9MkaX7VcqAzfdB7UzFj9LsRaKZJjulfn6VpjoCBx3qxHbjPOCBT1i+fB6fSghojjRXHKkCnGHA6g1KyhBn04qLnnrQQ0RPGQ3+eaVGktpY5oXKSocqy9QaeeBzVnTIo5r0GYb44keZk/v7VJ2/jigykrFG4luZLpr4bxJu3+ZGm1Q3qMcCoNWv7jU5xPeOGmCCPcFxkDOPx5rqTczjX4bQ3l0odUX93gIGYZG1OhQZH1FY2uwQCSGaOIRiaISlU6K2SDtHoSMj60GRuRqRICQNnbNSOgkzjp2xRRWR1oYsTAcgADrQp25x270UUGkdR6AcFzknpSAHkA4HWiimUSLHuH1qF4lV9uMH370UUio6lO/s0mgI/AiuMvYpNLufmB8on5D6e1FFNFIlc+aqXETdD8w9qt2hR0ZCd3dcUUUGuxYDAY8wHI+6TShszKD8pI6UUU0D0JLKQLK0bj6VZlAhYyICV64oopGnYZFKFczJnHTFXYQJFLHAJ70UUxPc2LCeKJdrrnb/F61PNebyBExx60UUr2QlFN3K9xKyg5y/rVmybzbfAQ7s/SiihPUdR+5csWi7UYvlccdetWbdkjDSpKSTyRmiirSMJbstwSiV9zLkY9KrN53nuVA2kUUUnsZJ2bE+0ABQ8RXB6+9VLy5lSf5jtRujUUVDNIpc2xEJTFIu5C7MeOKv8A2iYplowhHAFFFUi6iVkENwXQpIhJB6ig3Sqm1EGQPyooquhKirlWaVo4Su8gv6Hn61DIiSK0of2z3NFFO1xd2Yt+USbKdfWq0Tb5GklYEjoD0oorM6oIsxySEnByBjrUF0pBOZF9aKKS7BLR6GXK+8kn7gPAHU06Z02hQcu4wAOgooqkiJMqTZhj2x5LdPxqIDaoLZ3EdfeiimIqyqHY7m7557Cql5PHCnTLfwj0oooRnIl0bRzOVnuSB3Vf611NvAoGd+4nrmiihmRYFspPJGaTYoXLEZoopIzZFIAGOAAKiPqvHtRRVEyGtC/BxxRaSPa3STxYDocjI4Psfr0oopmLNdNQgERTOoJHtI+zpIuwD+6HI3Bfasi/na5nMkqKnAVEToijoBRRRuRyq5//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous papules and plaques with accentuation in abdominal striae and relative sparing of the umbilicus are present on this patient with PUPPP. Erythematous papules are also visible on the hands.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18872=[""].join("\n");
var outline_f18_27_18872=null;
var title_f18_27_18873="Pratt cervical dilators";
var content_f18_27_18873=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82709%7EOBGYN%2F74741&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82709%7EOBGYN%2F74741&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pratt cervical dilators (uterine cervix)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 412px; height: 233px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADpAZwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAoqG7u7eyhM15cRW8Q4LyuEX8zWRP4v8Pwrkatazn+7bN57dM/dTJoA3aK5lPG+jvnYmrt9NGvDn6fuuakn8aeH7eLzJ9QES9MPDIrdM/dK56UAdFRXOReOPDMs6QjWrNZH+6HfZn88etSy+MvDEUgjl8R6KkhOArX0QOeOMbvcfmKAN6isNfF/ht5CieIdHZwMlRexEgf8AfVIvjHwyy7l8R6MVzjIvosZ/76oA3aKxx4o0Dbu/tzStucZ+1x4z+dSw6/o0wzDq2nyDGfluUPHr1oA06Kof2zpgbb/aNln089f8anhvrSdcw3UEg5OUkB6daALFFIGB6EH6UtABRRRQAUUUUAFFFFABRUc00UIBmlSMHpvYDNSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFMmmigUNNIkak4y7ADPpzWNeeJrGKeK2tWa8u5ZWhWOBS2xgCSXwCVXjBODjI9RQBuUVykUXifVpXN1JHotpgBRFtkuAQx3f3kGRjDEtkHlFPTD8V6jbaH4r0r+wYE+23EsQvxbYLyxPMIxvGCCN7sS5wwIAz8xoA9HooooAKKKzvEWtWHh3RbvVtXnEFjbLukfBJ5IAAA5JJIAA5JIFAGjWJrPivQ9GuxaahqUCXpUP8AZUzJMEP8ZjXLBB3cgKO5FcdZDxp45aKe/jPhTw0+WFossi6nMATt8xlC+SCNrbUbcCMEkEitO18M+B/AsAu786davcEW/wBt1WdS0pyWCBpDjPGcDk7QTnGaAFTxhqWsW9yfDejyMB8sFzcfPHKf7ybD5br/ANtV/Dmon0XxRrNlJ/at20X2lE/0cXTWq2xyd2Bb/vCSMf8ALwRz7cpdfE2yktFudB0TXdZtnUst3FafZrbaASWM05jXaAPvZIOeCecRR/EZpruL7PpxubAMfNn07zdRJGcKF+zxsuSCCdzDGCOetAFiD4eQC7guZbq1ingG2OW202Ey45A3SziZycEgndz7V0K+H1YD7XqmrXDev2ow8c9ogg7+nYVxlxr/AI9uVtpNN8P3W0sDJ5tvbxDaCOivchhuGeCMrn1BFS2Wm+M7m+ivdQvdUjjRQ32IXNrGrHkYOyI845ILEZPBGBgA6a48HaVcl/Pl1l1cAMh1m82kem3zcfXjnvUQ8E6Sq26RG/SKAERxm+mYAkqcnLnP3e+eprGXT/ElvbFBBqdyZHaR2bVFDjK7QucAAd8LgZqhFZ+LZ4zA1jrlgsLuUmTW4JWmDZIzvRsAdvbHXkUAdTc+DbCYx+XeavbLGHISDUZ1G5h977+cjt/9c1SPw/s1Zmt9b8SQSMEVnXVZWLKpOASxJ/ib889a515PHcDts03XXwmxPLurF1B3lmc73BJIIUA8AL0HeO71D4iSMv2Tw/q6MibMz3Wnsjnj58K+QcjgZxyRzxQB0E3w+ctIYPFXieLezNg6jI4XPQDJ4AH+NSSeCboXKyp4v8Qp2CNcgg8YHGMHjnpyea5e61H4oF7drXRrlQsarIsv2JsyBMM4xOOCxLAZ4wOxxUK6j8SI7RIP+EQv5F8gIrfa7DfDIA6lgxk5yNh5BxzknOAAdfF4R1SEuU8Z6yS6lUL+W+M9DyMEjn9PSrEfh3X0kyfF1y6bicPZxE4Pvjrnv+Fczp83xDdA11YSqrx+VLHILUyfe+/uSUD7pIA4IIyTziqo1Tx9FIbeTSZreSXzla4S3V4gQDtchJGYgljgDDfuwCTkUAdNd+EteuLOWF/Fsjl025k0y2fJ4xnKnI4757VRb4cyyS+ZcanYTyMpBeTRLQkHPBHyZ6ZzknnH0OLceIPGN3bKbrRLy1mMYzB5M0gJBGAxiG0ZG7OG5+XhMHMTeLfFsMF2F0jUpTwUi/sq5wVzjYDyQ5DctuC/JxgkkgHTxeAbSBEjjkaOSRtrSwadp6bVG4nIMJyrHHAyckdOaWPwNdQXFxcQapZvPNne02k237w9i5RFJ29Rz165HFc5/wALH1iKad5vBWuify8wTRaTcugDBCysoXO/dnOOPlxuPBMp+JOoi8MjeHfFZiJYCNPD90AEywXnacscqTwB8vvQBuzeAGnvfOmu9Nkh37lgl0a2cKpxuXdtBPseOeuelSXHgRXcBF0Nog7MEm0hPun+HKMvcA7uvX1rmx8Q9de6utujawkDSqLcS+H7/cibU3F9sfzcmTABBGFz7rB8RfECmd59Fu3VEOwHRdQhBOepLQncT8oAGMfMT6AAv/8ACtJFt5Iom0GMbm2bLG5T5SO5W6GG9x+GKZL8Or3J8tdA25IKxx3kBK/Vbg4PXnBrJb4t6ral/tfhvUXkzIfLFhdRKEG7YQzw8lvlz1GOnenah8ZJrKIt/wAI/fSESBdqxv8AdCBmYsFxgk7eAcEEHB6ACt8NdfYKvnaOPnBZ47vU4yUyMgYucg8Nz05HHBra0T4f3tqqm8u4QwxkW91qGCcjB+a6PQcdOSM8ZxXN2nx2stl19otbcGJlKF7l1V0IGSGMIDYOcAduoBBraHxs8MLfNb3MslssaRSSzTQTrFEsgDKWcxYAIPykn5iOOxIBjQfD2HXPFHiKORLOddMls7NX1GJb8yt5KzSuFnWQQ7vOVcIQPkyR0Nad58LI5pzHb6T4Rit0JZJJtEt5CeThNoQYXGBnOfrU+h+L9O0i/wDEGqakZ7e21jWo2td0Y/eR/YrSMSfexs3cbgSDkHpWlN8W/CUEKyT3+zc4QKCrknkn7rEcAAnnjcucZoA5G1+HerWq7v7A8ME7yGit9NggEiheCxQqeG5XGD1B7Gri+CtRaFfO8Mad50YSNHiupE4xhmIEwzySeTnBAycA10Vt8XfB1xlP7U8mbeseyWFyQzAYztBGOcZzgkEZ4q1Z/EXw5f232i01mBI3YqgmgcHK/fAHG8jj7vTI69wDlH8GamwQSaNdou47/I1u7wQOBtH2pcA5z3x3HSnnRfFBPljRtSA5LN/wkV1y+BtIP2rO0Y5Xv6jqeoj8dae9xEI9S06W23v5k22ZDtUbjgbSPlXq27HHbcMRf8JwyXVussmkrFKBtYzTL5xwvKEx425dTnnhhjOaAMS0sfFkEUynQrltyoCX8QXJ5wN23MzEfxcjH44ybKz6+XDxaHqkUKRiUtPrTpyvUHcpHIOecdDntXQ/8JYHgSW2bTZkf5l3XDx8ZwesfPIYZOBx2rNk8SprFsltd22jSNxM0FxcpIqujLwyjcQVZlIbByQPu7lNAGfLrWtsDjT9dOeA9rMJYmypIKOIPmXp8w454zisebWPFcfmfuPF0Sb2HmjyG2ruwCAbMjp8xz06AtXSyeLotDtYItPsdGewXIItL6OJFkYlgiqRzycZ4yckhazLf4nTeZbw3CaSHdE5OowqzsY2ydrMuF3gc+gI7igDFn17xPsYy3fjK1lO8+WlraOEAJ2/esgTkYOOoz36mo/ifxLHYJOb/wAciQ/KyHT7I/ODggZtU4z0POR05xXQH4nXsZlnlt9KMKOoCpqUGCpBIUkOTuxznGMKeOeJ18e+IVEYbSLZ/L3NOPPUtt6g5DbUGCcctnaeR0oA5a48YeIhGzRav4rXDlWB0vTG2kdR/rBz9f8ACrFn8Rtfs4UhuJ7yf5BIbq80uz4GWyGEV8oJAGMKuQRznOK68ePdW81EPhe5yxGcSbsDIyxAGcEEY78jrkVBJ418UFWaLwrdoN2cPbSnC8kdOSSMDgcHkjkCgDm4PibrbzMkupafEowN7+H2HJxt4F+eozwcH9a2YviLdLNGZdRsniDDzB/ZEqEjoQCJ3xzxnBwexrQt/GfiBrdmm8MXe9grIVtpcHj5iQAe+MDOcetVrjxrrrsyjw4yFDGxW4tpBgs5C5/u8jIbkZB79ADXX4i6UQCdwbzTEU8uXcGyMDGz0Oc9OvPBqp/wmWoaijXWiYa1lYC3SXTcPxt3KS9zGCckdh1A5PFZf/CcXnnzxx+HEacL5+BbSZMQHU/L6/xdODxW1H40u1kdDYR+SZEihZQwP3d3I5znGBg/nQBsrqus3ULtFo7Wy45M84Ei54HyorqSOcjJ+73BFRWtr4qugi393pllChQjyVknmbA5y+Y0znB+4VOSNtc3efF3QtPjMl/faagUFnj+2xK8YL4TKltxbAJKhcj07VkRfFzVdbZV8GeEtW1qOcuIbpLZ4LbgE8zTbFB7dPzJxQB6HbeF4PKA1C8vLyY4LybxbliG3c+UEyM9jkY46VV1vxP4Q8B28VvqF9p2kiZmeO1iUB5CSSWWJAWYk55A5PHU155b3Xj7xN9nkudcisYGYk2fhuJLqUlSQVe6k/cx8YPclicDgAdJ4N+FOlaBczXYiCXsuFkuxO893KAAMtcv8yk858oR9uuAaAMbUvFHi/xpeSab4bsLvw1ZbP3k91Gr6g2WGCsO4Lb4AJzMwLK+URiMV1fgb4f2fhwyXNy7XmpSyLJJczSNLLKVXahklb5pGC9B8qDqqKck9hZ2lvZQ+VaQxwx5LbUUDJPUn1J9anoAKKKKACuN+K/h6/8AEPheIaMd2p6de2+p20DTeXHcvDIG8qQ4IIYZxnjdtJ4FdlRQB4/eal418SNLbaPYeKtNgz5Mr3kVnZSCQBgWWctLiIgj/VwM2QCJAOD0Gk+AH+0Lf6tPaR6opAS7tYPOu1jHAja6uN7txnLIsXXIC16BRQBgr4R0E3S3VzpsN7dqAFuL7N1KgyThXkLFRyeAQK3qKKACiiigAooooAKKCcDJ6UgZTnDA4ODz0NAC0UZ5x3oByMjpQAUUUUAFFFFABRRRQAUUUUAFFFFABUV1bw3cDwXUMc0L8NHIoZW+oPBqWigDCi8JaLbwpDYWj6dAmSItOnks48kkklYmUE5J5IqcaBZhAvnangf9RO5z+fmVrUUAZaaHaL0k1A/72oTn+b1lXXgHw5d3rXdzYSSzks25rqbgtyxHz8EnmupooA4aX4W+G3mMiJfxncHUJeyYU4A4yT2HfOcmmN8K/DrSSuxv2eUKHLXBJIUgrzjsQMHrxjpxXeUUAedf8Km0kXPnJqusqTjcvmQsr4xjIaM9MUx/hBoUiAS3moyPnJkZbcsxzn5j5XPPPPfmvSKKAPK3+CeiSEeZrGssFGFGy0Xb0wRiAc8dfzzViP4N6DGUb7XfzlTnbceWys3y8naikH5R90gZ57CvTKKAPOLj4SaDOo3wQeYGBDhZQQN27AxIMfNz9fbis2b4KaQXH2d7eKNZfNQGKUlDxnBEw64HavWaKAPHZvglDJJga0Et1LNFELQnyic4wTJk43HG7PXkms2f4CFrySaLV9L2k/IsumTsUGOQCLsDBPPTjjGK90ooA8Fn+Bep7VEfiDTW2vvVlsbiIqcn0uWBHPQ/nnk3ND+ClzYyk3etXUmQpElrfTROGVQON/mDAIyvcZ6nGa9uooA8pn+GV+6PjxB4oOcARDxTcKgGMdRFnsOPc/jTPwQ0F4ITLo1ndX6YT7Vqeo3V6do/2cxjuemAK9iooA4vR/h7pOlP59hZaRp1+v3L3TdMiinGQQ2Xk8wnJOfwwc1vL4fsXhgS/EuotE28NeSGUM+CN+0/IDyeigDPAFa1FACIqoioihUUYAAwAKWmySJFGzyuqIoyzMcAD3NcfL8QtKvBcReFRJ4ivIo95WwVnhBwdoaYAou7HHJPfGOaAOyorhZdP8U6/d3D6lJFpWm9La181t3KjmYROCxyWACyhSCMrkA1DBNp2i+NNM0fwk1lFbic2+rafa42wbrZ5IXKDiM/uAOg3BucnFAHoFFFFABRRTJpY4YXlmdY4o1LO7nAUDkknsKAH02SRIo3kldUjQFmZjgKB1JNcw/iDUdYllg8K2IaOOXyn1PUFaO2GCNxiUYefGeMbUODiTIxWPr154Z8P6il14z8Rveao6RiOwMjMud33obKPJb5ifmKuwXgsQKAOg/4S/SZ4bhtHmfWpITtaPS1+0YbONpcfIrcHhmFOe98RXMqrZ6Ra2kOfmkvrvLjjjEcasG75y69OM5zXMJ4z8RX8cSeHfBrafZ/Kkc/iG6WwHBIwsKh5AMAYyq9enHOfJB8RdXsrI3eu2tg8s/zDQ9LZtijnLSXMi/Lxt+4cls49AD0eG3v2g23d+nm7mIe1gEY25+UYcvyB1Pf0FV5tFiuXm+0ahqUm91fal20OzGcAeWVIHPPrjmuIXwNr80TTXHifxBPNJGCY3vorNtxBBDGGFsYB4KsfxIBrZX4e6XdsJdYfVbiYZwDrV2yDcgDfLvCjnPIUdAeuaAOjOi2ZIL/AGlyF2Ze6lbjOe7f56VWHhnRF1SO8+ww/bQhCsWOSN2ScZweSMnr0HpVVvBWjPaJbOt/5K87P7SucZzz/wAtOh5B9QSDkE1j2/wn8JwXRuYbCaC4E5uUeC8nj2yHPzcPycHHPA5IAJNAG3/whujLBLDFFcwrIzO5jupQSWbccndyN3IB4B6DrUN94PiuGk8rWNdt9+SBFqMwCktuOPm5/HOBwOBisJfh3NbIIbHU5Eg3beZ7jesZySVYynD5LcjruOc1Un+HuuLLHPDr7zSLHIjxvNNEkhI4JKsSCT147cUAdBZeCLS3d9uu+I5W2un7zWLhypYdQC+OOoyOP0pJPBMrIWHiXxEk3OCL5ipxnbkH2xnHBx71yth8PfE9nPPPDrjpI8BRQ2ozShXKqAw3ocYxxwcdh2rXTwx4rQWkg1mYzRpEsqnU3KPhMOP9T/eyQ2M5IzlRsIBrHwjcD7nivxAkxZWZ/tCNuA4wFKFVH0HJ65q1H4duo8vD4i1OSQlP3kqW7nAIzg+V6BsdgXY9+OZuPCfitozFDr1zGHVSzi9Ztu0KCi5Tvg8kcnP3cgCtc+DvGM11OP8AhJLqOzQOYUhn8vO5wdmAMYAGB6A4znkAHU2vhnU4EijTxNqMcMcoYJFBahdg/wCWeDCTgcYOc4FMsdA8QxyIbnxLKV3738u2gDEYwRnywPTBx25rnf7H8eLf83wMIkD5DBlOBgDlgdvPoCSASMCo9Ns/HlgtpIbjUboxO6vbywWexwRkcrMu1AV7cgEALgnAB2K6VrbeTnxFMqhQJEa2id923s4VRndz93BxjAps2k+IyD5PidFO0Ab9ORhncSScMOoIHb7o9841xN4yuxJHaaVFpUzzFHusRS/IQP3gXzvmPyj7wzjgDvWY8nxCBW3a5VCUkVpm01XG4k7SNk2RgFTz129+hAOqfT/E62bL/bdjNcDJSQaeyYJJwSBMAwGenGcde9Qm08ZiRf8AiaaLICjf8uEke1yOMjzjwOnB9T6YxJ5PHCzTFrqERsrCJk09sFhI20sBIxUbSMjGeASR0LLfXvHTwNK9npynaSsT6ddqx54yQSM9sdx8wI+7QB1cVv4mU5lvtJYYbKpbSLz8u3kuf9rjHcUkw8VKG8ltEkJkyAyyptj2jg8nLZzzwMdvXk7rxT4z0+WMTaPZ3EI3PI0FrfOzJ1yoWJsH/ZyW5GAcEVE3jPxZAt15uk2zPEFKRiy1A7yxJPz+Rt4wRjnJxyMjIB3ULa+bVWmj0sXIYhkWSTYRv6hsZB2c4x145HNR+f4kEzj+z9IMQUbG+3yBi27nI8ngbeep54965nTfFviC5V0ay0p7hBHFtDXEReRyo3qrxA+X82TzkYI9zrRa94gjncXvhyBLdZVQyw6kjEJsJeQqyrgK23jrtOe2CAUrPW9a1DVddl0+ys5bewv3sIxcXjwE7IoSPlAZWLSSSjJx8oTgmpr7VPGUZSS38N6fMyKMxJrBUMTkHO6DOAQCCOSpJIBG05XhPxjDbWA8/QvECG71O9Ehi09pxbv9qkXbKYt2DgA5GRjucVLqHxPt7Qqw8K+NZYSyjzI9FkGc7s8NhgF24PHO5duaAL8Gq+NIldJPC9lIQWbe+sjB5GAu2DPQnqB059afFqvi+UASeGreEtkuRqisFwPuqfKBOSByR0J9qw4vi9pvyCTw34zQM+zfLozqM5H+PQc/jjOrYfErRriLzJ7fVrMeQtxi4tDnyzn5vk3cAggnoCDQBcuta8RwMo/4RW4mxuz9nv4CpwePv7TyPYfyqjL4q8QRzuG8G64YzgRNHJatkLnczfvBtJ+XC9xyD1ArWfxe8LXJGW1OFecvNp8yquB3O314x1yPTmpl+K/hN5YxHfTvE6yOZRZzbVCEKc/Jzyeo7c9OaAHXHjbVPN2w+DPFAQkEP9mt2yNuSMeeMYOB7ntjmqz/ABDv0mLf8IN4zeKOP50SytySxPBBE/JG1sgZ6jp3i1D4zeDLOM/8TeKSQDJDQzIFHIy37s7fmwMcnn0yazr74k+HtZ02KRNVtxJuDqsN7JaMFOw4YsYw3G5iA4ztUDduNAGjN8UIkiGdB8RROs3lSs2mbljYYyhxJ9484wT06dAVX4saZGqfadL8QoWlYNnSZV2JjIc5P3cHG4ehOAKoD4l6RbW8FrHqHhdILZACr6k0oj2JnaGK5Y4GQxxxz1zUi/EbTrl/NivPCLtIu90OpqSAAMKzlQNxYAAHB46cUASXnxYsYnaaG3uzaqoc+dYyx/KQMfONwyScYKjODjPGaLfGaFd6/wBkT+b0UGK7wx5yP+PbORxkYz6A8ZfJ8TNOYoWbwokoES4m1MAxq7BSG/d5UdfYDHXOKQ+O7F7hvN07w3NFukjdhfRgZAAPJXJzk8YGQw560AEPxfLWcU8ml2qGSESqv2i55OTkAm2xgKOpwd3G0YJp9x8Z9OUE29tFKMKVy843Z5A4gODj5sddvPTmpm8U6L50wTR/DU+IlS38rULZjIMLui6feHOFGc7e3FJN480/fIj6JpLSKyJKhv4DyX2lc4xuBPQ4HqVGCwBHY/Gzw/c3IhlnsoASSJWnkKbQMltwi4GOMnAzgZyRWg3xc8NLnOt+HgQeN2p7c84/ijH1/Kr9v450e1NwkWm3FvsLyTKjW3UEKSQsvJJ/MAnpzW4uuzsBs0PUWzwAJbU5buv+u6jvQBhR/Evw9PatNaanp9xsYo3lTNINwwSAURs/KQeAetN1Lx5PbIDZ6JdXrlgmEgulVCT952NvhUABJbnpjFdDHrcr4B0y5iDPsDyzQBCcZ4IkJPQ9B2PSuO1v4u+HNKUNNrPhzdwGQap5jqTgj5Y4249TnjigCvY+NvG2tQySaV4PW3jMbyRyXcuVypUbeCNxOW6YzgYzzViLSPiVqrQjVPEmnaFbqzCUaZbLPLID0CtKuF7c4JPoK5vTvjBq3iJUPhnw9qV/FIhPn2tkwhR8j5TPMUQcdyPU8dKiOt+PNYuraKODQobjIJG+bUZ4gpBG4QBLdH37WAeQDg9QKAOw0v4TeHIzBceImvvFN5ChVZteumvVTP3tqP8AIMn/AGewqDX/AIteEvDqyWej79YubdhHJbaRGrx2+cgGWUkRRjK7eWz7dcc9B8KNd16AweM9fubyxESolrK+2LcrcObeHZEDxuG5pQDgHPOfRfDngbQdBjtvs1jFNcW2DFcTorPGcEZQABY+CRhFUc9KAPPCvxK+IEh3yjwlohKZitnYTSKVjbPnlRIxB3DaiwjDY8xsGvRfBXgzR/CFkINHs4IHaNI3eNNgYKOw+uTySSTkknmukooAKKKKACqerxPPp06RIJWwG8ogESgEExnPHzAFcnpmrlFAHD67Y6/r+qRrb3+p6fpSgRz2kOy1MjCVd5Nzh5cFM7REqZwcyLkY0vC/gvSPDUbppNrBaK7BnNshR5iOQZZCTJIcluWY9enr01FAEMFrb28kskEMcckuDI6qAzkDALHqcAY5qaiigAoprOiDLsqjIXk45PQUkUqyglN+P9pSv8xQA+is/Utc0nS/+QnqljZ4/wCfi4SP/wBCI9Kgj8S6FJD50Ws6bJF5iw70uoyN5OAuc/eJBwOpxQBr0ViHxTowhjlOo2flSIZQwuYiPLBwZOG+6DgEjpkVUi8eeFpLhbc6/pi3BAPlm7jJGRnGQxBwAc4JxjPSgDpqK5u18deFrtEa28QaZLuTzMJcoxUYU/Ng/Lwy8H1rRt9f0e5jWS21bT5o2AIaO5RgQRkcg+hB+lAGnRVeC9tLhisF1BKwzkJIGxjr0qcMCM5GOv0oAWimvIiMgdlUu21QT1OCcD8AaRpY1iMjSIIwCxYtwAOpz6UAPophmiCsxkQKoyx3Dgepp9ABRRRQAUEgdeKZJNFGcSSIhPOGYDsT/IH8qBLGZDHvXzByVzz+VAD6QgMCGAIPBB70FhuC5G4jIGef88ilBBxgjnkUAVX06yeTzHtLcvkNuMYzkYAP5Ko/AUh02181pBEVZjk7XZcn6A1M9xCkojeVFkOMKxwTn09aaLy2MaOLiHY+Nrbxg5OBg+54oApNoGnPbwwSQySRwyieMSTSOVcDAbJbPeopPDenO6sxv8qrIANQuANrdRgPgiteSRIlDSOqKSFyxxyTgChXViQrKSOwNAGUnh3T1XaPtm3Ei4N7OQRIcvn5+cnnmmf8IzppheJxeSoysjCW+nkyrHLDLOeD3HfpWyrK4yjBhkjIOeQcH9aWgDFl8N2TwLCkt9GoGCyXku9vm3cuWLHnnrVVfBulqbjBuGFwytKsriZWxnAAcEKOTwMDHGMV0lFAHIj4e+HtpD6faSA9fNsrdyfqTGSfx6Z4xVa7+GPhq4jKDT7GIEKPl0yyb7vA+9Ce3H0FdvRQB5vJ8HfDToyhERX37gNOsDncRk825x07dMmq1x8GNEZl8idI494d4jpOn7WIZWH3bdSOVHQ88+pz6jRQB5g/wc0WVYzcm2nkS5+05axijVjgYVljCAgEE+uWOSeMZp+BOhJhbU21ugXbtSCQc4xu4lA3Yzyc/oMew0UAeMv8AfD0kOycW07AYDSxz8cAY4nHGFCgdlyBjghkX7PHg9AS2l6Yz8gHbeAYxjp9qr2migDyW3+BHg+3bfHouj+apBjYw3DBfqDcc11mjeAdJ0e6M+mxW1kQRsSzsLWFY1HVVYRb+eMksTwMEV11FAGS/h3TJlkW9tjfo5Vil9I1ygKnIKrISFOcHgDoPQVrAYGB0oqrcajZW15b2lzeW0N1cZ8mGSVVeXHXapOT+FAFqisTWfE+maRAkt7KY0kYJG0uIUkYkAKryFULHPA3ZPJAODXN/wDCYaxrF5HbeHtDvHjPMl08e2FVZeCJnKrkMTkxrP8AdPHIyAd1dXENpA011NHDCuN0kjBVGTgZJ9zXKX3j/TbWe42Wt/cWtpGJLyeGHJtlPQtF/rDwCSApIGDj5hnm9emsfD9ubv4k+J4YmnjCR2NlI6yzZwCoIPmudxxmFYVIJ3KRwKela34k8Ua5ptno3h1tB8HxEpeWN5GsN5KpA3B0UMtuo8xWCkiSTqvylmUA9btbiG8tYbm0mjnt5kEkUsTBkdSMhlI4IIOQRUtQWNslnZQW0ZJSJAgJ74FT0AFFFQX15bWFpLd31xFbWsS7pJpnCIg9STwKAJ6a8iIyqx+ZjgDuawZPEDTWk11a2xt9Pgy099qRNrEkQUlnUMNxxx94IuMkNxzyTeLbHWCItKiudcW9kNuszMbOxkcIGZEz80oKZbgSblDYJAxQB1Gp+M9KsNTl08SteX0SgyWlhG91cITjG6ONTsHI+ZiAMj1pmo3uvXLK9tp9nptgsXmy3Wp3GWiIBODDGcMB1JMq9Oneudi8P+MtQtLKKLUrLwtpqjnTtItVyqEqQPOccMACPljUHdyOMVJD8JNDuZi/iW4v/EJUDY2o3crsDkls/PtI54XAAGRzmgCXVvE+g2xE+rfEOwtIYhiW3s57eJJMg8HO+QHrjYynj2JrN0nUvBDtHJaW2va8zOxE9zaXt8AcHGDIpAU7iFxwc5HHNdvpHhHw/pESx6fo9hCqtuXbbpleCAAcZwASB6DjpW0kaI0jIqq0jbmIH3jgDJ/AAfhQBwlrrmkWI3ab4K1lPLLr+50cRFdqlhjdtyG3MARkZJBxVybx2sbHZ4Y8VSxjYd6aaedysx4JDfLtweOpAGc12IAHQAdqKAOH/wCFgoUkZ/Cni6MBvLBbSWfccKRwpJx83U4HByRio7fxppMotzP4b8Qw8GQtNoMyCEYYDJ2nkjjAyfm5A5rvKZHFHECIkVASWIUYyT3oA8pn+JXgggtJpMkh8lnKf2aWkKKgbaF28ncwTHQHvjmo4PGngF5lRvD8MAmdTLv0oZMe0bZThcFPmUbskDOPXHqz2ds+7fbwtu5bKA5781StfD2i2mPsukadDhdo8u2RcDBGOB0wSPxNAHn6+Kvh6zEwaNZsW3HH9mAOcMdxK7M87cqf4jipn8V/Cyae6BfQpHt3VndbQEM5Y8qQvz4KkkrnA5PBrth4Y0FbkXCaLpqXAYMJUtkVwQcg7gM5yAfwrX2jAHPHuaAPNrrxT8K1kiNxfeHMTW4mBKIYzGWQgtgbQdzLw2D+tPt/EHwva9Nulz4ahuWKKYn8mPOHJQ84Gc/Mvfnjk16GIUBfILbgAQzFhx7GonsbWQOJYElD53eYN+enr/uj8hQBy2t33g57O3h1y8sPsUsyyQvcXilHf5sHdvzjBxzxhlXviqmnzeAMF9N1fTQsbrH+41LKwvggfKHIU/N3HJweuK6yTRNKkR1bTrMq/wB4eSo3Y6Z45qOXw5okoPnaRp8pK7GMtujll9CSMmgDmb6HwVcXwW81wrP5LBY21yeMbUJDOF80DILY39R68Vb0tfC88kIsdau5muImnjX+2bltyblBbmT1Kj8SO5rTn8JaFOT5ulWLqS5Km2jIw+N4+70bHI75JPNYt38MvD1xJCfKeKOHPlxRRxKgBXbgjZzz83Ofm9uKALKw+HrhZY4fElwxVST5etSExgMcn7/bOOfQdxWXPH4aSSeUeO7i3k3RpIw1iIlWAAA+bOCcAkd+uKnf4WeG5EUSwO7hCjPtjUuCCCCAgGCG6YwMDAGKr3nwg8L3cjNLFNhpUlYERtuKqVUElCcAEjr0JoAWPRdMt7d4oPH2rRiJhI7NqULEFmP3tynALHpx6DjityTRVvbe7e28SamkEwch7e4jxBu5Gw7cAKCMA5HQndXPRfB7wzbNH9jiaBVdpTiOMl2OMbiVyQNo478k5PNadx4FiuYFe7u5JdRjiMaXcBa1kILZIbYShGPl5Q8E9iRQBB4O8P2i6VctLfamHOp3m6b7bJG0z/aCuX2kAnMYA4xjgAA4q+PCkggAg8Ta4isyyGT7VvLAKwwC2QAQc8d1B9QcKz8Ea5Yr5Nn4l1mCBXDswmhmeZ2X95I7NGpJJIGOny5ABPEM/hXxbNbhI/FmuRSMGV3ktLOXIxjG0tgA9e/px3AOiPhW/wDKHm+K9ZLLuyVKKCvOBgDPGRznPApF8J6lGsmzxdrTMd3lmXy2C5IJyAozwCB0xnjFc2fBvjdLhZY/H2pfKGKp/ZVmUU4xgAtkDvtzjIHpUkWh+OrZ0S21aGSJbR4UeWxgRo3LjDAK5wQoHCkKRgbQQCQDox4Z1ZZldfF+sbRklDHbkE4OMZj45OccjtjphDoXiVVlKeLp2dkVVDWUACsCMtwmTkcEflisQaH48FzJ/wATvTdjRKN405SfMU9SC+SOrDLZDMfvAYMEmkfEC5uJZLi/0kEECN/sAGFzkkYkJBOR1J+72JBoA6IaR4rCk/8ACTRFt5YD7FGBtycL0+nv7mkmh1WxKDUNX1W4LDPmWljE8a4ZAAUCM24licjjCt04rmY4fiHbzxz3Q0uaIgSTCKCSMplVByElYsw24wuAeo96lxeeP0MMmp6Rpd55HmC4WOG5BmVcFdoVmU8qflO4HI5HOQDq7nT/ABoWnksdXslVgTDFcwLuUkHAkKAg44+76dTS3dp43EbC11HRtwYFHlibJGBw2AARnPTHbnvXE2rfErVtKVJrDwwluAFdZV1KBlAZiAkZXOQP4hnPGemKSaD4iXEOdS0/QnUwh1WC71FNzjruHlthsAEH5SD3bFAHWGx8f+ZITdeGpAXCqZLSRmEZIyMhgCeCenUjg45oJpvj+KZ52i8Jyt8yogsGUqrH5lDebn5uCSc5wOK4260v4iQJJ9g0PSrSOJfMhi/ta5dUcMC0g3Jlm7cngEY7g595e+Jhqcb3FlpBmhkjikX/AISJBLwwEm3eFCvgID/u5IyaAPTbdfiHbsB9n8MvhCPNjt3QscZGR5vGW7Z7nn1rx2Hj174v9i8LQsijyZ/LmTyxtK7SqyEtgH/ZAP0Bryw+KNasLi2VrCUTwv8A6IINbjuEij5DncAQSAFJXg46Yp8fxK1K6ht3ltL9Z0UxSf8AE6t9sOCW80ZVeSSRxwoAHzdgD02Xw748e7uHe98OyJOrB2STUIjkjZ8oE5C/L3GMHkc81dj0/wAdxQquzw/MVIJH9oXqbgc7huO4jHGDz1PA7+c2HxB1KO9KwJfxQY891j1KzZS2BkBSnBOfuggE+mTiY/FTWoyITpM15viWeZv7dtImgUlt2AqAn5Sh24+nQ0Aejajb+MFimNhZ6VNL+8UB9Uu0xwNn8PORnOCMdiTms2Kw+JE8pMv/AAjdqoKkn7Veyl/74CiRQvXg5PTGO9YEPxI1+5gSSz8H3F1C2JEmk8S2kQZP9rBG3G7kYzkYNUrjx54xjcCHQ9B0neYpFGq+J0nDA5z8yygj5uBhSDj8gDtU8JeIpdPltrrVtGtEK486HT2uJcccs9xI+44yMnP054uS+E7MW0z654p1q6twhaRjepYqqpkMSbZYjgEnOScdK80l0r4ialIk2seIdPs7K4gMLx6PpM12ZVkGWU/u8AZC/Nu2nk5G41oWnwaF9c2j+LZdU8SOoIm/tG9+zQEdNypGZHLYCDG5RhRnOMUAal143+GHhC9R9GhtdT1qcPJGNHtxeXUwJJb96M5GWbGX9QOmKzbvxh8RfFN3JbaPpsXhSzLxqPNiW91Ta7fK5gzsgGAc+dgAHgk16N4f8FabokQi0+G3sISCrRadCLcSAnPzOMyEg5xhwOenFdDY2VtYW629lbxW8K9EjUKP0oA808JfCi3sr+TVdXu76fVZGOb2S5L3siENlWmH+qB3fdg2EYwXcE59OtreG1hENrDHDECSEjUKoJOScD1JJ/GpaKACiiigArN16G+ksxJpZRrqEl1hkICTHaQFYkHGGKsCOcqBkAmtKigDhL74eRazrCah4l1S71jyXR7a2ulX7PbFUYb0hXEbOWdjvkVyBhRjGT2Fhp9vYqfIV2kYYaWV2kkfkkZdiSQMnAzgdqt0UAIxCgk9BS1R1bV9N0eJZdW1C0sYmzh7mZYlPTuxA7iqy6/bTlRp8N1flnVM28R2AHf829sIV+Q8gnqv95cgGvRWFeXfiCREfTNKs1JA3JfX3llcjP8AyzjkyQeDyB1wTxnKOmeLJpEmvPEOkwNEXiIt7GXaytjBIM4AfpgkHGeOtAHZUVgWazl4t/iNZWc5CpFEu/bncBwT2OfTb7Gq7y2UKzST+LSpj4eR3tAYyCep8vg9uaAOnorlJJ7R4yw8auA5KRt5lmQHC5OP3fJA+bH17U1YppJLcWnjXEbAxhFjtWMkpyRj5fQH5RycdaAOtorz6XQvETlUj+JM6s0Zkz9gtC3GAWHy4284wQRyO/Vg8NeKpWWS3+IzOAvl7Tp0TKU2YP3WB387t2euOMUAeiUVxB0fx1CCE8YaS6gKzPPopJJzz92cADAH68jrVqOz8dKyq2teG2XJ3OdJnyRjg7ftOB6EZ9/agDraK5Ur4zWMOL3w3IOo/wBGmQMMDv5hxzn16D1wEMnjUTr5kOgC125kMLytKCD0RWAUkrwMsMH+8KAOrorAnbxJHBHJZwafNIHZZILqdlLKCdrLKiYGRj5SnGevHMM8/isQsEsNLaXjDretgYOfumLkkcdR0z8ucAA6WiuVh1Hxc2Xk0CwUAlPL/tDlsYw4OzHPzfKemB83JxDZaz4sEj/2j4ZxHG4Gba4ifzV9V3SDHUcEdm9qAOworlF1zxBHOon8N3LIEYsYXibcwGNoJkGMn5skdOOTSP4k1iN3WTwnq33wIyht2DA/SbgjI64HBOewAOsori7TxxcSWyNP4T8SpKVJKC2iPI4I4kOOc4BweM9ME6l74jms7SW4k8Pa24j3/JDHFI7BVLZVVkJOQDgdScDGTigDoKK4GP4hJPZTONF8SRskrWkjLpoLQyhI2DtGGLKrCZCARxg5xjNX7Xx3YMsxuLHXrcoSSs2kT5Uc8fKp/unHfmgDr6K5Cb4g6JHEzMdSAVQS39k3ZHvgeXk9Og9vWoB8UPC+SHn1NCrbTu0e9AB565h46UAdtRXIn4j+FFl8ttWCyb/L2tbyghs4wcrx+P1p6/ETwm3C65abvM8raWIO70wf19O+KAOrormE8f8AhOSWOJPEGmmR+MfaF+Tgn5ufl6d/b1qa48a+G4FQtrVkQ4JUpJvHBIPIzjkEfWgDoaKw18XeHHfZF4g0d5cMQgvo8nacN37Hg+lV28a+H0ZPN1vSVU4B/wBLXIbaWxj6YxnGc8dsgHSUVhHxboSoGbUoAdrOUBJdQrbSSuMjnjkU4eKdHKxsuo2jrKSsRWdCJGBwQDnGeQfxoA26KzINbspTh5YoWLBVV5o8txnIwx4qtf8AiFLSeKKOwubppSfL8mWDDYJyfmkHAAz+I78UAblFVbG7N2hf7PLEu51BdkYMFbAYFWPDdR3x1APFIt/GQxMVypXGQbd/6Dn8KALRVW6qD25FAAUYAAHoKotq1uE3+XeFfazmJ/LbRbarbXO7yku/lfYQ9pKhBwD/ABKOzDnp19DQBforJvNcjt7JbqOzvJoc/OSq25jGR8zecyYHP6Gq03ivS0kYJe2TJGNzkXKO2M4O1E3MxB4xgc+tAG/SMwVSzEBQMkngAVyw1jU75ALWzvRvUsfJtTGY/mUr89xszlc5AjOMnuOcLX7mHRbK4uvGuu6Zpdo255I7mb7XJMijIMauFRWwCCiQsT2JJoA1fEvxD0bRtPubmCT7cLdzE8kTBYI5AAdrzH5AeVG0FnOQArHise88aeIrIPqtzpdtFoUaISlwrwXE7lcukCvh22ASNukSMsFwExl685HxAl1nxDKnwo8K3evarbzSo2ta0HlSAtnKwguPJRh1AMQHA2E8V3ngr4da39sudW8e+ILnUtRvbeS1ubWKTFu0LFSExgbAMHhMZycswOKAPUo3WRFdDlWGQfUU6iigAoopCMggEgnuO1AGTqHiCztb17C3Et/qap5hsrQBpAuV+8SQqZ3Ajey55xnBrltcvb2KzF5408R2fhXS5ASbS2nUSsBjKG6YDkjOVjUMCTtc4Bqzc6T4hWwi0nw+1rosjTeZf6wII3M+Vy0scQ4MzvjcZBgZY/OcGmaF8LvD1herqWpxza7rQZZP7Q1RzPKrKBgJuzsUEEhR0zQBhW3iCwlu7KfwP4K1DW7z5LddU1CB7YRxs27c9xODOVG524R85PrztQw/EjVYXa5vfDnh3J+SKG1k1CQDH8Tl41zknop6DntXeABRgAAegpaAOKuPA97qMNums+NPE9wY+WFpNFYq5/7YRq+PYsf51X/4VB4Ga7N1c6Iby4Ocve3k9yTkYyfMdsnHGa72igDjbf4XeB7aNkg8LaSgYtlhANx3dRu649s4HGOlaFn4I8LWSRrbeHNITyypVvscZbKghSWIySAzcnnk+proqKAOeXwR4USMRp4Y0NUD+YFFhEBuwRuxt68nn3NRv4C8IuF/4pfRFKsHVksYlZWByCCFyDnuK6WigDiZvhX4HlJJ8L6TuKCPJg6LnoPTOTn1zzmmH4V+EfKnjTRrWJJ18uRYWljV0wF2kK442jbjp19TXc0UAeYR/BnRElkIv9T8uRiWj89sbcYC5znGMLznK5B4Jqy/wqs2WNE1zXYo42MgVL+blznLHLnrnoMDAA7V6NRQB5xD8MZIbi3lTxRrP+jqiRBriRsAIqtnLnJYqGyfUjpVnRPAN/o89vPB4q1O4ktg5hiumeSEu67S8ibxvOMnGQNzFsc131FAHK+KtE8Q6tp8UNhr0dhPHIsgkt4DGzEKQVJLMNpznGOwrnz4K8YySyeZ48vEhLHascKZxuLA5xnOccZwBwOOK9KooA8ts/CfxDt7nzG8ZCZdhjUOEKgAfKSvlctnOTkZz7DFufQPiL5g8rxZZuqSF032yoSNhABATkZOcHP14r0eigDzufR/iI4kKeINNX7wQLHgn5gVbPlkBgowRgg5PAplzF8S4ZlWO80q5QOyBo7UKGzyrsGkyFXO0gcnH4n0eigDy22ufidJOrTQRW8cqhSptLeTyDjBY4ul3c8/Q/hV/T7/AOIiyltQtdCFuI3dt8U0cgOcKMRtKp6buDnDAYBBr0OigDxLTvGHi7R73VinhSwur/Ur4XE0UviCCFLc/ZbdFVCwJkDGNsEAAEEdjjol8f8AimNIjfeA/ILSFGK69Zsq4HQEsCWzwRj8a9LqOaCGbHnRRyY6b1BxQB51B8QfEMiWxk8CXKmbj5NZsXGQedv735sDB/H8afB8Sb2SdoP+EP1RrgoWjiivrKQseOuJ8Bec7jjjpmvQDaW5REMERRDuVdgwpznI9OeaYNPswGUWluAwwwEa89ueKAOCX4oW8cjR3nhjX7abPyxlIHZuvPyykegyT1OBmnSfE+3hkUN4U8WKgldHYaaGC4CtuJD8A7lPcnpjNdp/YmlfZTbf2ZY/ZigQxfZ02FQdwGMYwDzj1qo3hLw40vmN4f0gyddxso89c9dvsPyoA4ZfiZot2jmbQNWE7puDyaPKyTnCggfLuA3HqQRhfUgUSeNNGvr8zW1zr2n2dxEqSoNtuARIdxMUg8yM4YEumNwcYJYDHeR+F9AiDCPQ9KQMctttIxk+p4p6+HtJjjCW9jFaqOcWuYO+f4MUAeXTfEvwHc3KraaRBPDKwm+0S6ZKiEl8kn9yWzuCHoSc57ZqpqXj/wCHZ0kZ0XR5pZQZBbtZnbsADOzHyuACpBB67RjIIr1lvDli03mGXU92c4/tO525zn7vmY6j0qVNDslleRTeb3QISbyY8A5/v/me/fNAHhcnjf4OvJKknhvwzHGZVRTNpwVmTpvOISAPQZPQ9MCnzeK/g2uXtvDWhMz7dpisUQGQA4CkLgYJUZHOW6cV7hNoNlL95r0DG3at7Mox6YD4rKu/AWgXdytxcQ37yLEIf+QndAFAcgFRJg49SM0AeOT+IPg1N5wGjaS8ayq3yzeUWYkguisVOcgBuAcdelaGmy/Ba41CKCOHRoLgoDGY9SGPm28KVk4PJ44Py8gV6XL8NvDEscaNZXJEf3S19O2OQT1c5yRyT7+tVG+E/hJmLf2dhjxnIyOc8Ejr79e2cUAc9bf8KrsoZZbTVvs4mLh3g1a5Vn2jc3KyZOAx9wM9MHF+6/4QZEieTWvEAUqGiEWsanl0/vKFkyy853DIx3wOJrr4MeDrgrmyZAoxtARhtznb8ynj2966H/hDLLGFuZ1OAAfJtzjGMEAx4GAMYxjHagDnhF4KsrSS8HiDV/KiIUtL4i1AqCcYBzKeOQM4471R1bXvhppwunv9Xju5IXVpEk1Sa4wWxjG+TBA4zjpnnGee1Pg7Q2UCTTrOUh96GS0hcoeehKe/U8+9NsvBukWd79qgtoI5c7sxWsETA4/vJGG9+tAHmc3in4YTwT3Gh+ELXWZYy3NnoPm5YFBnd5eDnsQSD5ZwcDNXta+J/iSK1x4d8A3hmkMYhhvJkWWQnG4iGLe20A8s20DByQcLXo6+GNJKzrcwTX0c5JeO/uZbtPwWVmCjnoAK14IYreCOG3jSKGNQqIihVUDoAB0FAHiuoaN8X/F0stvdaxaeF9PLoweyUeYEPPBDMxYdCpKDnqa0/DnwG8KWOpPqniBZfEmqyMHebUTvRnxyxQk7snJO8t14wAK9aooAgsrS2sLWO1sbeG2tohtSKFAiIPQAcCp6zPEWv6V4b0yTUNdv7exs04MkzYBPoB1J9hzXN6L8RrHVX06VdK1e30zU5Fisb6e32pcEjIbZneqH5drlcHcORQB29FFFABRRRQAUVDd3MFlay3N5PFb28SlpJZXCIg9STwBXPR+Kn1MuvhnS7nU0HyreuRBZk+okb5pF/wBqJHHbPXAB09MlljhieSWRI40GWZiAF+p7V514l1P+z4Y4PG3jq10e4kImjtdHRYZXRQSynzPMkcHHVAnTHfmjDeaPOr3eheB9X1q4YxLHcaqNihW+6Ve6feqbSThFPJwQCTQB3cXivQ58/Y9Tt70gEkWRNyeOvEe706Ult4khundLew1ZyoLfNYTQggdsyqgyfQVz8Wp+O7tWOm+H9F0+0UFYRd3UjSDAZcGMIoGGCnhsFc4J4zr2ll4tZoDfa5o6psHnJbaW6tuyc7WadgByByp6ds0Aa1xfXMVukkelXkzs+0xI8IZRgnccuBjgDg55HHXEgupvm/0C54VWHzR/MT1UfP1HfPHoTWJqWga3d3cktv4w1Oxid1bybe0tSqAKAVUvExwTk8kkZ64pg8P64nmOPGOrOWO5Ue1szt4+6MQjPtk+uc9gDRfV75WwPDuqMMqMiS279es3b/8AVmojreoIrb/DeqMVA5SS3IJyBgZlB9T06flWe+h+IRGoj8WakZEyCXs7Qh+nOAg9+461Rk03x3FLM8HiO0nQA7Ip9KQZJHGGWYYwfUHNAG5b+IppGYT6BrNvt4+eJG5BIP3GIxwMHPOaQeKIhatPLpOtxhcfJ9gd3JIU4AXPTdjPTg+lc+9j8R44y8Wt6DM/mH90+kuoA5wdy3IyMkcEdBz7vt1+JLIguJ/C/mkL8y2c6ohwd2R55LYO3HTv0oA6hNdtmWRvs2pgIu450+fJ4BwBs5PPb0PoatSX8KbNyXJ3IHG22kPHHXC8Hnoea5WS48eZYR22i8RiTe0bcnHMYHm9Qf4iQD7Uy4m+IaNi1tvDsqqfLHnNKhfAH7wlSdoJzwASPegDsIruOVYyqzgOcDdA6kcZ5BHHXvTluUe4eFRIXTG47CFGc9yMHp2zXHS33j63sZydK0G4uQ4EZS6lAxhcnbs5Gd4AyDjbnvU2i6z4ol1OL+2tItLXTjHOWNuZZZQyv8gxtAwUIz6tnAxQB1dzdQ223z5Am7gZ7/5/lzVZNZ013KLfW+7cqYMgGSRkAevHp/Sob+/vIhajS9PFyGZfO853h8qMjO4fI25ug28fWsOLWPGgMZn8KaeUKrvEOr5ZWyQfvRAEDAPuG9RigDauPE2hWxP2nWNPhAUuWkuFVQBjPJOP4hx7iiXxPoMKO0mtaaoQbm/0pOBx7+4/MVnQaz4kEQN54YiiYRbnMepIyBs9MlQcY5zgc8c9ac+sa4UCP4XzK0iKy/b4tojP3nJ68HPGDn9KANRte0dfN3arYDyiBJm5T5CTtGeeOePrxTota0uVykWpWTtnGFnU8+nWuOute11LG6l1P4fKoMZDhtTtCjHLA7mYgbDhDnk/NyoI55m7+IGg7Fa88CDzs5KSyWGQSvJBMuO7DJxkDPcCgD2ZWDKGUgg9CKr3l/Z2Q/0y7t7fjd+9kCcevJryqHxP4ZNwRZ/Dm4mYStlrW306U7kJJI2THLAr0HORgc8Vd1TVfA0NhNa6r4ai0wXLSSomo6QsMck0ZC7yxXaCNyNvJACknI2ttAO+03X9K1Kzt7mzv7d4riJJowzbG2ugdSVbDKSrKcEA8ii48QaNbAG41fTogc48y5Rc469T2wa5Dw54t8EQ6RYw3mveHkv4LaBrgS3cO6OSNFHzEngr09Rz71fTxz4Amh8seJvDLKVdih1G3PB+Zs/P3xk/TmgDo21vSl66lZZxnHnrnpnpn05qa31KxuQDb3ltKGQygxyq2UBwW4PTIIzXM2viDwUYbxLTUdEkhjCCXyrmJ9+1QVXhiTwRge/vV63u/DVyyLbnTHjBIjljaIqSGBIDKeCGxx1zQBuLdQNIEWVGc4wA2eoyP0qRHDjK5x7jFc62g+F72fcLXT5JprcQhkYbmh3M6gYP3cszD65FMTwh4bWWIR2EaSLuMe1j8uPlOCD1BPHcEnHegDp88470VzJ8L+HZ4ZQ2moEm8ouHjYEmLIQnIzkbiB6gnrWbfeF7C3u4Y/sNktp5uyFvtEkcsZcoDIWLfMxOQMZIOwZ5OADtyQMZIBPA96GZVKhmA3HAyeprj4fC+gWexhNqcZdE2K95PuQMAqgAnKndg/3t3ftVrV9BsTHLNLqut2yGP51hvZckZALAcsOw+XFAHTg5GR0pNy7sbhn0zXEt4Y04R+e/inxCIpE8sH+1nC5GfmHoR37ccjrWZP4d0GZVnn8T605t1MQkmvS7x73CkE4yNx2DaeD8oxQB6VRXAPodhOiRHxrqbRkMm1b5DvU5UqeDn+IeoOOhAqiPDmn6lEIT498QPCYljaFrqJAyEYAZTGDuwOffORnigD02ivNYPhxBb6gLiy8YaxHqS5lWUrZvIN2QX/1GTnJ5PHt1rTuNB1C0ieaf4h6ytsihh58diFAB6lhApI4Pce+aAO3ormToV9cIxXxZqgkdSVaJbcAA4IIHln0/In1qs/hW6uCXfxh4pzLlRgwR7cgZOBAAOAeo78c4NAHX1maz4g0bQ1B1rV9O04MNwN3cpDkZxn5iO/FcZq2n+CYrMXGtaxfm0IYia81y6SLaWwRlpQp28DH3hjnnNczbeNfhX4cvFTwj4eXUr9F4fRNH8x2wevnFQG5x824/eBzzQB27fEjSLl1Tw9aav4hkZwitpdi7wkkAj/SH2wgYPUvxVe8vvGl8PNnbR/COlkohkunF5dlmI4ADLEhJIUcyc54PFchJ8QfHHiWK4g8L6Jb2VxnyiOLuSElN2S4YQg89HIAwR8x+U24fhRqPiG/nvfHGt3M8coVVtYn3MqqwIG4jagIzlVUkEttkORgA44+ItGOpNc+DNO1Px34kO5otZ11HeC2YKMiGIICThAf3UYJzyxHT0jwV4S8RT3T6j4/u7a+vDJvQKOYwkyyRBAPlhUGNSyrvMh2Fn+QA9toPh/StAhaPSLKK2DYDuMs746bnOWbHbJ4rUoAKKKKACmyMVQldu7sGOAT2GadRQB5l4m1A2epi2uLS88VeLWiW7tNFgQx2dttZtkhZ8IoDJ/rJGLFlygXhRtjw5rusXj3HiPXZbW3OVTTtGkaFAuf45yBIzY/iTyu/FdlRQBh6F4R8PaDDPFoujWFiJ8ec0EIV5cEkb26tjccZJxmttVCjCgAewpaKACignAyelFABRTJJY42CySIrEEgFsZA61UbV9NVmU6habkkjiYecuVdyAikZ4LFlwO+RQBeoqK3uIbiLzbeaOWLkb0YMOOvIpzSxqwVpEDEkAE8k4z/LmgB9FJkbsZGRzigEHkEEdOKAFooooAKKKKACiiigAooooAKKKKAGsitncoORg5GeKPLQBgEXDZLDHX606igCtHY28cMUSRKscRyigDCgdAB6DoB2wPSkmsIJVIKIGLbi4Rck+vI6+9WqKAOan8E6BNKZZNOtTJsWMMLaIbQAwBHy8HDEZ9OKpP8ADbw0/n5061zMjRMTaQN8jMrFeYzwSv6nvzXZUUAcbcfDLwjcTNLPoWmSOZA+TYwA4H8GQmSpHBB7fU1Vm+E3g6aGWJtEsFRzkCOzgTYe23CDHUjHQ5Oc13lFAHnQ+DvhFRIqabbhX6DyI/k+UAEYUdBuxnI+bpWjp3w+0vSf32lKLa9DPtcPN5SqxJwIllC5HGD1GK7SigDyuH4KeHISscNnZpbB9/lqbsHOQeCLnjkDt2HpV7/hT/hb5c2krZaMyA3l1g7QF+X97kEhVHJI45Br0aigDyW6+C2kNHKtt9ogMjrJhNSulVSMZ435JIHUnP5VUtPg1PbyeYuuXiSgH54tQvVLE4HP78445+vXI4r2WigDxaf4QaubjzI/FGrOBlQX1e7HyHqvLHpzznnJOKqn4L6sYJkPiPUd7qsYddWuBlRjqCD2UD6Cvc6KAPArj4MeImguIx4g1CY/KYTLrRweMsjD7KcDcFwecenGDvaD8H7iNPO1HxR4mtLlHBjW01WOZFUDjk2ydCTgbeMDFev0UAcFqXgS4khWWz1/X1mVAv2db2OGN2Iw8pKwn52+ZiQOWY9M1iX3wc0zUbzzdVk1PVIwGYR3uszFNzKARtVAdvA6MOB7kV6xRQB5nb/B7w9B8kNhpMMeGIk+wC5njcsDuR7lpVHv8h+orqbLwXodvHaia0+2NboqIbpvMUbVKhhH9xTgkZVR6eldHRQAiqFUKoAUDAA4AFLRWBrXjDQdGvFs77UYvt7kBbOBWnuDkEjEUYL9AecUAb9Fee6v4j8RX2ltdWsVl4N03J36l4hZGlVcHlYFcKOe8kgIA+6c8Z3w88RtrXiryNJv/EOp6d5D3Vxqd/bKlrdZ2LGsAAUxgHfjCAOFfl8BgAep0UUUAFFFNkbYhbGcdvWgB1ZGpeItNsLoWjyyT3x4FrbRNNL0JBKqDtXjG5sLnjNeb+LNTnk+0ab4uGpavcSDEmjaBDLDZxJIpCLcXTbd+cEY3LuLYEROBWro3hvxPd2kdut7aeE9FjDJFpuh2yKNjDIJlkTfnPULHCwyec4NAHUX2salFapO9pY6bC7opk1S7WMpkDjam5WbqMbxn1rnbbx3Y3U4is9YudcuFdVKaBpbyRHJIyZTvQAcknePu+pwblh8LPCVvfT319pi6vfzYDXGrSPfSKBnAVpixUDPY9hXcAYGB0oA4lE1MR3X2fw/rUswYR51LWFjSZTwWURyOAMY/hU9ePV88HiiefzV8P8AhaMna5M17LK5fHPIgGOQgzz0z2APZ0UAchdafq9ujyW+ieHZRFExiRAyuCwLMg+XHL85yN2eQOtW5G19TLFb6dpCbEHlO0rlO+AQEzxjke4xnJA6SigDjLq18RNBJGfD/hWWHaUWNrmXGCOcjyDxwOO4FU7i21exCzweCfDU12FEZ8i6YEqQSyhvs3cnABIHJJI6V39FAHnt5LeW1tNP/wAIPpMoRgVjjdjI0cZby+PIxvGMhc4GevTMkc9486Wp8FaaLWWVlYx3SqdwQyHKGJc/MAM9MnOe576igDibXxHqYaGS78G39tcy58pFvrVyxKkn/lqBjC/4VfTXLiWRmi8Oay7NKFDJPblSM7d3E3CgEk8djgEgZ6eigDib3xLaadHe239ja+4t5DBiB1YyYDEFGEvcA8ZDDjIHFaPh2ayl1K5Fpb6rbyFAW+1zuyHcWb5UZ22tyTnaCRjtiulooAxNc1yDRxcvcWeo3IgtzOWtrcyZBbAjXHViRwO3UkDmoLnxJpthfRwyLqLT3BjRFS3lkU5JORgFeASSfQd8CugkRZEZJFDIwIZWGQQexqEWNoJA4tYN6gAN5YyADkDPselAGBeeONDslcX015auqO7JJYzhlCnBONh79PXjGc1ijx/4UnnNwniq6gWaHYm+ApF8u4b13xY3ZbntwvGOD2406xDIws7YMhBU+UuVI6EccYpn9k6dgf6BaYDFgPJXhj1PTr059qAOfuPFWhXkcqW/iVYjGjQuUKgqzYVZDleMHoeFJJ69BQvte0mK3hZ/iLbWvIAeeW0HmFozgYKjJ+YOAO6jqMiuxOm2RhaIWsKIyeUQiBfk5O3jtyePc1lz+D9Cm1BL1rIrcoSVaOaSMDIAPyqwHQAdKAMuw8W6NBMFvPHPh+5RQSytNDG/PTJD4GMf3aua54ht7Lw7qmoxapa3L2VtLdCO0dAXCZ+Xnf1Ybc46n1pifD3woqlTottIhYsUlLSKSRgkqxIP4jrz15puq+BNIu7C+t7SC3sZLmKZFkhtYgY2kQqWBChuN2fvDNAGpeW009wRb6/c27BihiRYGAJBIHzITkDpz0HOetZU+heIpEJtvGlwmQoDNYW7455PCjqPy96ypvhP4auJTPc6TphudxdZIoZYyGLFt3EvXpz14PY4FWT4MeEmlSVNKs1kVVUHdc8bRhRgTjgDgDtx6UAdVDo+ux3CH/hJpHt1ZT5b2UZYgADBYY6nJz15q6ttrChgdStHBDYLWbZBPTkSDgf5Ncg/wu0mC1eKxtkVpMlnN5dq2cAAhvNJGAPxwPSodJ+FllbgPey3JuPM8ySS01C5hEpHIJG8kZOCQDjjjjigDvokvxMvnXVq0eclVt2ViOeh3nvt5x2PrxXkg1pm+TULBV3Z/wCPJ8gen+t57A9O/SuSbwAYpg9td6tg5DA69cL0HyHO0t1A4zgcnmoLr4c3U9k8KeIvEkLlpG3prcm/ewIDhjH8pwT8oGOfagDsp01wSHyLjTGXBwHgcHOD6Oe+Kx7jVPEVvqcVpNHpcfmvtjdllKyjA+6RnBBPQ4OATjAJrm4/hvrjLKv/AAnHiq1UxlRt1RZznPHLQAjqeQc9PTJ330XXLDSVs9OvryRzbNC1xJdo8iuLfYsoDRfMxcAkblAIz0JUgEgufHgVC+l+GmOVLBdRn5+X5gMwDHzchueOMHqJotQ8XmCdpdB0oPGMqq6kxMpxkhR5QA7AEkdeQOtefQ+FfiKls0n9vX6SRSRsIFSyfzUBHyglAAR/tZyBjPQVHb6B8SEDxrrGuwEHeoEdjLGcjH32kDg4/hxtyPfgA7/+2/FouAh8JwmMOoZxqScrnDMPl9wQP9k+1VrfW/HLRr5/hSzSQoQSuoKQGAznscHGAPUjJA5HCSeFPiSlrCR4l1p2j2kxJZ2IaRizcs/nLlVATKnt0zzSHw78Twt4Ita1TbIqhRNFb9ASSBtuTtP045wPUAHocfiDxN5I+0eELyORkXHk3FtKEfndkGZcjpgj3yB3lfXtfNshtvDd9LcKSkiy+RCrH1B88kD3w2e1eTwWfxmgJ2X6EKmNs1uWI6cA+awLYwMk4znB7m20vxltPN3SaXcBSrCQQz8qAM7VCkkkjvgcngjNAHo0vjW9skVdR8IeI/Pxlvsdulwnfoyvk9O4B/Sq1x8QbtADa+BvF1yNxViLWOPbxkcPICePT6deK5azufipJH5rtoPKtmOWK/jKk4C9Ij0wcjJznPpi3b3/AMUoZAi23hieQfJIZPt4QAE8rmHB4BycnJIoA6D/AIT3UcKo8BeK/NKFihS2GDxxnzsEc9R+WeKX/hLPFU1rdS2vw81MMqhrZLnUbSIzZ7NiRjH78GsmfVPif9tURWvhRYSpOHivmPO3AJEeMjnoeazZY/i1fQwu+pRWRf7w07S4CUAUHP8ApE+ck5BGODg9MigDrG1D4hXETiDw94aspAzIGuNYmmBweHCrbjK9eCVP0qCey8aNp4m17xjoujDb8507TQBGc5/1lxI4Ix6oP61zkXgvxlrGgq2seKfE8eoEhmto76209MjqPMgikbb+OauD4L+HJruLULyxt59UZNs9zevNqLt8oHH2h2QkYPLRntgLQBWuPGHgmEizj1zWvGupx27M1tpjy35nVpS5LpbgQZBOOQuFAA44LNP1XXFR7LwD4V0Pw1Z+cWmikjSa5bKgbvs9swijbJAzLMv3TkcV6HYeF9NtIbeILI8UG7ZDu8uEBs5BhTbEep/h6nPXmtmGKOCFIoI0jiQBURBhVA6AAdBQB51p3w4a8vftni7ULnW5w29Wv3EhQ7EGY4lCw25BU8xoX7iXkivQ7a2htUZbeJYwzb2wOWbuxPcn1PNS0UAFFFFABRRRQAUUVzaeNNGumKaLcNrUocRldMX7Qqtzw8i/InT+JhigDpKK87k+IsN3qSWOm3ekm480hoLaR9TulQcHfBbgiP5jjc0m1ep9BuWGqatdWQnGmak0okZTHMsNsrDpnBZmAHUc555zQB1FVrrULO0Vmuru3gVWVSZJFUAscKOT1J4HrXM3Ol6nqMTtfaJo0kgnk8uO8vpbpFXorgNHgE7VOwAY55yTWZB4X8SQzTfZLnwrpylMZtdAyW5Hc3A5xkcrj+gB3i3Vu0MkqzxGKPO9w42rjrk9sU2S+tIsebdQJ8wT5pAPmIyB9SOcelcyuieKY7SSJPEWmkuQWI0YD/eAHnY56c5x71ONM8TCAeVr1mkgJYl9LBZiOinEuNvGOOcE8g4IAOkkmijUtJIiKOCWYAetIk8ThCkqMHGVIYHcPb1rkW0rxNDC0Et5pN9HKCcDSQiI23ncDPyC3Ixk44J/iqjdaRr7Sqq6N4akEuxHlayH7sbPnJBk+YZVQBnuM9KAO/DDcVyNwGSM8/54NLXlM+heK5nurv8A4RXwS9wwdQs1rh5D5hCsXDHgj5ypGeSM5pc+JLW9SwHhHw95Rk5kgtpfJI8vdu3bRtJYEdD270Aeq0V5sH1ZHuIj4WtDG+FAimuIz5WF8sEiPAI4BCkj5STjpVsvr1qYZ4/BysYV84JBrTffIJZSpUBsE4GfVuncA76ivOzqGrWTz3A8Jaq86QFcLrDvG7NjgAn/AGT8+3I4x96tjwzPd6nJdtcaZqemIojiikkvjN5ihG52sflI3DJwdzFcltpwAdZRXIa5rw0qfMtnrMzEZAhkhBY+YIuEdx1ITBAwfNGOScchF49sm/tFpJ/GlmpLgK9vbSCMoCSkbAPln+YAEliVwMHAIB69RXnMXiuzl8yYal4pgQwPLsfT0GwRuMjBiLBvlK4bqG9cEPtPHeli8WB9R15zL5Sq76epjRmbgFkj6/KQewHoeaAPQ6K4OfxzpKhGbWb+1b+NLnSJl5GMjBjGCNpB5OC3bim33i6O3ml/4qGKECdol8/Rbhl3fe27gV3YVhyPY/UA76ivNtN+ImjiaIXnjzw0yzIBGkls1szNnG755uhOeMfjW3qni20h0+GfTtZ0m9klmtIFS3IkLGW5SBmGHPGXIHUKRzuwRQB11FcP9vLfaIIPH+mtL56KC8duzxAv8qYDAbm4XJHPOADgiSQ63LFILTxno3yTfO7WCvsQZyhxMBnIGSfQ8DoADtKK5q0tfEjQp/xUWkzvsGGGmNhm2nJ4n6ZKkAYxjGTng8vxWsoj/tTw/I+CSPsEqHrwceeeMfzoA6WiuXhHjLDpJceHJXD7d6RTJhcdSu4898Z/EdaWeTxis+bePw9Nb/PkvLNGwwPl6Kw65z6dOetAHT0VyhuvGiwxbtO8N+cQRJ/xMZgFYgYx+55AJ56ZGOlRQa54mnMqw6Hp0siNhVa7uYAwBwx3Pbbc5xgZORkg8cgHYUVyU+r+MIzmPwtpkqlgBs1kgkYPPMAHp3p0WueKCzLP4Q2nzFAaPUonUpjLHkA5BwAMc5zkUAdXRXKN4g8RhUx4MvCxI3D7fbYHBzj5+cED8/aq1x4o8TxSfJ4D1GSPBO5dQtc+wx5nU/kPWgDtKK4z/hM9TFzsbwR4jEABYzf6Oflxn7olyT14x275FNTxpqRu5Ek8Ha7Hbqy/vtiMSpAydoJJIY4wM8DJIoA7WisXSNdfVLWWeHR9Vt1QlQt3CsDuR6KzZxnjJwPTI5q6Lyfkvp9yoC7iQ0bevGA2ew/OgC7RXI3nju0tjGF0TxPOz44i0W4OOnJJUAd+/b6Zqr8QZJZSlp4M8Yz4zljYJCOP+usiZz7fjgUAdxRXnyeL/Gdykf2T4c3SSMVDG81W3hRQRnJK7m46EBakeT4iTeZLeXPhDQbPaxJ2T30iDBOSS0K5AxngjgnpxQB3tZeveINH8PwLNrmqWWnxvnYbmZYy+MZCgnLHkcDJ5HrXjfiLxr4VtTG3iD4natqgjI32mjSJbIzbeubdRNtPBGJD1J5HSr4YvNXupmHw1+GqaUjqdmu+IEKS7clvmLMZZgx6HfxnpgcgHo2oeOb65s7mfw/oskVlCCX1fX2Om2aDZncA485wCR/Aqnn5xWJ8NfGF54m8RtDpmr3/AIg0y3M5vtT/ALPjtbAOSNkFvx5hKcdWf5WJLNldtnT/AIXz6rd2+o/ETXLjxDdxl3FiFEdhEzLj5Y8Z+UdGyD1z1r0m0toLO2itrSGKC3iUJHFEgVUUdAAOAKAJaKKKACorqSSKB3hi82QfdQsFGc9ST0A6nqcA4BPFS0jKGGGAI9DQB5zdW+t+MCubALpcigk6urxwBlYkMtmNskwJC5E7xjCgqvJzcT4bafqNtEni+8u9fKeWVtpn8myjKHICW0e1Nuem/e2PlLMM57uigCtY6fZ2EMUNjaw28MSlI0iQKqAnJCgcAE8nFWaKKACiq817awNtmuYI23pHh5ADuY4UfUngDvWSfGHh37VDbDWbFp5oVnjjWUMXRvulcdc9gOaAN6isqy8R6NezSxWeqWU8kT+XIscysVb0PPBp8eu6TJcC3TU7I3B6Reeu89D93OehB/EUAaVFZ8et6VIWEep2LFRuIW4Q4GcZ69M8U+21XTruETWt/aTRFS2+OZWXAGScg9MEGgC7RTBLHjPmJjIGcjqeR/MU4MCSAQSpwcHoaAFooooAKKKKACkIDDBAI9DS0UARTW8MzBpoY5GAwCyg4H+QKgTS9PTOywtFycnEKjJ9elXKKAKL6PpsjBn06zZgAATApIAII7dsD8qz5/B3huYoZNC035OF226rtHoMDjrW9RQBl2egaXZwiG2tFjhySYwzFSSMHIzg/j9ah1jwvpOqxWiXFnCjWt3DewvFGqskkcokBBx3IwfUE9+a2qKAOIT4Z+GVgWH+wtA8oSCTaulRJ2x/Dg59+tZ998LdOm3pa2fh6GJm3APpbs2eOSROvOR2AB9K9HooA8qX4K+HREUOleHl3DafLsJ0BDDDjAuO46enHWlsPgt4ftdrNbweamI43hlvItkX9wYuTjtz7cg16pRQB59B8MtLgkkEH2mCOZT5z2+pXkUjEsW4PnEYyeQQc/jUF98MYmLtZ6t4gRpJvOdRrcyq5HTcGV85wu71wM5wBXpFFAHmUfw61CKIiPxBrxJIl2PrBZfMDDA/1GMYGc4JyBxxmtXVNA16/iukWVbffF5cZTUizIuVygc2+7DbcksXPzMBjgjuKKAPGm8AeNIrSSKDxhrxkkQf625hmTPGQd0YxwCDgEEduuXS+E/HglDDxJrUmxmaMt9lOSysCWQBRxu49OoGea9jooA8atvCPj/7Ncyt4p1OC8uFUMqWls4Ur/dYSrnIAGSM/XnKzeHviaVcr4mndN6SbPsUSNj5QyKRc84Az83U5HfNeyUUAeKzaX8U4iWbXXmBmk3Z09ApQFyrAJcFhklRhRkA8524qrNb/E2xgtxJqIOITGwe0uZWkIUKGZomk2tu+YkADB+Ucce6UUAeGQ6t8TYmESLpjqp6Nbapz97I3G2JON3XPRV6nrrz638ULaJYU0/w40gkKtNKuoS5w3zcJAOMcA9+vOa9cooA8otNc+J+p3Dw2tp4aszgkGeyv9uCePndYxkDORg5Ppmr0dr8TbiCNbjWtItXxvZ7bRw/XOF+e67Z54HQcnmvSaKAPLbPwT4yvowniDxzrZA432L21mSO5KJAeenAk45+appfg14a1F5X8Rxz6xIVWOOa8uriaVYwQxUvLI+CSDkoE4JwB1r0yigDntB8FeGtACf2PolhalBhWSIEqMk8E8jliePWuhoooAKK5HUPH+kR3ZstGS71/UgQpttKi87ZnOC8mRHGMgjLuOh9DUXhLxjLrOvz6PewWceowWwuLqCxuDdLYsX2iKaYKqiRuSEHI2N1GGIB2dFFFABRRVe8hmljxbzmFwDjK7lJI43Dg4HXhh9aAIdV1OLTostHNcTMCUggTc74BPfCqOMbnKqCRkjNcnfeMp7xkj0GGSeVod4S2tjesGYMArSK628ZVgDzMcgHp1rci8LWEkLx6rv1VXVVaK8w0AA6BYAPLXHqF3epNboAUAKAAOAB2oA4yyk8U3FtGgs5ctJG8j6neR28keDkhVt43Vhkfd8zkcFuebZ0bxBLHBBLrllFZoqo6RWDSSsAOQZJZXBye5Un1zXU0UAc+ug3y3LyjxBqQLKuWEVoCxGeD+4zj8e5qF/DE5lE39vaxLIuCkclyVjyDkEiMKTyO/GCRiumooA5K28O6xHIztr+pRl5SzLHOjoAdvQSRORyDwDxk4PNXLLStYt3Ky63fXMQUOrStb7i3IKELbj5eh3ZJJ9O/Q0UAcpP4e1qZLlG8T3zLIHUB7e1YbWyAP8AUdhg85yeox1pReD9YiIUeIbeSNS2N+kW+7a33lGAAMjgnHOTx0ruKKAPNpfBGqv5qI3hkJHEEjMnh2Ny7gjD4Ey44GMcD6Yq4fCN621xaeFzdpIGEsmgqFIWNV4xOWXJBIPJAwuOMnvaKAOJ1HRtZMsZjstAuo44T5YNkUKvncR/rSADgjAznIycA1ag03VJVKyafpkEczrv2yOjrGEKgYQkbgCBgNt4PPSusooA424sLwC5tV0WNt6Jh49TnjjJBGOQuVOFJLKCRwOQxNa3hqznj09xewtbyNI2FW+muMqOAd0oDDPPAGO/WtyigDlZrTVTfLCbST7E0Ig+0DV5RIq7VBYoI8eZndggnOAcgnAq24vUv7pJP7diIaGNnWbzlbfjld0ZUY53FenOe1dpRQBxr3WqRJbPd22uLGW+YLNbbkwMgvgBeowRuxyOvOIV1S9uI1nt7fxUVkVZlGLJCflI2bXIII25Ix1cdeMdxRQBxUGszm0kluP+EmtmjQyyRywWrSDDcqAoYE4OPlz9098msu/1y7tLoxPqnim3JJjjafT7VkY9dxwgIGAcZ2/icCvSaKAPJ9P8Y37RGaTU9beFZTEu7wzI5kOAFIaMkEFjgEY9OOp3NV8SzPDYR6df3K3f26zSWO402S2MsT3EccgzIox8pcjHJxgV3ZAPBAI680yGCKFpWhijjaV/MkKKBvbAGT6nAAz7CgDzSDxp4dkiMqfEWXG77SJJo4UjVMldp/dKMcgcnORn2pw8VaaY7mSP4o6MscI3yeYLb92CeM/MD14x6nHoK9Ilt45XVnDZH91yAeQeQDz0HWqt5pVpdsjyIyyK4fejlWOOxI6j1HQ96AOQj8QsGKQ+P/CkzRqAwlhQnnoW23C4JyPQe3NXLXXJ2uAZPGHhWWElkCxW5Vi+3gZ+0npgkjGcDt1q+PBeh4IlsYrg4wrXEaSlOhyNwPORn6k1NL4X0+WKRJI43aR2Yu1tAThvvLzHjB78ZOTQBXi1We5RFttd0GaXgnyx1O4cD94eNvH1Ofaq89/4g2H7Hf8AhqWTev8ArGkUKm3LdCecg47Y5q0vgrw8oDDSNO84MX877DBu38AP9zG4BQM46Cqknw78NyMN2l2BWNdkCGwttsC9cJ+7zjPzYJOT7cUAWZbjxUXDWsPh+S2LsRK1zKCY+dhwEIz0zzg44xnAfHfa/PBcG3sI47hQwijvQsSk5XBZ45JCBjefu88fdxziN8LfDbzJJLpekyMJTKzNp0Ss/wA2UDFQudv6981rax4RttW0n+z737O0J25ZIWhcBcbdrROjL9xBwRwuOlAFtLvxD87SaRp4UBdqJqDFicnd1iA6Yx/SoLzU/EcaMbfw9BKRjGL9ecckHKjGRwDk89QAOefb4U6KYGRGmhcENEYbu6VY2xgsE88jJHHb1680qfDK3EPl/wBs6uqhlYBNSvAMhg2SDOcnI6npx6UAazeIPEaQqx8GXckhUMyR39tgHnKgs4z0GDgde2KdFr/iEtF5vg28UNIFfZfWzbU5y3LjJ+7xx/FzwN3MS/COOSNFfxLrJwzOQbmVlZizEOVaQ/OFIXd6KOgAFY+ofBzXTaSjTfiJ4ijndGVle6lEbkgAZ+c4wB1xngDgdADuZ/FmtRyuq+A/ELomcus9jg8jG0faMkEZPqPT0gm8b6nHvJ8DeJdqDJO2BiT7BZDnpXDRfC3x1bPGbfx7qrRqACk1+zFsbcfMYjg8HqG69PWQfDXx2kSlPGE4uEwQ/wBtfaSD1C+VkZHXk9AOmcgHeWvjO5kMhuPCniK3jRtu426sScZ6KxJHbIyPpziwfGduryrLo/iFQjhARpUzBidvTap4+br0GDk8EVxtl4B8bJC8V3461MBJHNu1vLH8qckBwYssST68DGDgYq0ngbxtABs+IupSBMsA1pAxY5LDOVGeT0yBjC9BQB1UvjCCON5DpHiBghwVXS5iSCcbgNvPfpzjnHSqV38QLeBZ/L8OeLLiSJynlxaNMN+BncrMApHbr1rmk8O/EW2sbi5l8d3gEavL9nTRbaVyOW2r87EsegGcZwOlTL4T+Jf29C3xEY2W5dwGnWqybeNxH7kjPXA+menIB0Fl411C8kCx+BPFaAkfNMtnGB3z81wDWjJqPiOSOc2mg2cRXHl/btR8vdzzny45MYH68dOa5m38A6xfSNP4g8W+InfcQtvb6n5UeODuJgigOeox0x+kyfCjQJ7kTawsuq4DL5d/I94pzj5j9oaVgwAAypUcnAGaAM3WPiDY6dJBFrnjrQLKUuUltNHtzd3IbkgA5fC46kxfiK5VvEEviq5ni8L+FPEni53LQSXniK4+yaYvRQxt+I3weSvlK+OnWvVdC+H/AIT0K2jt9M8P6fFHG25d8Qkbd/e3Nkk9Oc5wAOwrqKAPJrP4Y63rVulr468SD+xYx5cegeH4jYWQj6eW7D946Yx8uRjHWvStD0bTNA05LDRLC1sLNORDbRCNc9zgdSe56mr9FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hegar cervical dilators (uterine cervix)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 423px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These dilators are double-ended and of progressive sizes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18873=[""].join("\n");
var outline_f18_27_18873=null;
var title_f18_27_18874="Endometrial carcinoma: Epidemiology and risk factors";
var content_f18_27_18874=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Endometrial carcinoma: Epidemiology and risk factors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/27/18874/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/27/18874/contributors\">",
"     Lee-may Chen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/27/18874/contributors\">",
"     Jonathan S Berek, MD, MMS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/27/18874/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/27/18874/contributors\">",
"     Barbara Goff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/27/18874/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/27/18874/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/27/18874/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 30, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1267292\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Worldwide in 2008, 288,000 women were diagnosed with uterine cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/1\">",
"     1",
"    </a>",
"    ]. The mortality rate was 1.7 to 2.4 per 100,000 women. In the United States, as with other developed countries, uterine cancer was the most common gynecologic malignancy, with almost 50,000 new cases and 8200 deaths from the disease in 2013 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Adenocarcinoma of the endometrium (lining of the uterus) is the most common histologic site and type of uterine cancer.",
"   </p>",
"   <p>",
"    The main risk factor for endometrioid endometrial carcinoma is an excess of endogenous or exogenous estrogen without adequate opposition by a progestin (eg, postmenopausal estrogen therapy without a progestin). Other risk factors include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    therapy, obesity, and nulliparity (",
"    <a class=\"graphic graphic_table graphicRef62089 \" href=\"UTD.htm?38/30/39403\">",
"     table 1",
"    </a>",
"    ). In addition, women with Lynch syndrome (hereditary nonpolyposis colon cancer) are at a markedly increased risk of endometrial cancer.",
"   </p>",
"   <p>",
"    The epidemiology and risk factors of endometrial carcinoma are reviewed here. An overview of endometrial carcinoma can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/7/21624?source=see_link\">",
"     \"Overview of endometrial carcinoma\"",
"    </a>",
"    .) Related topics are discussed in detail separately, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Histopathology and pathogenesis (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/7/36983?source=see_link\">",
"       \"Endometrial carcinoma: Histopathology and pathogenesis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Clinical features, diagnosis, and screening for high-risk women (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/6/37992?source=see_link\">",
"       \"Endometrial carcinoma: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Staging and surgical treatment (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18810?source=see_link\">",
"       \"Endometrial carcinoma: Pretreatment evaluation, staging and surgical treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Adjuvant therapy (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/41/8855?source=see_link\">",
"       \"Approach to adjuvant treatment of endometrial cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Worldwide in 2008, 288,000 women were diagnosed with uterine cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/1\">",
"     1",
"    </a>",
"    ]. Uterine cancer is the most common gynecologic malignancy in developed countries, with an incidence of 12.9 per 100,000 women and a mortality rate of 2.4 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/4\">",
"     4",
"    </a>",
"    ]. In developing countries, it is the second most common gynecologic malignancy (cervical cancer is more common), with an incidence of 5.9 per 100,000 and a mortality rate of 1.7 per 100,000.",
"   </p>",
"   <p>",
"    In the United States (US), uterine cancer is the most common gynecologic malignancy and has a higher incidence than the average for developed countries. This may be attributable to increased obesity or other risk factors in the US population. In 2013, there were approximately 49,560 new cases and 8190 deaths from the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Based upon data from the US national cancer database Surveillance, Epidemiology and End Results, the incidence of uterine cancer from 2004 to 2008 was 23.9 per 100,000 women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/5\">",
"     5",
"    </a>",
"    ]. Incidence rates were higher in whites (24.8 per 100,000) than in black (20.9 per 100,000), Hispanic (18.9 per 100,000), or",
"    <span class=\"nowrap\">",
"     Asian/Pacific",
"    </span>",
"    Islander women (18.2 per 100,000). However, mortality was almost twofold higher in blacks than in whites (7.1 versus 3.9 per 100,000), possibly due to a higher incidence of aggressive cancer subtypes, as well as issues of access to and quality of healthcare services [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/6-9\">",
"     6-9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The average age of diagnosis of uterine cancer in the US is 61 years old [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/5\">",
"     5",
"    </a>",
"    ]. The age distribution of cases of uterine cancer from 2005 to 2009 was:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      20 to 34 years old &ndash; 1.5 percent",
"     </li>",
"     <li>",
"      35 to 44 &ndash; 6.0 percent",
"     </li>",
"     <li>",
"      45 to 54 &ndash; 19.0 percent",
"     </li>",
"     <li>",
"      55 to 64 &ndash; 32.6 percent",
"     </li>",
"     <li>",
"      65 to 74 &ndash; 22.6 percent",
"     </li>",
"     <li>",
"      75 to 84 &ndash; 13.5 percent",
"     </li>",
"     <li>",
"      85 or older &ndash; 4.8 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    From ages 50 to 70, women have a 1.4 percent risk of being diagnosed with uterine cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/5\">",
"     5",
"    </a>",
"    ]. Women in the US have a 2.6 percent lifetime risk of developing uterine cancer.",
"   </p>",
"   <p>",
"    The majority of women with uterine cancer are diagnosed at an early stage: confined to primary site (68 percent); spread to regional organs and lymph nodes (20 percent); and distant metastases (8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most of the data regarding incidence and prevalence are for uterine cancer in general, not just endometrial carcinoma. Adenocarcinoma of the endometrium is the most common site and type of uterine cancer. Other types of uterine cancer are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/22/2408?source=see_link\">",
"     \"Uterine sarcoma: Classification, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44585?source=see_link\">",
"     \"Clinical features, diagnosis, staging, and treatment of uterine carcinosarcoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among endometrial carcinomas, there are two histologic categories, which differ in incidence, responsiveness to estrogens, and prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type I tumors include tumors of endometrioid histology that are grade 1 or 2; these comprise approximately 80 percent of endometrial carcinomas. These tumors typically have a favorable prognosis, are estrogen-responsive, and may be preceded by an intraepithelial neoplasm (atypical",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      complex endometrial hyperplasia). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26535?source=see_link&amp;anchor=H381678#H381678\">",
"       \"Classification and diagnosis of endometrial hyperplasia\", section on 'Risk of carcinoma'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Type II tumors account for 10 to 20 percent of endometrial carcinomas. They include grade 3 endometrioid tumors as well as tumors of non-endometrioid histology: serous, clear cell, mucinous, squamous, transitional cell, mesonephric, and undifferentiated. These tumors are often high-grade, have a poor prognosis, and are not clearly associated with estrogen stimulation. A precursor lesion is rarely identified.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The histopathology of endometrial carcinoma is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/7/36983?source=see_link\">",
"     \"Endometrial carcinoma: Histopathology and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrioid histology tumors (type I) comprise 80 percent of endometrial carcinomas, as noted above [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. This section will describe risk factors for these tumors. Risk factors for type II endometrial carcinomas (serous and clear cell) are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/3/22584?source=see_link&amp;anchor=H4548904#H4548904\">",
"     \"Type II endometrial carcinomas (eg, serous, clear cell, mucinous)\", section on 'Epidemiology and risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endometrioid endometrial carcinoma is estrogen-responsive and the main risk factor for this disease is long-term exposure to excess endogenous or exogenous estrogen, without adequate opposition by a progestin [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. Other risk factors include obesity, nulliparity, diabetes mellitus, and hypertension. Risk factors are presented in the table (",
"    <a class=\"graphic graphic_table graphicRef62089 \" href=\"UTD.htm?38/30/39403\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Excess estrogen exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exogenous estrogen exposure includes postmenopausal estrogen therapy and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    , while endogenous exposure may result from obesity, anovulatory menstrual cycles, or estrogen-secreting tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H844020\">",
"    <span class=\"h3\">",
"     Exogenous estrogen or estrogen agonists",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h4\">",
"     Unopposed estrogen therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic (oral, patch, vaginal ring with systemic dose) estrogen therapy without an opposing progestin in a woman with a uterus results in a markedly increased risk of endometrial hyperplasia or carcinoma.",
"   </p>",
"   <p>",
"    Endometrial hyperplasia has been demonstrated in 20 to 50 percent of women after one year of receiving systemic estrogen therapy without a progestin [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. Multiple case control and prospective studies have shown an increased incidence of endometrial carcinoma, with the relative risk ranging from 1.1 to 15 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. The risk is related to both estrogen dose and duration of use. Although some reports suggest that endometrial carcinoma in these women is less aggressive than in hormone nonusers [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/21\">",
"     21",
"    </a>",
"    ], others have found an increased risk of metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/53/16218?source=see_link&amp;anchor=H533431036#H533431036\">",
"     \"Preparations for postmenopausal hormone therapy\", section on 'Low-dose estrogen'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H383248\">",
"    <span class=\"h4\">",
"     Estrogen-progestin postmenopausal hormone therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of endometrial hyperplasia and carcinoma with estrogen therapy can be significantly reduced by the concomitant administration of a progestin [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, combined estrogen-progestin preparations do not increase the risk of endometrial hyperplasia. One notable exception is based on analysis of unpublished data from the Postmenopausal",
"    <span class=\"nowrap\">",
"     Estrogen/Progestin",
"    </span>",
"    Interventions (PEPI) Trial, which showed a statistically significant increase in endometrial hyperplasia after two years of cyclic combined therapy (3.3 versus 0 percent in the placebo group) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/17,25,26\">",
"     17,25,26",
"    </a>",
"    ]. The regimen used in this trial was conjugated equine estrogen (CEE) 0.625 mg daily plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    10 mg for 12",
"    <span class=\"nowrap\">",
"     days/month.",
"    </span>",
"    The reporting of summary data for all histologic types of endometrial hyperplasia is a limitation of this analysis, since atypical hyperplasia is most likely to be associated with carcinoma. A further limitation of this study was inclusion of only oral therapy; thus, it is uncertain whether the results can be generalized to non-oral hormone therapy (patches or vaginal rings). Summary data for the risk endometrial cancer was not reported or most interventions in this analysis because there were too few events. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26535?source=see_link&amp;anchor=H2#H2\">",
"     \"Classification and diagnosis of endometrial hyperplasia\", section on 'Histology and classification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It appears that most regimens of combined estrogen-progestin postmenopausal hormone therapy do not increase the risk of endometrial carcinoma. This was illustrated by the Women's Health Initiative randomized trial, which compared continuous estrogen-progestin therapy with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/27\">",
"     27",
"    </a>",
"    ]. The trial found that more women in the hormone therapy group required endometrial biopsies to assess vaginal bleeding (33 versus 6 percent for placebo), but there was no significant difference in endometrial carcinoma risk between the two groups (hazard ratio 0.81, 95% CI 0.48-1.36). However, some data suggest that cyclic regimens may increase endometrial cancer risk. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=see_link&amp;anchor=H256689856#H256689856\">",
"     \"Postmenopausal hormone therapy: Benefits and risks\", section on 'Ovarian cancer'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=see_link&amp;anchor=H256690730#H256690730\">",
"     \"Postmenopausal hormone therapy: Benefits and risks\", section on 'Protective effect of progestins'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/53/16218?source=see_link\">",
"     \"Preparations for postmenopausal hormone therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptomatic vaginal atrophy is treated with low dose vaginal estrogen therapy (vaginal administration of a low dose) rather than systemic estrogen therapy. The systemic absorption of these preparations is small, but some may require use of an opposing progestin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/50/6954?source=see_link&amp;anchor=H323915#H323915\">",
"     \"Treatment of vaginal atrophy\", section on 'Use of an opposing progestin'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H843977\">",
"    <span class=\"h4\">",
"     Tamoxifen",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     Tamoxifen",
"    </a>",
"    use increases the risk of endometrial carcinoma in postmenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. The risk of endometrial cancer in premenopausal women has not been established.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     Tamoxifen",
"    </a>",
"    is a selective estrogen receptor modulator with both agonist and antagonist properties, depending upon the individual target organ and circulating levels of serum estrogen [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. In breast tissue, it blocks estrogen stimulation and is used for prevention and treatment.",
"   </p>",
"   <p>",
"    The endometrial activity of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    appears to depend upon menopausal status [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/31\">",
"     31",
"    </a>",
"    ]. For postmenopausal women, the increased risk of endometrial cancer with tamoxifen use is well-established. This effect is dose and duration-dependent. For premenopausal women, however, there is a lack of evidence that tamoxifen increases the risk of endometrial cancer.",
"   </p>",
"   <p>",
"    This was demonstrated in a meta-analysis of two large randomized trials including over 20,000 women that evaluated",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    use for five or more years for breast cancer prevention (National Surgical Adjuvant Breast and Bowel Project P-1 and International Breast Cancer Intervention Study-1 trials) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/28\">",
"     28",
"    </a>",
"    ]. Tamoxifen compared with placebo resulted in a significantly increased risk of uterine cancer for women &ge;50 years old (2.6 versus 0.8 percent; relative risk [RR], 3.32; 95% CI 1.95&ndash;5.67), but not for women &lt;50 years old (0.3 versus 0.3 percent; RR 1.19, 95% CI 0.53-2.65). An important limitation of this analysis was that it is underpowered to detect a difference in the &lt;50 age group. In that age group, there were very few events (13 in the tamoxifen group and 11 in the placebo group). Further study of this issue is needed.",
"   </p>",
"   <p>",
"    This was also demonstrated in a meta-analysis of individual patient data from 20 randomized trials including over 20,000 women that compared women with breast cancer who were treated with approximately five years of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    with those who did not receive tamoxifen [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/29\">",
"     29",
"    </a>",
"    ]. The risk of endometrial cancer was increased with tamoxifen use was increased overall (rate ratio 2.40). When analyzed by age groups, the increased risk of endometrial cancer with tamoxifen use was significant only in women age 55 or older: ages 55 to 69 (0.9 versus 0.2 percent; rate ratio 2.96); 45 to 54 (0.5 versus 0.2 percent; rate ratio 1.75); &lt;45 (0.1 verus 0.1 percent; rate ratio 1.04). The risk of endometrial cancer persisted after discontinuation of tamoxifen. The usual duration of use of tamoxifen was five years, but over 15 years, women aged 55 to 69 years who had used tamoxifen continued to have a higher incidence of endometrial carcinoma than those who had not (3.8 versus 1.1 percent).",
"   </p>",
"   <p>",
"    The effect of a progestin on the risk of endometrial cancer due to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    has not been well studied. Many women have progesterone receptor-positive breast cancer, and use of a progestin would raise concern regarding increasing the risk of recurrence. A meta-analysis of two randomized trials found that use of a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    intrauterine device decreased the incidence of endometrial polyps, but was underpowered to detect a difference in the risk of endometrial hyperplasia or carcinoma or breast cancer recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/33\">",
"     33",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Women on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    who develop endometrial carcinoma do not differ from other women with endometrial carcinoma in terms of stage and histology.",
"   </p>",
"   <p>",
"    The American College of Obstetricians does not recommend routine screening for endometrial carcinoma of women on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    but advises that women be counseled about the risks associated with tamoxifen, be monitored closely for symptoms of endometrial hyperplasia or carcinoma, and undergo evaluation if symptoms of endometrial carcinoma are present [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/6/37992?source=see_link&amp;anchor=H1268046#H1268046\">",
"     \"Endometrial carcinoma: Clinical features and diagnosis\", section on 'Women at average or increased risk'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of uterine sarcoma is also increased with use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/22/2408?source=see_link&amp;anchor=H15672769#H15672769\">",
"     \"Uterine sarcoma: Classification, clinical manifestations, and diagnosis\", section on 'Tamoxifen'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3338292\">",
"    <span class=\"h4\">",
"     Phytoestrogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of phytoestrogens on endometrial carcinoma risk is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/35-38\">",
"     35-38",
"    </a>",
"    ]. Phytoestrogens are nonsteroidal compounds that occur naturally in many plants, fruits, and vegetables and have both estrogenic and antiestrogenic properties. Most studies, including randomized trials, have not found an increased risk of endometrial hyperplasia or cancer with phytoestrogen supplements or dietary intake, and some have found a decreased risk [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/39\">",
"     39",
"    </a>",
"    ]. As an example, a meta-analysis of seven comparative observational studies including 3516 women with endometrial cancer found that high soy intake compared with low soy intake was associated with a significantly decreased endometrial carcinoma risk (OR 0.70, 95% CI 0.57-0.86) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most randomized trials that have addressed this issue have had only 6 to 12 months of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/39\">",
"     39",
"    </a>",
"    ]. A potential increase in the risk of endometrial cancer was found in the trial with the longest follow-up period. The trial assigned 376 postmenopausal women to receive soy isoflavone supplements (150",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or placebo for five years and found a significantly higher rate of endometrial hyperplasia (detected by endometrial biopsy) in the soy intake group (3.8 and 0 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/36\">",
"     36",
"    </a>",
"    ]. However, the quality of this trial was limited, since the total number of events was small and the malignant potential of the findings was uncertain (there were only six cases endometrial hyperplasia, five of which were simple and one of which was complex). Atypical endometrial hyperplasia and, less consistently, complex hyperplasia, are the precursors lesions for endometrial carcinoma, not simple hyperplasia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26535?source=see_link&amp;anchor=H2#H2\">",
"     \"Classification and diagnosis of endometrial hyperplasia\", section on 'Histology and classification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The benefits and risks of these agents are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/53/16218?source=see_link&amp;anchor=H8#H8\">",
"     \"Preparations for postmenopausal hormone therapy\", section on 'Phytoestrogens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Endogenous estrogen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common reasons for excessive endogenous estrogen are chronic anovulation or excessive endogenous conversion of adrenal precursors to estrone and estradiol by adipose cells in obese women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/41\">",
"     41",
"    </a>",
"    ]. Several studies have demonstrated that a postmenopausal woman's risk of developing endometrial carcinoma is correlated with higher circulating estrogen and androgen levels, and lower sex hormone binding globulin (leading to increased steroid hormone activity) levels, compared to unaffected controls [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/42-45\">",
"     42-45",
"    </a>",
"    ]. Estrogen-secreting tumors are rare, but may also result in endometrial carcinoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h4\">",
"     Chronic anovulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In anovulatory women, sex steroid hormones are produced, but not cyclically, resulting in irregular uterine bleeding. In particular, chronic estrogen production unopposed by adequate progesterone production allows continued proliferation of the endometrium. This can lead to endometrial hyperplasia or carcinoma.",
"   </p>",
"   <p>",
"    Anovulation is common both at menarche and during the menopausal transition. Polycystic ovary syndrome is the most common endocrine disorder associated with anovulation. Thyroid dysfunction and elevated prolactin levels are other common endocrine disorders related to anovulation (",
"    <a class=\"graphic graphic_table graphicRef79628 \" href=\"UTD.htm?12/36/12876\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/25/20887?source=see_link&amp;anchor=H10#H10\">",
"     \"Initial approach to the premenopausal woman with abnormal uterine bleeding\", section on 'Anovulatory bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H843677\">",
"    <span class=\"h4\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obese women are more likely to develop endometrial carcinoma. In a meta-analysis of 19 prospective studies including over three million women, each increase in body mass index (BMI) of 5",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    incurred a significantly increased risk of developing endometrial carcinoma (RR 1.59, 95% CI 1.50-1.68) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/46\">",
"     46",
"    </a>",
"    ]. Higher BMI is also associated with the development of endometrial carcinoma at a young age (&lt;45 years old) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H34868595\">",
"     'Age'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    One explanation for these findings is that obese women have high levels of endogenous estrogen due to the conversion of androstenedione to estrone and the aromatization of androgens to estradiol, both of which occur in peripheral adipose tissue. Unlike some other disorders, however, the risk of developing endometrial carcinoma is not related to the distribution of adipose tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/48-50\">",
"     48-50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Obese women may also have other endocrine abnormalities. They may have lower circulating levels of sex hormone binding globulin (leading to increased steroid hormone activity), alterations in the concentration of insulin-like growth factor and its binding proteins, and insulin resistance, all of which may contribute to the increased risk of endometrial carcinoma in these women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Premenopausal obese women, especially those with polycystic ovary syndrome, are often anovulatory, as well (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Chronic anovulation'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Severely obese women (&ge;40",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    who develop endometrial cancer are more likely than women with a BMI &lt;30",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    to have a less aggressive histologic subtype (endometrioid: 87 percent versus serous or clear cell: 75 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/53\">",
"     53",
"    </a>",
"    ]. This is likely due to the greater likelihood of developing an estrogen-responsive tumor in women with a higher level of circulating estrogen. Accordingly, severely obese women are more likely to present with stage I disease (77 versus 61 percent) or low grade histology (44 versus 24 percent).",
"   </p>",
"   <p>",
"    Paradoxically, among women with endometrial carcinoma, severe obesity is also associated with an increased risk of death [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/54\">",
"     54",
"    </a>",
"    ]. The magnitude of this risk was illustrated in a prospective cohort study of 495,477 women followed for 16 years in the Cancer Prevention Study II [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/55\">",
"     55",
"    </a>",
"    ]. The risk of dying from endometrial carcinoma among those with the highest BMI (&ge;40",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    was 6.25-fold higher than that of normal weight women (BMI 18.5 to 24.9",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"     ).",
"    </span>",
"    The pathophysiology of this is uncertain, but may be due to continued stimulation of metastatic cells by endogenous estrogen or may result from obesity-associated conditions, such as diabetes or cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/56,57\">",
"     56,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H844119\">",
"    <span class=\"h4\">",
"     Early menarche and late menopause",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early age at menarche is a risk factor for endometrial carcinoma in some studies; late menopause is less consistently associated with an increased risk of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/12,58-61\">",
"     12,58-61",
"    </a>",
"    ]. Both of these factors result in prolonged estrogen stimulation and at times of the reproductive years during which anovulatory cycles are common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H843444\">",
"    <span class=\"h4\">",
"     Estrogen-secreting tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some ovarian tumors produce estrogen and may result in endometrial carcinoma. Granulosa cell tumors are the most likely to be associated with endometrial neoplasia. Endometrial biopsy will detect endometrial hyperplasia in 25 to 50 percent of women with granulosa cell tumors and carcinoma in 5 to 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/62-64\">",
"     62-64",
"    </a>",
"    ]. The endometrial adenocarcinomas that are associated with granulosa-stromal cell tumors are usually early stage and well differentiated [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8778?source=see_link&amp;anchor=H12#H12\">",
"     \"Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34868595\">",
"    <span class=\"h2\">",
"     Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial carcinoma usually occurs in postmenopausal women (mean age at diagnosis is 61 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/5\">",
"     5",
"    </a>",
"    ]. Women under age 50 who develop endometrial cancer often have risk factors such as obesity or chronic anovulation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/66-68\">",
"     66-68",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Epidemiology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H6\">",
"     'Chronic anovulation'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H843677\">",
"     'Obesity'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;A familial tendency toward endometrial carcinoma alone has been suggested for first degree relatives [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/69-71\">",
"     69-71",
"    </a>",
"    ], although no candidate genes have been identified consistently. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Lynch syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with Lynch syndrome (hereditary nonpolyposis colorectal cancer) have a high risk of developing endometrial cancer and are likely to develop the disease at a young age. Women with Lynch syndrome are also at an elevated risk of colon and ovarian cancer, along with other malignancies. Lynch syndrome is an autosomal dominant disorder that is caused by a germline mutation in one of several DNA mismatch repair genes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\", section on 'Genetics of Lynch syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lynch syndrome accounts for two to five percent of all endometrial carcinomas [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. For women with Lynch syndrome, the lifetime risk of endometrial carcinoma is 27 to 71 percent compared with 2.6 percent in the general population (",
"    <a class=\"graphic graphic_figure graphicRef57830 \" href=\"UTD.htm?2/0/2049\">",
"     figure 1",
"    </a>",
"    ). The mean age at diagnosis of endometrial carcinoma diagnosis in women with Lynch syndrome is 46 to 54 years, compared with a mean age of 61 years in other women. The majority of Lynch syndrome-associated endometrial carcinomas are endometrioid histology and present at an early stage, similar to sporadic endometrial carcinoma.",
"   </p>",
"   <p>",
"    Screening for endometrial carcinoma is advised in women with Lynch syndrome. Endometrial carcinoma in women with Lynch syndrome is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18233?source=see_link\">",
"     \"Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     BRCA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carriers of mutations in the BRCA genes are at a high risk of breast and ovarian cancer. Some data suggest that BRCA1 mutations are associated with endometrial carcinoma. A multinational cohort study involving 11,847 BRCA1 mutation carriers reported a significant increase in the risk of uterine cancer (RR 2.65, 95% CI 1.69-4.16) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/74\">",
"     74",
"    </a>",
"    ]. However, data from a prospective series suggested that the risk of endometrial carcinoma was significantly elevated only for BRCA mutation carriers taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/75\">",
"     75",
"    </a>",
"    ]. Further investigation is required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=see_link\">",
"     \"Characteristics of hereditary breast and ovarian cancer syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There have been some reports of an increased risk of serous carcinoma of the endometrium in BRCA carriers [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/76-80\">",
"     76-80",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34202?source=see_link&amp;anchor=H10#H10\">",
"     \"Risk-reducing bilateral salpingo-oophorectomy in women at high risk of epithelial ovarian and fallopian tubal cancer\", section on 'Concurrent hysterectomy'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8894433\">",
"    <span class=\"h3\">",
"     Other genetic syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with Cowden syndrome, an autosomal dominant condition in which there is a mutation in the PTEN tumor suppresser gene, exhibit characteristic mucocutaneous lesions, have a high prevalence of uterine leiomyomas, and have an increased risk of endometrial, breast, thyroid, colorectal, and renal cancers. There are few data regarding this rare syndrome; available studies report a lifetime risk of endometrial cancer of 13 to 19 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/81-83\">",
"     81-83",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29530?source=see_link&amp;anchor=H462459902#H462459902\">",
"     \"PTEN hamartoma tumor syndrome, including Cowden syndrome\", section on 'Cowden syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=see_link&amp;anchor=H21#H21\">",
"     \"Characteristics of hereditary breast and ovarian cancer syndromes\", section on 'Cowden syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34869286\">",
"    <span class=\"h2\">",
"     Dietary factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no specific foods or beverages that increase the risk of endometrial carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/84\">",
"     84",
"    </a>",
"    ]. Studies have found an association between a high glycemic load diet and developing endometrial carcinoma, but this is mostly dependent upon obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alcohol use is associated with elevated estrogen levels, but it is uncertain whether alcohol consumption increases the risk of endometrial carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. A meta-analysis of 20 studies found no overall association between alcohol intake and endometrial carcinoma (RR 1.04, 95% CI 0.91-1.18), but subset analysis suggested that the type of beverage may be important, with an increase found for liquor intake, but not wine or beer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34868692\">",
"    <span class=\"h1\">",
"     ASSOCIATED FACTORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Nulliparity and infertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of endometrial carcinoma is inversely related to parity [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/58,89,90\">",
"     58,89,90",
"    </a>",
"    ]. Nulliparity and infertility do not appear to independent risk factors for endometrial carcinoma; instead, the association is probably with the high frequency of anovulatory cycles in infertile women.",
"   </p>",
"   <p>",
"    Data are inconsistent regarding whether ovulation induction for treatment of infertility is associated with an increased risk of endometrial carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/91-94\">",
"     91-94",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=see_link&amp;anchor=H26#H26\">",
"     \"Ovulation induction with clomiphene citrate\", section on 'Uterine cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34868833\">",
"    <span class=\"h2\">",
"     Diabetes and hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with diabetes mellitus and hypertension are at increased risk for endometrial carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/95-97\">",
"     95-97",
"    </a>",
"    ]. Comorbid factors, primarily obesity, account for much of this risk [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/50,98\">",
"     50,98",
"    </a>",
"    ], but some studies have found independent effects, as well [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/12,99-107\">",
"     12,99-107",
"    </a>",
"    ]. The risk of developing endometrial carcinoma is higher in type 2 than type 1 diabetics. Diets high in carbohydrates and associated hyperinsulinemia, insulin resistance, and elevated levels of insulin-like growth factors may play a role in endometrial proliferation and development of endometrial carcinoma; this is an area of active investigation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/85,100,108-110\">",
"     85,100,108-110",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H332741\">",
"    <span class=\"h2\">",
"     Breast cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history of breast cancer is a risk factor for development of endometrial carcinoma, clearly in women treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    , but also in part because both diseases share some common risk factors (eg, obesity, nulliparity).",
"   </p>",
"   <p>",
"    Some data suggest that women with breast cancer who develop endometrial cancer have an increased risk of having serous endometrial tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/111,112\">",
"     111,112",
"    </a>",
"    ]. As an example, in a case-control study of women with endometrial carcinoma, women with serous histology were more likely than those with endometrioid histology to have a personal history of breast cancer (19 versus 3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/112\">",
"     112",
"    </a>",
"    ]. The etiology of this association is unclear, since serous tumors are typically not estrogen-responsive in contrast with most breast cancers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     PROTECTIVE FACTORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Hormonal contraceptives",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of estrogen-progestin oral contraceptives (OCs) decreases the risk of endometrial carcinoma by 50 percent or higher [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/113-116\">",
"     113-116",
"    </a>",
"    ]. A systematic review of 19 observational studies found that use of OCs decreased the risk of endometrial cancer by approximately 50 percent and that the protective effect persisted for more 10 to 20 years after cessation of use [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/116\">",
"     116",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    The benefit of hormonal contraceptives is likely due to the progestin component, which suppresses endometrial proliferation. Studies have found that progestin-only contraceptives (eg, depot",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    , progestin implants, progestin-releasing intrauterine devices) provide endometrial protection against development of endometrial neoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/117-119\">",
"     117-119",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2830444\">",
"    <span class=\"h2\">",
"     Increasing age at last birth",
"    </span>",
"    &nbsp;&mdash;&nbsp;Childbearing at an older age, independent of parity and other factors, was associated with a decreased risk of endometrial carcinoma in a meta-analysis of individual data from 17 studies that included over 8000 cases of endometrial cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/120\">",
"     120",
"    </a>",
"    ]. A significant decrease in risk was found per five years of increasing age at last birth (odds ratio [OR] 0.87, 95% CI 0.85-0.90); rate of endometrial cancer in women with last birth at age &lt;25 years was used as the reference standard. As an example, women who last gave birth at age 35 to 39 years had a 32 percent decrease in risk (95% CI 0.61-0.76).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cigarette smoking is associated with a decreased risk of developing endometrial carcinoma in postmenopausal women; obviously, the major health risks associated with tobacco use far outweigh this benefit. The effect in premenopausal women is uncertain. In a meta-analysis of 34 prospective and case-control studies, the risk reduction in current and former smokers was significant after (RR 0.71, 95% CI 0.65-0.78), but not before (RR 1.06, 95% CI 0.88-1.28) menopause [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/121\">",
"     121",
"    </a>",
"    ]. The mechanism suggest for this effect is that smoking stimulates hepatic metabolism of estrogens, leading to a reduced incidence of endometrial abnormalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H333024\">",
"    <span class=\"h2\">",
"     Diet and exercise",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18452296\">",
"    <span class=\"h3\">",
"     Physical activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sedentary behavior contributes to the development of endometrial carcinoma. This was demonstrated by a meta-analysis of nine prospective studies found a significant decrease in the rate of endometrial carcinoma for women with high compared with low recreational (RR 0.73, 95% CI 0.58-0.93) and occupational (RR 0.75, 95% CI 0.68-0.83) physical activity [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/122\">",
"     122",
"    </a>",
"    ]. Several plausible biological mechanisms have been proposed to explain a possible association between high levels of physical activity and reduced cancer risk; these include decreased obesity and central adiposity, favorable changes in immune function and in endogenous sexual and metabolic hormone levels and growth factors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/123\">",
"     123",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3340233\">",
"    <span class=\"h3\">",
"     Coffee",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of comparative studies found a decreased risk of endometrial carcinoma proportional to the quantity of coffee consumed [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/124\">",
"     124",
"    </a>",
"    ]. The reductions in risk were: low-to-moderate coffee drinkers, RR 0.87 (95% CI, 0.78-0.97) and heavy coffee drinkers, RR 0.64 (95% CI, 0.48-0.86) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/125\">",
"     125",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3340245\">",
"    <span class=\"h3\">",
"     Tea",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of seven comparative studies reported a decreased risk of endometrial carcinoma proportional to the quantity of tea consumed; however, a subgroup analysis found that the decrease in endometrial carcinoma was statistically significant only with consumption of green tea (RR 0.8, 95% CI 0.7-0.9) but not with black tea (RR 0.8, 95% CI 0.5-1.3) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/126,127\">",
"     126,127",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H333032\">",
"    <span class=\"h3\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;No association has been found between vitamin D and endometrial carcinoma risk; some data suggest that use of calcium supplements may be protective [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/128\">",
"     128",
"    </a>",
"    ]. This issue requires further study.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     Aspirin",
"    </a>",
"    use appears to be associated with a decreased risk of endometrial cancer. In a meta-analysis of nine studies, this association was found only in obese women, defined as BMI &ge;30",
"    <span class=\"nowrap\">",
"     kg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    (OR 0.72, 95% CI 0.58-0.90) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/27/18874/abstract/129\">",
"     129",
"    </a>",
"    ]. No association was found between endometrial cancer and nonsteroidal anti-inflammatory drugs or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/12/23747?source=see_link\">",
"       \"Patient information: Uterine cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/55/19314?source=see_link\">",
"       \"Patient information: Endometrial cancer diagnosis and staging (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/12/8388?source=see_link\">",
"       \"Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the United States, as with other developed countries, uterine cancer is the most common gynecologic malignancy, with approximately 46,470 new cases and 8120 deaths from the disease in 2011. In developing countries, it is the second most common gynecologic malignancy (cervical cancer is more common), with an incidence of 5.9 per 100,000 and a mortality rate of 1.7 per 100,000. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women in the United States (US) have a 2.6 percent lifetime risk of developing uterine cancer. The average age of diagnosis of uterine cancer in the US is 61 years old. The majority of women with uterine cancer are diagnosed at an early stage (68 percent). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endometrioid (type I) endometrial carcinoma, the most common type of uterine cancer, typically has a favorable prognosis and is estrogen-responsive. Type II endometrial carcinomas (eg, serous, clear cell) may have a poor prognosis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The main risk factor for endometrioid endometrial carcinoma is an excess of endogenous or exogenous estrogen without adequate opposition by a progestin (eg, postmenopausal estrogen therapy without a progestin). Other risk factors include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"       tamoxifen",
"      </a>",
"      therapy, obesity, and nulliparity (",
"      <a class=\"graphic graphic_table graphicRef62089 \" href=\"UTD.htm?38/30/39403\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Estrogen-progestin or progestin-only contraceptives are protective factors for endometrial cancer. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Protective factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     World cancer research fund international. Cancer facts and figures: Endometrial cancer rates. file://www.wcrf.org/cancer_statistics/cancer_facts/endometrial_cancer_rates.php (Accessed on January 30, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/2\">",
"      Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/3\">",
"      Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/4\">",
"      Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.",
"     </a>",
"    </li>",
"    <li>",
"     file://seer.cancer.gov/statfacts/html/corp.html (Accessed on August 13, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/6\">",
"      Yap OW, Matthews RP. Racial and ethnic disparities in cancers of the uterine corpus. J Natl Med Assoc 2006; 98:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/7\">",
"      Allard JE, Maxwell GL. Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control 2009; 16:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/8\">",
"      Smotkin D, Nevadunsky NS, Harris K, et al. Histopathologic differences account for racial disparity in uterine cancer survival. Gynecol Oncol 2012; 127:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/9\">",
"      Elshaikh MA, Munkarah AR, Robbins JR, et al. The impact of race on outcomes of patients with early stage uterine endometrioid carcinoma. Gynecol Oncol 2013; 128:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/10\">",
"      Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983; 15:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/11\">",
"      Felix AS, Weissfeld JL, Stone RA, et al. Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control 2010; 21:1851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/12\">",
"      Brinton LA, Berman ML, Mortel R, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 1992; 167:1317.",
"     </a>",
"    </li>",
"    <li>",
"     Barakat RR, Park RC, Grigsby PW, et al. Corpus: Epithelial Tumors. In: Principles and Practice of Gynecologic Oncology, 2nd, Hoskins WH, Perez CA, Young RC (Eds), Lippincott-Raven Publishers, Philadelphia 1997. p.859.",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists Committee on Gynecologic Practice: Tamoxifen and endometrial Cancer. Committee opinion 232. ACOG 2000; Washington, DC.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/15\">",
"      Woodruff JD, Pickar JH. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group. Am J Obstet Gynecol 1994; 170:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/16\">",
"      Schiff I, Sela HK, Cramer D, et al. Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril 1982; 37:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/17\">",
"      Furness S, Roberts H, Marjoribanks J, et al. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev 2009; :CD000402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/18\">",
"      Henderson BE. The cancer question: an overview of recent epidemiologic and retrospective data. Am J Obstet Gynecol 1989; 161:1859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/19\">",
"      Persson I, Adami HO, Bergkvist L, et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ 1989; 298:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/20\">",
"      Beral V, Bull D, Reeves G, Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005; 365:1543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/21\">",
"      Chu J, Schweid AI, Weiss NS. Survival among women with endometrial cancer: a comparison of estrogen users and nonusers. Am J Obstet Gynecol 1982; 143:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/22\">",
"      Shapiro S, Kelly JP, Rosenberg L, et al. Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. N Engl J Med 1985; 313:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/23\">",
"      Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975; 293:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/24\">",
"      Voigt LF, Weiss NS, Chu J, et al. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991; 338:274.",
"     </a>",
"    </li>",
"    <li>",
"     Furness S, University of Manchester, Manchester England, personal communication regarding unpublished data from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial, 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/26\">",
"      Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 2004; 94:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/27\">",
"      Anderson GL, Judd HL, Kaunitz AM, et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 2003; 290:1739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/28\">",
"      Iqbal J, Ginsburg OM, Wijeratne TD, et al. Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. Cancer Treat Rev 2012; 38:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/29\">",
"      Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 2011; 378:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/30\">",
"      Riggs BL, Hartmann LC. Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice. N Engl J Med 2003; 348:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/31\">",
"      Mourits MJ, De Vries EG, Willemse PH, et al. Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 2001; 97:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/32\">",
"      Goldstein SR. The effect of SERMs on the endometrium. Ann N Y Acad Sci 2001; 949:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/33\">",
"      Chin J, Konje JC, Hickey M. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Cochrane Database Syst Rev 2009; :CD007245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/34\">",
"      American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG committee opinion. No. 336: Tamoxifen and uterine cancer. Obstet Gynecol 2006; 107:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/35\">",
"      Horn-Ross PL, John EM, Canchola AJ, et al. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 2003; 95:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/36\">",
"      Unfer V, Casini ML, Costabile L, et al. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril 2004; 82:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/37\">",
"      Bandera EV, Williams MG, Sima C, et al. Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control 2009; 20:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/38\">",
"      Ollberding NJ, Lim U, Wilkens LR, et al. Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study. J Natl Cancer Inst 2012; 104:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/39\">",
"      North American Menopause Society. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause 2011; 18:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/40\">",
"      Myung SK, Ju W, Choi HJ, et al. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG 2009; 116:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/41\">",
"      Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987; 45:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/42\">",
"      Zeleniuch-Jacquotte A, Akhmedkhanov A, Kato I, et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer 2001; 84:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/43\">",
"      Lukanova A, Lundin E, Micheli A, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 2004; 108:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/44\">",
"      Nyholm HC, Nielsen AL, Lyndrup J, et al. Plasma oestrogens in postmenopausal women with endometrial cancer. Br J Obstet Gynaecol 1993; 100:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/45\">",
"      Potischman N, Hoover RN, Brinton LA, et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996; 88:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/46\">",
"      Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/47\">",
"      Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gynecol 2005; 193:1640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/48\">",
"      Gredmark T, Kvint S, Havel G, Mattsson LA. Adipose tissue distribution in postmenopausal women with adenomatous hyperplasia of the endometrium. Gynecol Oncol 1999; 72:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/49\">",
"      Folsom AR, Kaye SA, Potter JD, Prineas RJ. Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study. Cancer Res 1989; 49:6828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/50\">",
"      Lindemann K, Vatten LJ, Ellstr&oslash;m-Engh M, Eskild A. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer 2008; 98:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/51\">",
"      Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 1996; 88:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/52\">",
"      Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet 2005; 366:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/53\">",
"      Everett E, Tamimi H, Greer B, et al. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 2003; 90:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/54\">",
"      Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009; 114:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/55\">",
"      Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/56\">",
"      Abu-Abid S, Szold A, Klausner J. Obesity and cancer. J Med 2002; 33:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/57\">",
"      Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst 2004; 96:1635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/58\">",
"      McPherson CP, Sellers TA, Potter JD, et al. Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study. Am J Epidemiol 1996; 143:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/59\">",
"      Xu WH, Xiang YB, Ruan ZX, et al. Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai. Int J Cancer 2004; 108:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/60\">",
"      La Vecchia C, Franceschi S, Decarli A, et al. Risk factors for endometrial cancer at different ages. J Natl Cancer Inst 1984; 73:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/61\">",
"      Karageorgi S, Hankinson SE, Kraft P, De Vivo I. Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004. Int J Cancer 2010; 126:208.",
"     </a>",
"    </li>",
"    <li>",
"     Berek JS, Hacker NF. Nonepithelial ovarian and fallopian tube cancers. In: Practical Gynecologic Oncology, 3rd, Berek JS, Hacker NF (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2000. p.539.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/63\">",
"      Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol 2003; 21:1180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/64\">",
"      Zanagnolo V, Pasinetti B, Sartori E. Clinical review of 63 cases of sex cord stromal tumors. Eur J Gynaecol Oncol 2004; 25:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/65\">",
"      Evans AT 3rd, Gaffey TA, Malkasian GD Jr, Annegers JF. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 1980; 55:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/66\">",
"      Soliman PT, Oh JC, Schmeler KM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 2005; 105:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/67\">",
"      Schmeler KM, Soliman PT, Sun CC, et al. Endometrial cancer in young, normal-weight women. Gynecol Oncol 2005; 99:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/68\">",
"      Lachance JA, Everett EN, Greer B, et al. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 2006; 101:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/69\">",
"      Ollikainen M, Abdel-Rahman WM, Moisio AL, et al. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome? J Clin Oncol 2005; 23:4609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/70\">",
"      Lucenteforte E, Talamini R, Montella M, et al. Family history of cancer and the risk of endometrial cancer. Eur J Cancer Prev 2009; 18:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/71\">",
"      Sandles LG, Shulman LP, Elias S, et al. Endometrial adenocarcinoma: genetic analysis suggesting heritable site-specific uterine cancer. Gynecol Oncol 1992; 47:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/72\">",
"      Lancaster JM, Powell CB, Kauff ND, et al. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 2007; 107:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/73\">",
"      Kwon JS, Scott JL, Gilks CB, et al. Testing women with endometrial cancer to detect Lynch syndrome. J Clin Oncol 2011; 29:2247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/74\">",
"      Thompson D, Easton DF, Breast Cancer Linkage Consortium. Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002; 94:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/75\">",
"      Beiner ME, Finch A, Rosen B, et al. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. Gynecol Oncol 2007; 104:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/76\">",
"      Biron-Shental T, Drucker L, Altaras M, et al. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma. Eur J Surg Oncol 2006; 32:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/77\">",
"      Hornreich G, Beller U, Lavie O, et al. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature. Gynecol Oncol 1999; 75:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/78\">",
"      Lavie O, Hornreich G, Ben Arie A, et al. BRCA1 germline mutations in women with uterine serous papillary carcinoma. Obstet Gynecol 2000; 96:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/79\">",
"      Goshen R, Chu W, Elit L, et al. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol 2000; 79:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/80\">",
"      Lavie O, Hornreich G, Ben-Arie A, et al. BRCA germline mutations in Jewish women with uterine serous papillary carcinoma. Gynecol Oncol 2004; 92:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/81\">",
"      Heald B, Mester J, Rybicki L, et al. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 2010; 139:1927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/82\">",
"      Riegert-Johnson DL, Gleeson FC, Roberts M, et al. Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract 2010; 8:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/83\">",
"      Pilarski R, Stephens JA, Noss R, et al. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet 2011; 48:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/84\">",
"      Bandera EV, Kushi LH, Moore DF, et al. Consumption of animal foods and endometrial cancer risk: a systematic literature review and meta-analysis. Cancer Causes Control 2007; 18:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/85\">",
"      Mulholland HG, Murray LJ, Cardwell CR, Cantwell MM. Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis. Br J Cancer 2008; 99:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/86\">",
"      Loerbroks A, Schouten LJ, Goldbohm RA, van den Brandt PA. Alcohol consumption, cigarette smoking, and endometrial cancer risk: results from the Netherlands Cohort Study. Cancer Causes Control 2007; 18:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/87\">",
"      Setiawan VW, Monroe KR, Goodman MT, et al. Alcohol consumption and endometrial cancer risk: the multiethnic cohort. Int J Cancer 2008; 122:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/88\">",
"      Sun Q, Xu L, Zhou B, et al. Alcohol consumption and the risk of endometrial cancer: a meta-analysis. Asia Pac J Clin Nutr 2011; 20:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/89\">",
"      L&oslash;chen ML, Lund E. Childbearing and mortality from cancer of the corpus uteri. Acta Obstet Gynecol Scand 1997; 76:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/90\">",
"      Parazzini F, Negri E, La Vecchia C, et al. Role of reproductive factors on the risk of endometrial cancer. Int J Cancer 1998; 76:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/91\">",
"      Parazzini F, Pelucchi C, Talamini R, et al. Use of fertility drugs and risk of endometrial cancer in an Italian case-control study. Eur J Cancer Prev 2010; 19:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/92\">",
"      Venn A, Watson L, Bruinsma F, et al. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999; 354:1586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/93\">",
"      Althuis MD, Moghissi KS, Westhoff CL, et al. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 2005; 161:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/94\">",
"      Lerner-Geva L, Rabinovici J, Lunenfeld B. Ovarian stimulation: is there a long-term risk for ovarian, breast and endometrial cancer? Womens Health (Lond Engl) 2010; 6:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/95\">",
"      Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 2003; 104:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/96\">",
"      Noto H, Osame K, Sasazuki T, Noda M. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complications 2010; 24:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/97\">",
"      Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007; 50:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/98\">",
"      Shoff SM, Newcomb PA. Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 1998; 148:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/99\">",
"      Soler M, Chatenoud L, Negri E, et al. Hypertension and hormone-related neoplasms in women. Hypertension 1999; 34:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/100\">",
"      Soliman PT, Wu D, Tortolero-Luna G, et al. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 2006; 106:2376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/101\">",
"      Zendehdel K, Nyr&eacute;n O, Ostenson CG, et al. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 2003; 95:1797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/102\">",
"      Weiderpass E, Persson I, Adami HO, et al. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/103\">",
"      La Vecchia C, Negri E, Franceschi S, et al. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994; 70:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/104\">",
"      Parazzini F, La Vecchia C, Negri E, et al. Diabetes and endometrial cancer: an Italian case-control study. Int J Cancer 1999; 81:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/105\">",
"      Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev 2007; 16:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/106\">",
"      Lucenteforte E, Bosetti C, Talamini R, et al. Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension. Br J Cancer 2007; 97:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/107\">",
"      Zhang Y, Liu Z, Yu X, et al. The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol Oncol 2010; 117:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/108\">",
"      Hale GE, Hughes CL, Cline JM. Endometrial cancer: hormonal factors, the perimenopausal \"window of risk,\" and isoflavones. J Clin Endocrinol Metab 2002; 87:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/109\">",
"      Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003; 35:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/110\">",
"      Session DR, Kalli KR, Tummon IS, et al. Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent. Gynecol Endocrinol 2003; 17:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/111\">",
"      Gehrig PA, Bae-Jump VL, Boggess JF, et al. Association between uterine serous carcinoma and breast cancer. Gynecol Oncol 2004; 94:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/112\">",
"      Liang SX, Pearl M, Liang S, et al. Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger. Int J Cancer 2011; 128:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/113\">",
"      Parslov M, Lidegaard O, Klintorp S, et al. Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol 2000; 182:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/114\">",
"      Tao MH, Xu WH, Zheng W, et al. Oral contraceptive and IUD use and endometrial cancer: a population-based case-control study in Shanghai, China. Int J Cancer 2006; 119:2142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/115\">",
"      Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004. Br J Cancer 2006; 95:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/116\">",
"      Mueck AO, Seeger H, Rabe T. Hormonal contraception and risk of endometrial cancer: a systematic review. Endocr Relat Cancer 2010; 17:R263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/117\">",
"      Cullins VE. Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate. J Reprod Med 1996; 41:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/118\">",
"      Kaunitz AM. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. J Reprod Med 1996; 41:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/119\">",
"      Montz FJ, Bristow RE, Bovicelli A, et al. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 2002; 186:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/120\">",
"      Setiawan VW, Pike MC, Karageorgi S, et al. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. Am J Epidemiol 2012; 176:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/121\">",
"      Zhou B, Yang L, Sun Q, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 2008; 121:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/122\">",
"      Moore SC, Gierach GL, Schatzkin A, Matthews CE. Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer 2010; 103:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/123\">",
"      Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002; 132:3456S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/124\">",
"      Bravi F, Scotti L, Bosetti C, et al. Coffee drinking and endometrial cancer risk: a metaanalysis of observational studies. Am J Obstet Gynecol 2009; 200:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/125\">",
"      Yu X, Bao Z, Zou J, Dong J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 2011; 11:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/126\">",
"      Tang NP, Li H, Qiu YL, et al. Tea consumption and risk of endometrial cancer: a metaanalysis. Am J Obstet Gynecol 2009; 201:605.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/127\">",
"      Butler LM, Wu AH. Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res 2011; 55:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/128\">",
"      McCullough ML, Bandera EV, Moore DF, Kushi LH. Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Prev Med 2008; 46:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/27/18874/abstract/129\">",
"      Neill AS, Nagle CM, Protani MM, et al. Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis. Int J Cancer 2013; 132:1146.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3249 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-BFB688DDA0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18874=[""].join("\n");
var outline_f18_27_18874=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H39\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1267292\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Excess estrogen exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H844020\">",
"      - Exogenous estrogen or estrogen agonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Unopposed estrogen therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H383248\">",
"      Estrogen-progestin postmenopausal hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H843977\">",
"      Tamoxifen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3338292\">",
"      Phytoestrogens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Endogenous estrogen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Chronic anovulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H843677\">",
"      Obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H844119\">",
"      Early menarche and late menopause",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H843444\">",
"      Estrogen-secreting tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34868595\">",
"      Age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Family history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Lynch syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - BRCA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8894433\">",
"      - Other genetic syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34869286\">",
"      Dietary factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34868692\">",
"      ASSOCIATED FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Nulliparity and infertility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34868833\">",
"      Diabetes and hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H332741\">",
"      Breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      PROTECTIVE FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Hormonal contraceptives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2830444\">",
"      Increasing age at last birth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Smoking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H333024\">",
"      Diet and exercise",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18452296\">",
"      - Physical activity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3340233\">",
"      - Coffee",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3340245\">",
"      - Tea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H333032\">",
"      - Other factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/3249\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/3249|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/0/2049\" title=\"figure 1\">",
"      Lynch syndrome cancer risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/3249|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/30/39403\" title=\"table 1\">",
"      Risk factors endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/36/12876\" title=\"table 2\">",
"      Causes anovulation oligoovulati",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/41/8855?source=related_link\">",
"      Approach to adjuvant treatment of endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=related_link\">",
"      Characteristics of hereditary breast and ovarian cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26535?source=related_link\">",
"      Classification and diagnosis of endometrial hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=related_link\">",
"      Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44585?source=related_link\">",
"      Clinical features, diagnosis, staging, and treatment of uterine carcinosarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18233?source=related_link\">",
"      Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/6/37992?source=related_link\">",
"      Endometrial carcinoma: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/7/36983?source=related_link\">",
"      Endometrial carcinoma: Histopathology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18810?source=related_link\">",
"      Endometrial carcinoma: Pretreatment evaluation, staging and surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/25/20887?source=related_link\">",
"      Initial approach to the premenopausal woman with abnormal uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/7/21624?source=related_link\">",
"      Overview of endometrial carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=related_link\">",
"      Ovulation induction with clomiphene citrate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29530?source=related_link\">",
"      PTEN hamartoma tumor syndrome, including Cowden syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/55/19314?source=related_link\">",
"      Patient information: Endometrial cancer diagnosis and staging (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/12/8388?source=related_link\">",
"      Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/12/23747?source=related_link\">",
"      Patient information: Uterine cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=related_link\">",
"      Postmenopausal hormone therapy: Benefits and risks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/53/16218?source=related_link\">",
"      Preparations for postmenopausal hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34202?source=related_link\">",
"      Risk-reducing bilateral salpingo-oophorectomy in women at high risk of epithelial ovarian and fallopian tubal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8778?source=related_link\">",
"      Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/50/6954?source=related_link\">",
"      Treatment of vaginal atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/3/22584?source=related_link\">",
"      Type II endometrial carcinomas (eg, serous, clear cell, mucinous)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/22/2408?source=related_link\">",
"      Uterine sarcoma: Classification, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_27_18875="Accuracy US ulcerative colitis";
var content_f18_27_18875=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sensitivity and specifity of ultrasonography in the detection of active ulcerative colitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Sensitivity, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Specifity, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        84",
"       </td>",
"       <td>",
"        88",
"       </td>",
"       <td>",
"        181 (57)",
"       </td>",
"       <td>",
"        Pera, A, et al 1988",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        91",
"       </td>",
"       <td>",
"        98",
"       </td>",
"       <td>",
"        440 (36)",
"       </td>",
"       <td>",
"        Limberg, B, et al 1994",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        89",
"       </td>",
"       <td>",
"        97",
"       </td>",
"       <td>",
"        142 (18)",
"       </td>",
"       <td>",
"        Limberg, B, et al 1989",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        66",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        227 (29)",
"       </td>",
"       <td>",
"        Hollerbach, S, et al 1998",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        89",
"       </td>",
"       <td>",
"        98",
"       </td>",
"       <td>",
"        (28)",
"       </td>",
"       <td>",
"        Hata, J, et al 1992",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NA: not available.",
"     <br>",
"      Parentheses indicate the number of patients with proven ulcerative colitis, if noted.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18875=[""].join("\n");
var outline_f18_27_18875=null;
var title_f18_27_18876="Drugs causing SCLE";
var content_f18_27_18876=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62265&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62265&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drugs implicated in the development of subacute cutaneous lupus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Antifungals (griseofulvin, terbinafine)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diuretics (hydrochlorothiazide, spironolactone)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calcium channel blockers (diltiazem, nifedipine, nitrendipine, verapamil)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antihistamines (cinnarazine/triethyperazinec)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chemotherapeutics (docetazel, paclitaxel, anastrazole)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beta blockers (acebutolol, oxyprenolol)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ACE inhibitors (captopril, cilazapril)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antacids (omeprazole, lansoprazole, ranitidine)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anticonvulsants (phenytoin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antimalarials (hydroxychloroquine)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immune modulators (etanercept, infliximab, adalimumab, interferon-&alpha;)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lipid lowering agents (pravastatin, simvastatin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        NSAIDS (naproxen, piroxicam)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfonylureas (glyburide)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antiarrhythmics (procainamide)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Others (D-penicillamine, buproprion, leflunamide, ticlopidine, leuprorelin, tamoxifen)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Sontheimer, RD, Henderson, CL, Grau, RH. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res 2009; 301:65.",
"       </li>",
"       <li>",
"        Vedove, CD, Del Giglio, M, Schena, D, Girolomoni, G. Drug-induced lupus erythematosus. Arch Dermatol Res 2009; 301:99.",
"       </li>",
"       <li>",
"        Sheth, N, Greenblatt, D, Patel, S, Acland, K. Adalimumab-induced cutaneous lupus. Clin Exp Dermatol 2007; 32:593.",
"       </li>",
"       <li>",
"        Adachi, A, Horikawa, T. Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody. J Dermatol 2007; 34:473.",
"       </li>",
"       <li>",
"        Trancart, M, Cavailhes, A, Balme, B, Skowron, F. Anastrozole-induced subacute cutaneous lupus erythematosus. Br J Dermatol 2008; 158:628.",
"       </li>",
"       <li>",
"        Wiechert, A, Tuting, T, Bieber, T, et al. Subacute cutaneous lupus erythematosus in a leuprorelin-treated patient with prostate carcinoma. Br J Dermatol 2008; 159:231.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18876=[""].join("\n");
var outline_f18_27_18876=null;
var title_f18_27_18877="Antibiotic dosing babesia";
var content_f18_27_18877=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78563&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78563&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of human babesiosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Organism",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adults",
"       </td>",
"       <td class=\"subtitle1\">",
"        Children",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        <em>",
"         B. microti",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"6\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"3\">",
"        Mild*",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Atovaquone",
"         </strong>",
"        </p>",
"        <p>",
"         750 mg orally every 12 hrs",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Atovaquone",
"         </strong>",
"        </p>",
"        <p>",
"         20 mg/kg orally every 12 hrs",
"        </p>",
"        <p>",
"         (maximum 750 mg/dose)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        PLUS",
"       </td>",
"       <td class=\"indent2\">",
"        PLUS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Azithromycin",
"         </strong>",
"        </p>",
"        <p>",
"         500 mg/d orally on day 1;",
"        </p>",
"        <p>",
"         250 mg/d orally from day 2 on",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Azithromycin",
"         </strong>",
"        </p>",
"        <p>",
"         10 mg/kg/d orally on day 1",
"        </p>",
"        <p>",
"         (maximum 500 mg/dose);",
"        </p>",
"        <p>",
"         5 mg/kg/d orally from day 2 on",
"        </p>",
"        <p>",
"         (maximum 250 mg/dose)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Severe&bull;",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Clindamycin",
"         </strong>",
"        </p>",
"        <p>",
"         300-600 mg intravenously every 6 hrs",
"        </p>",
"        <p>",
"         OR",
"        </p>",
"        <p>",
"         600 mg orally every 8 hrs",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Clindamycin",
"         </strong>",
"        </p>",
"        <p>",
"         7-10 mg/kg intravenously every 6-8 hrs",
"        </p>",
"        <p>",
"         (maximum 600 mg/dose)",
"        </p>",
"        <p>",
"         OR",
"        </p>",
"        <p>",
"         7-10 mg/kg orally every 6-8 hrs",
"        </p>",
"        <p>",
"         (maximum 600 mg/dose)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        PLUS",
"       </td>",
"       <td class=\"indent2\">",
"        PLUS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Quinine",
"         </strong>",
"        </p>",
"        <p>",
"         650 mg orally every 6-8 hrs",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Quinine",
"         </strong>",
"        </p>",
"        <p>",
"         8 mg/kg orally every 8 hrs",
"        </p>",
"        <p>",
"         (maximum 650 mg/dose)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        <em>",
"         B. divergens",
"        </em>",
"        &Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"5\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        <strong>",
"         Immediate complete RBC exchange transfusion",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         Immediate complete RBC exchange transfusion",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        PLUS",
"       </td>",
"       <td class=\"indent2\">",
"        PLUS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Clindamycin",
"         </strong>",
"        </p>",
"        <p>",
"         600 mg intravenously every 6-8 hrs",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Clindamycin",
"         </strong>",
"        </p>",
"        <p>",
"         7-10 mg/kg intravenously every 6-8 hrs",
"        </p>",
"        <p>",
"         (maximum 600 mg/dose)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        PLUS",
"       </td>",
"       <td class=\"indent2\">",
"        PLUS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Quinine",
"         </strong>",
"        </p>",
"        <p>",
"         650 mg orally every 8 hrs",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Quinine",
"         </strong>",
"        </p>",
"        <p>",
"         8 mg/kg orally every 8 hrs",
"        </p>",
"        <p>",
"         (maximum 650 mg/dose)",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Treatment for 7 to 10 days.",
"     <br>",
"      &bull; Treatment for 7 to 10 days, but duration may vary.&nbsp;High doses of azithromycin (600 to 1000 mg) combined with atovaquone (750 mg) may be used for the treatment of immunocompromised patients. Partial or complete exchange transfusion is recommended in case of high parasitemia (&gt;10 percent), severe anemia (hemoglobin &lt;10 g/dL), pulmonary, renal or hepatic failure. In asplenic individuals and in immunocompromised patients, therapy should be &gt;6 weeks, including 2 weeks after parasites are no longer detected on blood smear.",
"      <br>",
"       &Delta; Treatment for 7 to 10 days, but duration may vary.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18877=[""].join("\n");
var outline_f18_27_18877=null;
var title_f18_27_18878="Evaluation of dyspnea";
var content_f18_27_18878=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F67095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F67095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Approach to the patient with dyspnea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 394px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An efficient stepwise method of determining the cause of chronic dyspnea using pulmonary function tests.",
"    <div class=\"footnotes\">",
"     WNL: within normal limits; VC: vital capacity; FEV",
"     <sub>",
"      1",
"     </sub>",
"     : forced expiratory volume in one second; TLC: total lung capacity; DLCO: diffusing capacity; Pimax: peak inspiratory pressure.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_27_18878=[""].join("\n");
var outline_f18_27_18878=null;
var title_f18_27_18879="Contents: Pediatric oncology";
var content_f18_27_18879=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?17/55/18302\">",
"       Pediatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric oncology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric oncology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Bone and soft tissue tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/51/37690\">",
"           Bone sarcomas: Preoperative evaluation, histologic classification, and principles of surgical management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/53/35673\">",
"           Bone tumors: Diagnosis and biopsy techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/8/39050\">",
"           Chemotherapy and radiation therapy in the management of osteosarcoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/56/37769\">",
"           Clinical presentation, staging, and prognostic factors of the Ewing sarcoma family of tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/37/7770\">",
"           Epidemiology, pathology, and molecular genetics of the Ewing sarcoma family of tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/1/28694\">",
"           Intradural nerve sheath tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/50/32551\">",
"           Langerhans cell histiocytosis (eosinophilic granuloma) of bone in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/22/20842\">",
"           Osteosarcoma: Epidemiology, pathogenesis, clinical presentation, diagnosis, and histology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/47/25338\">",
"           Radiation therapy for Ewing sarcoma family of tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/63/16377\">",
"           Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Epidemiology, pathology, and molecular pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/50/14122\">",
"           Treatment of the Ewing sarcoma family of tumors",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cancer survivors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/16/38151\">",
"           ACTH deficiency in survivors of childhood cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/7/7286\">",
"           Endocrine surveillance in childhood cancer survivors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/14/7401\">",
"           Pubertal development and gonadal function in survivors of childhood cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Central nervous system tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/5/22618\">",
"           Clinical features, diagnosis, and management of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/56/13192\">",
"           Clinical manifestations and diagnosis of central nervous system tumors in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/15/15609\">",
"           Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/22/37226\">",
"           Complications of cranial irradiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/60/24520\">",
"           Craniopharyngioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/1/2071\">",
"           Diagnosis and classification of low-grade gliomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/50/1832\">",
"           Diffuse pontine glioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/51/15161\">",
"           Ependymoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/21/38230\">",
"           Epidemiology of central nervous system tumors in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/15/14585\">",
"           Epidemiology, pathogenesis, and pathology of neuroblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/0/2058\">",
"           Epidemiology, treatment, and prognosis of medulloblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/40/40585\">",
"           Focal brainstem glioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/43/695\">",
"           Hemangioblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/23/41332\">",
"           Histopathology and molecular pathogenesis of medulloblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/33/44568\">",
"           Management of low-grade glioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/21/14678\">",
"           Molecular biology and pathogenesis of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/16/39176\">",
"           Optic pathway glioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/26/13736\">",
"           Overview of the management of central nervous system tumors in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/25/30105\">",
"           Pediatric intracranial germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/20/16714\">",
"           Pineal gland masses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/42/8874\">",
"           Risk factors for brain tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/30/17894\">",
"           Sacrococcygeal germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/9/18586\">",
"           Treatment and prognosis of neuroblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/6/35946\">",
"           Uncommon brain tumors",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Complications of cancer and its therapy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/27/4538\">",
"           Bone problems in childhood cancer patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/46/41706\">",
"           Cardiotoxicity of anthracycline-like chemotherapy agents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/12/40138\">",
"           Cardiotoxicity of nonanthracycline cancer chemotherapy agents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/33/15898\">",
"           Fever in children with chemotherapy-induced neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/55/31607\">",
"           Growth failure after childhood cancer: Role of growth hormone deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/19/39223\">",
"           Growth failure after childhood cancer: Role of hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/37/30296\">",
"           Immunizations in patients with cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/25/28058\">",
"           Pediatric palliative care",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/18/39210\">",
"           Prevention and treatment of chemotherapy-induced nausea and vomiting",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/55/33658\">",
"           Therapeutic use and toxicity of high-dose methotrexate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/12/41160\">",
"           Thromboembolism in children with cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/1/19481\">",
"           Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/20/3402\">",
"           Tumor lysis syndrome: Prevention and treatment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endocrine tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/14/38121\">",
"           Pheochromocytoma in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/51/40762\">",
"           Treatment of adrenocortical carcinoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Evaluation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/47/5882\">",
"           Clinical assessment of the child with suspected cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/15/44280\">",
"           Evaluation and management of pain in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genetic diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/38/34410\">",
"           Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/36/32328\">",
"           Tuberous sclerosis complex: Management",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genitourinary tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/37/5721\">",
"           Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/12/2249\">",
"           Presentation, diagnosis, and staging of Wilms tumor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/50/9002\">",
"           Treatment and prognosis of Wilms tumor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/24/33162\">",
"           Treatment of malignant germ cell tumors of the ovary",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hematologic malignancies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/53/21338\">",
"           Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/56/35720\">",
"           Epidemiology, clinical manifestations, pathologic features, and diagnosis of Burkitt lymphoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/6/32874\">",
"           Overview of Hodgkin lymphoma in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/44/40649\">",
"           Overview of the outcome of acute lymphoblastic leukemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/58/4009\">",
"           Overview of the presentation and classification of acute lymphoblastic leukemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/6/31850\">",
"           Overview of the treatment of acute lymphoblastic leukemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/53/32599\">",
"           Primary lymphoma of bone",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/55/37753\">",
"           Risk group stratification and prognosis for acute lymphoblastic leukemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/23/36217\">",
"           Treatment of Burkitt leukemia/lymphoma in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/45/34520\">",
"           Treatment of nodular lymphocyte-predominant Hodgkin lymphoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neuroblastoma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/15/15609\">",
"           Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/15/14585\">",
"           Epidemiology, pathogenesis, and pathology of neuroblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/9/18586\">",
"           Treatment and prognosis of neuroblastoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Treatment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/10/41129\">",
"           Emergencies in pediatric cancer patients",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tumors of the eye and orbit",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/24/27018\">",
"           Overview of retinoblastoma",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-997EA282E3-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f18_27_18879=[""].join("\n");
var outline_f18_27_18879=null;
